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There is evidence that the measurement of patient-reported outcomes (PROs) during or 
before clinical encounters can improve patient outcomes. Individualised PRO measures 
(PROMs) are known to empower patients by incorporating their values, goals and 
preferences in clinical encounters. There is no validated, individualised, generic, PRO 
assessment tool for paediatric populations available. The objectives of the PhD were to 1) 
assess evidence on the effectiveness of the use of PROMs in clinical practice; 2) adapt and 
validate an adult individualised health-related quality of life (HRQOL) measure, Measure 
Yourself Medical Outcome Profile (MYMOP), for clinical use for children 7-11 years old; 
and 3) conduct a pilot study to evaluate the administration methods and feasibility of 
application of the new tool in a clinical setting.  
A systematic search was performed using a controlled vocabulary relating to the terms, 
clinical care setting, and patient-reported outcomes. An English-language study was included 
if it was a randomised controlled trial (RCT) with a PROM as an intervention in a patient 
population. Included studies were synthesised and their methodologic quality appraised using 
the Cochrane Risk of Bias tool. Twenty-two RCTs reporting on 25 comparisons of efficacy 
were included in the systematic review. Overall, positive findings in favour of the PROM 
intervention were reported on 21 occasions, but these effects were robust in only five cases, 
(i.e. were statistically significant and adequately powered). While combined evidence 
supports the use of PROMS in clinical practice, standards of reporting remain inadequate, 
with many published RCTs failing to pre-specify primary and secondary outcomes or 
adequately power their comparisons for clinically meaningful differences.  
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Adaptation of the MYMOP was achieved via the following four iterative steps: 1. an online 
survey of local paediatricians and paediatric trainees; 2. a focus group discussion with 
paediatricians; 3. an online survey with paediatric research experts and paediatricians across 
Australia; and 4. interviews with child-parent pairs in a clinical setting. Four paediatricians 
completed the first survey, five paediatricians participated in the focus group, and four 
paediatric HRQOL research experts completed the second survey. Twenty-five children (17 
from general medicine, and eight from a diabetes/endocrine clinic) aged 7-11 years 
completed the draft paediatric MYMOP (P-MYMOP) with parental help in a few cases and 
were interviewed afterwards.  Analysis of the interview data were performed according to 
Braun and Clarke’s (2006) guidelines on thematic analysis. An inductive, interpretative 
approach with realist epistemology was used. Data from the completed P-MYMOP and 
interviews demonstrated that the majority of participating children were able to identify their 
own problems and activity limitations, and all children in the study understood the 7-point 
faces-scale. Most parents and children perceived that the P-MYMOP would be useful to 
complete before clinic appointments and enthusiastically welcomed the opportunity for their 
children to have a voice in a setting where they are often passive recipients of care.  
Finally, a feasibility pilot study was performed in the Department of General Medicine 
Outpatient clinic, Women’s and Children’s Hospital in Adelaide. The participants of this 
study were clinic nurses and doctors working in the Department of General Medicine. The 
study ran for 19 days with 11 doctors and eight clinic nurses taking part. The newly content-
validated Paediatric MYMOP (P-MYMOP) was distributed to children 7-11 years old, who 
were invited to take their completed form to their doctors to discuss it. Both the participating 
nurses and doctors found the P-MYMOP to be feasible to use in the clinic and distribution of 
the tool and its integration into the clinical consultation did not appear to compromise nurses’ 
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or doctors’ time management. In addition, interviews with clinicians suggest this tool would 
be a welcome addition to care of their paediatric patients.   
The P-MYMOP is the first content-validated generic individualised HRQOL measure for 
children. The wording, layout, and scale of the P-MYMOP have been successfully adapted 
for children 7-11 years old. Given validation is an iterative process, further research to assess 
its reliability and construct validity is needed but results thus far suggest that this tool would 
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CHAPTER 1 THESIS INTRODUCTION 
1.1 Project Title  
Adaptation and Validation of an Individualised Paediatric Health-Related Quality of Life 
Measure (Paediatric Measure Yourself Medical Outcome Profile) and its Evaluation in a 
Clinical Setting  
1.2 Background  
Routine assessment of patient-reported outcomes (PROs) is likely to improve patient 
outcomes [1]. Individualised patient-reported outcome measures are known to empower 
patients by including their values, goals and preferences in clinical encounters [2]. However, 
there is no validated individualised generic paediatric health-related quality of life (HRQOL) 
tool available [3-7].  
1.3 Objectives 
The objectives of the PhD project were to: 1) assess the evidence on the effectiveness of the 
use of patient-reported outcome measure (PROMs) in clinical practice; 2) initiate adaptation 
and validation of an adult individualised HRQOL measure for clinical use for children 7-11 
years old; and 3) conduct a pilot study to evaluate the administration methods and feasibility 
of application of the new tool in a clinical setting (Figure 1). These objectives were achieved 
by performing a systematic review of all publications of randomised controlled trials (RCTs) 
examining the use of PROMs as an intervention to improve patient outcomes, undertaking 
several iterations to adapt the contents of Measure Yourself Medical Outcome Profile 
(MYMOP) to make it suitable for children 7-11 years old, and performing a pilot feasibility 
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study to test the application of Paediatric MYMOP (P-MYMOP) in a general medicine 
outpatient clinic at a tertiary-care hospital. Figure 1 shows the methods with which each 
objective of the thesis was achieved. 













Objective 1. Assess the 
evidence on the effectiveness 
of the use of PROMs in clinical 
practice 
 
A systematic review of 
randomised controlled trials 





of the MYMOP tool for 7-11 
year old children 
 
Objective 2. Adapt and validate 
an adult individualised HRQL 
measure for clinical use in 
children 7-11 years old 
Feasibility of using the 
Paediatric MYMOP at the 
Women's and Children's 
Hospital Paediatric Outpatient 
Clinic 
Objective 3. Conduct a pilot 
study to evaluate the 
administration methods and 
feasibility of application of the 
new tool in clinical setting 
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1.4 Thesis Structure  
Chapter 2 provides necessary background to the research, considering patient-reported 
outcomes and the methods with which they are typically assessed. Chapter 2 also describes 
different types of measurement tools, measurement properties, and paediatric PROMs, and 
finally, focuses on individualised PROMs, identifying the absence of a validated generic 
individualised PROM for children.  
Chapter 3 is a summary of a preliminary literature search on the evidence of effectiveness of 
routine measurement of patient-reported outcomes. Based on this search, a systematic review 
protocol was prepared on the topic.  
Chapter 4 is a systematic review of RCTs on the effectiveness of PROM use in routine 
clinical care. The systematic review has been accepted for publication by the Quality of Life 
Research Journal. Chapter 4 also has a subsection (4.9) that elaborates on the methodological 
issues identified in the included RCTs. This subsection was not submitted for publication due 
to word count limitation.  
Chapter 5 is a primary study on the adaptation/validation of an adult individualised PROM, 
MYMOP, for children 7-11 years old.  
Chapter 6 presents the rationale for the feasibility study.  
Chapter 7 presents results of a feasibility study on the use of the new content-validated 
individualised measure in a busy outpatient clinic of a tertiary-care hospital.  
Chapter 8 provides a discussion of the thesis as a whole.  
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This thesis is presented in the form of ‘Thesis by publication.’ Chapters 4, 5, and 7 are 
written as manuscripts for peer reviewed journals. References and Appendices are provided 
at the end of each Chapter.   
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CHAPTER 2. THESIS BACKGROUND  
2  
2.1 Patient-Reported Outcomes  
The process of healthcare delivery involves the collection of much data, but only a small 
subset of this is reported by individual patients. Collected data, therefore, can be divided into 
two broad categories: a) data on objective measures and b) data on patient-reported outcomes 
(PROs). Examples of objective measures include mortality rates, lab reports, x-rays, and 
results from other imaging techniques etc. Alternatively, PROs are the direct reports of things 
such as patients’ feelings, satisfaction with care, or quality of life (QOL), independent of 
input from healthcare providers and/or anyone else [1-3].  
Objective measures have been the primary focus in healthcare for decades, but with the 
paradigm shift of the provision of healthcare towards patient-centred care, PROs are 
promoted to provide additional experiential understanding and insight into patients’ health. It 
has become clear that while clinical indicators provide only a partial view of the effect of an 
intervention on patients’ health, PROs typically matter most to patients with regard to their 
health and well-being [4-7]. Common aspects of PROs include: patient symptoms, health 
status, some aspects of functional status, quality of life, and health-related quality of life 
(HRQOL). 
The inclusion of PROs in research and clinical consultations is encouraged globally by 
health-governing authorities such as the National Health Services in the UK [8], the Food and 
Drug Administration in the United States [1,9], the Canadian Institute of Health Information 
in Canada [10], and in Australia by the Australian Pharmaceutical Advisory Committee of 
Australia [11]. The National Health Service, which provides healthcare to UK citizens, 
officially supports the use of PRO assessment, particularly for hip and knee replacements, 
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hernia and varicose vein surgeries [8]. The Food and Drug Administration has made it 
obligatory to collect data on PROs for all RCTs on drug labelling claims [1]. The Australian 
Pharmaceutical Benefits Advisory Committee recognises the assessment of QOL as essential 
in circumstances where improvement in QOL is the main aim of treatment or where a 
proposed medicine might cause deterioration to patients’ health [11]. 
2.1.1 Health-related Quality of Life (HRQOL), an example of  
Patient-Reported Outcomes  
In the current era of evidence-based patient-centred medicine, there is increasing advocacy 
for assessing HRQOL in clinical trials, physician offices, and for resource allocation (where 
HRQOL is often thought to reflect patients’/clients’ satisfaction with a healthcare 
intervention) [12-14]. HRQOL is a multidimensional, subjective patient-reported outcome, 
capturing an individual’s perception of personal well-being [15].  
It is important to define HRQOL comprehensively and to distinguish between QOL and 
HRQOL. The former is a broad term, defined by the World Health Organisation as  
individuals’ perception of their position in life in the context of the culture and value 
systems in which they live and in relation to their goals, expectations, standards and 
concerns. It is a broad ranging concept affected in a complex way by the persons’ 
physical health, psychological state, level of independence, social relationships and 
their relationship to salient features of their environment’ [16, p. 263s].  
HRQOL is a comparatively narrower concept and it includes QOL directly associated only 
with health-related issues. There are numerous comprehensive definitions of HRQOL in the 
literature. Leidy et al. [17, p. 114] stated that HRQOL is ‘an individual’s subjective 
perception of the impact of their health status, including disease and treatment, on 
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physiological, psychological, and social functioning.’ This definition is based on the World 
Health Organization’s definition of health (WHO constitution of 1948) as ‘a state of complete 
physical, mental, and social well-being and not merely the absence of disease or infirmity.’ 
Spilker defined the concept as ‘the functional effect of an illness and its consequent therapy 
upon a patient, as perceived by the patient [18, pp. 11-35]. This definition is clearly based on 
the underlying idea that HRQOL is a subjective construct.  
A definition reported for QOL that can be modified for HRQOL is ‘the extent to which our 
hopes and ambitions are matched by experience [19].’ For HRQOL this definition could be 
altered to state ‘the extent to which our hopes and ambitions regarding health-related issues 
are matched by experience.’ Currently, there is no consensus on the definition/dimensions of 
HRQOL. Given the variation in the field, it is important that the developers of HRQOL 
measures precisely define what they mean by HRQOL so that its implications in a clinical 
setting can be understood. As a recent attempt to promote standardisation within the field, 
The Dictionary of Quality of Life and Health Outcomes Measurement has defined HRQOL as 
‘a measure of the value assigned to duration of life as modified by impairments, functional 
states, perceptions and opportunities, as influenced by disease, injury, treatment, and policy 
[2, pp. 1325-1326],’ and this is the definition adopted within this thesis.  
2.1.2 The value of measuring Patient-Reported Outcomes (specifically with HRQOL) 
The continued advancements in healthcare has seen populations living longer and an increase 
in the prevalence of chronic diseases [20-21]. Clinical objective outcomes are often not 
sufficient for patient management of chronic conditions, in part as a condition of the same 
severity may affect individuals differently. For example, the same (clinically defined) degree 
of diabetes might affect two patients differently with one remaining active in many areas of 
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life and the other experiencing depression and withdrawal from many daily activities. Hence 
HRQOL measurement is important in order to assess the impact of chronic diseases in 
populations [14,20,21] and thus help to target appropriate help where it is needed most.  
HRQOL measurement is also crucially important in patients receiving end-of-life care, as, in 
the absence of a complete cure, the only available option is supportive treatment with the 
hope of betterment in patients’ HRQOL. It is particularly beneficial to provide symptomatic 
treatment to terminally ill patients, as symptom relief is usually associated with better 
physical, mental and psychological functioning [22-25]. Additionally, in situations where 
alternative interventions are comparably effective, their effect on patients’ HRQOL and 
hence patients’ satisfaction and preferences, might help to differentiate the most appropriate 
patient-specific choice of treatment.  
Beside the above-mentioned clinical uses, HRQOL measurement is also needed for resource 
allocation and policy making [26,27]. With a limited healthcare budget, different areas of 
healthcare compete for allocation of resources and decision-makers need some comparable 
index, which is commonly provided by degrees of change in HRQOL in the form of Quality 
Adjusted Life Years (QALYs). A QALY is a single index number that is derived by 
combining quantity and QOL.  
2.2 The assessment of Patient-Reported Outcomes 
The purpose of PROs is to elicit a patient’s voice and involve them in clinical decisions 
pertaining to their care. The PROs are assessed by questionnaires that are specifically 
developed for this purpose. Ideally a PRO measurement tool should be patient-centred and 
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meet the basic requirement of PRO measurement, that is, providing a voice for individual 
patients.  
PRO measurement tools or PROMs can be classified in a number of ways. One classification 
is based on the type of issues assessed in questionnaire: disease-specific and generic 
measures [27,28]. Disease-specific PROMs are designed for use by people with a particular 
health issue whereas generic PROMs are appropriate for anyone to report their health issues. 
Disease-specific measures focus on a particular disease or disorder and address the most 
relevant issues for a target population. Thus, these measures are specific and potentially more 
sensitive in identifying small differences for that population [25]. Generic measures, on the 
other hand, capture aspects that are broader and applicable to all types of individuals 
regardless of their illness or disorder. These measures are therefore useful for comparisons 
between healthy and diseased populations.  
PROMs can also be divided into standardised and individualised questionnaires [25]. 
Standardised questionnaires have a predetermined set of questions (e.g. Short Fort 36 [29]) 
that are applied across population groups [29,30], whereas individualised questionnaires do 
not have predetermined domains [28,31]. Instead, individualised measures examine patients’ 
own definitions of HRQOL and challenge the prevailing approach of pre-defined PROs. Both 
standardised and individualised questionnaires can be disease-specific or generic.  
Each approach to PRO measurement has strengths and weaknesses. While standardised 
measures of PRO are suitable for comparisons between different populations and are useful 
for economic evaluation, these tools have been criticised for their lack of patient centeredness 
and the extent to which they truly represent patient values [28,31-36]. For instance, 
standardised measures may not represent all health domains valued by each individual patient 
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[31-36]. By asking the same questions for each individual, the standardised tools limit the 
assessment of personal health and treatment experiences of individual patients [37] to their 
predetermined fixed questions. In fact, several studies have found predetermined sets of 
questions on standardised measures to be irrelevant to particular patients [28,31-37].    
Individualised PROMs (also known as patient-generated measures) also have some 
weaknesses. These tools cannot be used to compare different groups or for economic 
evaluations [28,31,33]. However, individualised PROMs are of particular importance to 
patients as they reflect their personal values that may not be measured by standardised tools. 
These instruments are designed to capture the true meaning of PROs by essentially measuring 
what an individual patient determines to be important about their health and well-being. 
Individualised measures are superior in picking up individual patient needs, values, and 
goals, and are reported in the literature to identify issues missed by standardised tools [37]. A 
recently published primary study by Mayo et al. compared the use of the Patient Generated 
Index, an individualised measure, to fully standardised generic and disease-specific measures 
across four populations with disease [38]. The participating populations identified a number 
of health-related issues that were not presented in the standardised tools [38]. 
The decision to focus on the use of individualised PROMs to support the provision of patient-
centred care for children is based on the following lines of reasoning:  
 There is evidence that PROMs support the provision of patient-centred care. 
 The cited comparative research indicates that individualised measures may provide 
advantages over standardised measures when used in clinical practice. 
 Individualised measures have been comparatively under-researched compared to 
standardised tools, especially in children.  
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2.3 Validation of PROMs  
Regardless of the type of PROM used for the assessment of PROs, accurate and consistent 
measurement of PROs result only from PROMs that are developed systematically and 
possess sound psychometric properties. Without the required measurement properties, an 
instrument might not measure what it is supposed to measure, not do so consistently under 
various circumstances, or might not capture changes in patients’ health when they occur.  
Important measurement properties identified in the literature include: content validity, 
construct validity, criterion validity, reliability, and responsiveness [39,40]. International 
consensus via a Delphi study has been achieved on the definitions of these measurement 
properties and are thus adopted in this thesis [40]. According to this Delphi study ‘content 
validity is the degree to which contents of a health-related PRO instrument is an adequate 
reflection of the construct to be measured,’ ‘construct validity is the degree to which scores of 
a health-related PRO instrument are consistent with hypotheses based on the assumption that 
the PRO instrument validly measures the construct to be measured,’ and ‘criterion validity is 
the degree to which the scores of a health-related PRO instrument are an adequate reflection 
of a ‘gold standard [40].’’ Reliability is defined as ‘the degree to which the measurement is 
free from measurement error,’ and ‘responsiveness is the ability of a health-related PRO 
instrument to detect change over time [40]’.  
Key measurement properties for any measurement instrument depend upon the purpose of the 
instrument [39-42]. PRO measures are usually constructed for three purposes: evaluation, 
discrimination, or prediction. The evaluative instruments are those applied to patients to 
assess their health in a longitudinal fashion. As a result, while content validity and construct 
validity are crucial, instruments must also have evidence of responsiveness and test/retest 
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reliability [22]. Discriminative instruments are applied, for example, to differentiate healthy 
patients from those with a disease [22,42]. These measurements are conducted at a single 
point in time. Important psychometric properties for discriminative tools include content 
validity, cross-sectional construct validity and internal consistency reliability [42,43]. 
Predictive measures are used for prediction of future health, survival [44,45], resource 
allocation, and health policy [46], and need to have content and construct validity as a 
minimum [44-46].  
2.4 Paediatric Patient-Reported Outcomes and Patient-Reported 
Outcome Measures  
Further to the psychometric properties discussed above, there are additional requirements for 
the valid self-assessment of paediatric PROs. These include requirements specific to children 
and the general characteristics of measurement tools [47]. Some of the challenges identified 
in the literature include: accounting for the variable cognitive maturity of children, and 
availability of a valid and reliable questionnaire designed with consideration of the 
developmental stage and cognitive skills of the target population [47-49]. 
The challenge of the assessment of PROs in children is implicit in their very definition, in 
that reports of outcomes/symptoms must come directly from patients without any input from 
family or healthcare providers [1]. For outcomes to be consistent with this definition, they 
must be self-reported by patients, which is not possible for children lacking necessary verbal 
capacity (e.g. infants, young children, and/or children with developmental delays). 
Accordingly, proxy assessment is the only option for these children, though patient self-
reporting is encouraged whenever possible among children with verbal capacity. 
Nevertheless, in today’s paediatric PRO assessment, proxy measurement is considered as an 
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evaluation of direct patient outcomes and is often discussed alongside PRO measurement for 
children [50,51]. Alongside discussion on other challenges in the measurement of paediatric 
PROs, the following paragraphs outline why proxy measurement is not synonymous with the 
self-assessment of paediatric PROs.  
There are other reasons why the application of PROMs to children in the context of clinical 
care and research is unsatisfactory [48]. Often, adult PROMs are applied to children without 
consideration of their suitability to this population [48,51-53]. In the healthcare system there 
can be a tendency to see children simply as small human beings who are only different in 
terms of their size, with no unique or special needs. The reality, however, is that children are 
a special population group, with unique needs and must be treated as such.  
Furthermore, existing adult PROMs may not be appropriate for use in a paediatric population, 
as they may not have content validity. In a 2011 systematic review (unpublished—part of an 
MSc thesis, University of Alberta, S. Ishaque) of individualised HRQOL measures used in 
children (0-18 years), six major databases were searched from inception to mid-2011; it 
included clinical trials and observational studies if they assessed HRQOL as their primary or 
secondary outcome with individualised tools. Sixty-eight studies were included. The review 
identified five disease-specific and three generic individualised HRQOL measures used to 
assess the HRQOL of children. With the exception of the Paediatric Asthma Quality of Life 
Questionnaire (PAQLQ), none of the disease-specific or generic individualised tools were 
validated for children.   
There are other limitations in this approach. For example, in situations when child-specific 
PROMs are utilised and/or developed, the self-reporting ability of children is often 
underestimated [52,53] and parents/caregivers/healthcare providers are assumed to be able to 
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provide an assessment of children’s outcomes [52,53]. Compounding this, the opinions of 
adults are given more weight, and parents/caregivers are often asked to choose and name 
what may be important to their child. Contrary to the widespread belief that adults are more 
reliable in completing questionnaires, there is evidence that parents’/caregivers’ completed 
PROMs do not match with their child’s perception of their well-being [54-46]. Considerable 
discordance between parent-proxy-completed to child-completed questionnaires is reported in 
the literature [50,51,54-58]. This discordance of proxy versus child-completed questionnaires 
is most profound in the domain of emotional well-being [16,47,54-56], and social interactions 
[54,55]. Despite this, a high correlation on parent-to-child rating of externally observable 
measures has been reported [54,55]. Based on this, some argue that the use of parent-proxy 
for the measurement of externally observable factors is appropriate [56]. However, it is 
important to remember that the proxy assessment of PROs is still inconsistent with the 
definition of the concept. Though it may be theoretically sound to assess a child’s QOL from 
a ‘parental perspective,’ it does not equate to the self-reporting of a QOL. Questions have 
also been raised about which parent (mother, father or other carer) to use as a proxy if the 
need arises [16,51,56]. This is because there is evidence that mother’s ratings of children’s 
PRO is different from that of their father’s [16]. Given this finding, one solution 
recommended in the literature to avoid systematic error with parent proxy assessment in 
longitudinal trials is to use the same parent throughout the study [57]. Another important 
consideration in parent-proxy assessment of children’s PROs is the impact of the child’s 
disease and the increased responsibility as a carer on parental well-being which, in turn might 
affect how parent rate their child’s health. Given all the issues with parental-proxy 
assessment, and most importantly to attain the subjective perspective of children, self-
reporting and self-completed PROMs must be applied, unless this is not possible due to a 
child’s inability or unwillingness to do so.   
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As argued above, self-completion/self-reporting is clearly a necessity for the assessment of 
PROs for children. Besides the requirement of cognitive maturity of a certain level, another 
challenge in the assessment of paediatric PROs is the ongoing and sometimes rapid change in 
developmental stages and needs. Furthermore, all verbal children who are able to complete 
PRO questionnaires cannot be considered as one homogenous group. For example, the term 
child is loosely applied to individuals 5-16 (or 5-18 years old in some countries) and within 
this age group children differ considerably according to their developmental stage. A child 
beyond the age of 7 (or in some cases 5) is considered to be able to reliably complete a self-
report PROMs [59]. However, it is not likely that a questionnaire appropriate for a 7 year-old 
would be suitable for a 14 year-old child. For example, a domain related to sexuality would 
be important on a questionnaire for teenagers but may be less relevant and possibly 
inappropriate for young children. Therefore, the consideration of the age-appropriateness of 
measurement tools is critical for a paediatric population. While developing a PROM for a 
paediatric population it is critical that the children in the age bracket for which the tool is 
being created are at a relatively similar developmental stage and are reasonably homogenous 
in their cognitive abilities [47,60-62].  
As mentioned above, to promote self-reporting of PROs for children, there are certain 
requirements specific to the measurement tools. For example, even for children who have 
achieved a reasonable cognitive ability and are developmentally mature enough to understand 
their issues and disease processes, instruments should be simple so that the child can 
complete them with minimal to no help from their parents/caregivers. Thus, the development 
of self-reporting paediatric PROMs requires consideration of domains and content suitable 
for children. This can only occur when the primary respondents, that is, the children, are 
consulted in the development of a PROM.  
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Consulting a primary population is also a pre-requisite for achieving content validation of a 
PROM [47]. Adopting an appropriate reporting or recall period has been identified as one of 
the potential difficulties with children’s self-completion of PROMs. Young children may 
have difficulties in recalling information and/or in understanding questions asking about what 
happened over time, for example, 1 week, 2 weeks, or a month ago [50,54,55,]. Therefore, 
testing what recall periods the target population can comprehend is vital. For the assessment 
of PROs, after the selection of a domain, the respondent is asked to measure it on a scale. 
Selection of a scale for a measurement tool can affect the ease with which a child can 
complete it and thus affect the self-reporting property of a measurement tool. There are 
different types of scales used in PROMs, such as the Visual Analogue Scale (VAS), Likert 
Scale, and faces scales [63]. Although several types of scales have been used for children, 
face-based tools have been found to increase self-reporting among paediatric populations; 
children as young as three, and as old as seven years have validly used them for pain [64,65] 
and nausea [66] measurement. Examples of face-based tools include: Faces Pain Scale-
Revised [65], Wong-Baker faces pain scale [67] and the Baxter Retching Faces Scale 
(measuring nausea) [66]. 
2.4.1  Evidence regarding a Valid Paediatric Generic Individualised Tool  
The search for a validated, generic, individualised, paediatric PROM began during my 
research project within the Master of Clinical Epidemiology at the School of Public Health, 
University of Alberta in 2011. This unpublished systematic review aimed to specifically 
identify any generic individualised paediatric HRQOL tool used in children. The review 
retrieved 68 studies and identified five disease-specific and three generic individualised 
HRQOL measures used to assess paediatric HRQOL or QOL. The disease-specific tools 
identified were: PAQLQ [68], Asthma Quality of Life Questionnaire (AQLQ) [69], Patient 
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Specific Index (PASI-pg) [70], Rhiniconjunctivitis Quality of Life Questionnaire (RQLQ) 
[69], and Global Quality of Life-8 (GLQ-8) [71]. The generic HRQOL measures identified 
were: Measure Yourself Medical Outcomes Profile (MYMOP) [72], Patient Generated Index 
[55, 73], and Schedule for the Evaluation of Individual Quality of Life – Direct Weighting 
(SEIQOL-DW) [74].  
This review was wide in its scope and included all clinical trials and observational studies 
that assessed paediatric HRQOL by an individualised HRQOL measure. The included studies 
were therefore not necessarily about the evaluation of psychometric properties of the eight 
identified tools. It was hypothesised that if a measurement tool was applied to a paediatric 
population, it would have evidence of validity and reliability for such use. To confirm this 
hypothesis a further search was performed that targeted paediatric and mixed population 
studies on the psychometric properties of these tools. The initial search began with the view 
of identifying a paediatric validated generic individualised HRQOL measure. A second study 
within that Masters dissertation (unpublished – review of psychometric properties of generic 
individualised paediatric HRQOL measures) focused on the identification of psychometric 
studies of the three generic tools used to assess paediatric HRQOL. This search identified six 
studies [75-80]. The Terwee criteria was used to assess the quality of psychometric properties 
reported in the studies [81] and the Consensus-based Standards for the Selection of Health 
Measurement Instruments (COSMIN) were used to evaluate the risk of bias among the 
included studies [82, 83]. This review of the measurement properties established the lack of 
sound psychometric properties of the identified tools and a lack of a paediatric, validated, 
generic, individualised HRQOL measure for their use in a paediatric population [75-80]. The 




The database searches for both of the above described literature reviews were conducted in 
2011, and thus an update was required to ascertain the development of any new paediatric 
generic individualised tool between 2011 to August 2018. This update was performed by: 1) 
retrieving and the reviewing literature reviews on generic paediatric measures, and 2) a 
search update of the unpublished literature reviews in the Masters dissertation summarised 
above.     
2.4.2  Published literature reviews on Paediatric Generic PROMs 
In this section, I examine the available generic paediatric PROMs by in published literature 
reviews on the topic. A Scopus search was conducted to identify literature reviews evaluating 
the psychometric properties of generic paediatric PROMs. Two recent systematic reviews of 
generic multidimensional PROMs for children [52,53] provided specific citations, followed 
by examination of the reference lists within these. A number of literature reviews of 
paediatric generic PROMs, HRQOL measures, and QOL measures have been published in 
the literature [50-58,84-90]. Of the 16 identified reviews, four were systematic reviews 
[52,53,58,87]. Seven of the identified reviews (including one systematic review) discussed 
methodological considerations for the use of PROMs in children [50,51,54-56,86,87]. The 
remaining reviews appraised the currently available generic and disease-specific paediatric 
PROMs. My focus was on the identification of a valid, generic, individualised measure for 
children, and the following sections will examine the relevant available references.  
Janssens et al. [52] published a series of systematic reviews in 2015. In the first, the authors 
aimed to identify all generic, multidimensional patient-reported outcomes for children from 
birth to 18 years old, and map the construct that the PROMs claimed to measure; the authors 
included 35 PROMs meeting their inclusion criteria.  [52]. In the second systematic review 
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psychometric properties of the identified PROMs were evaluated within 35 identified PROM. 
[53]. Only five PROMs had six or more psychometric properties evaluated, and positive 
findings for some of these properties were reported for four PROMs. None of the included 
measures in both reviews were partly or completely individualised.  
A systematic review by Solans identified 30 generic and 64 disease-specific HRQOL 
measures for children of 0-18 years old [87]. This review included all the identified HRQOL 
measures from the previous three literature reviews [85,88,89] reporting on the literature 
from 1980 to 2000. The Solans systematic review also included an original search for any 
additional paediatric HRQOL measures published between 2000 to 2006. Again, no 
individualised paediatric PROM was included.  
Two further literature reviews by Rajmil et al. [89.90] identified paediatric HRQOL measures 
for Spanish-speaking countries. A narrative review by Schmidt [86] identified 16 generic 
multidimensional instruments that claimed to measure paediatric HRQOL. Of these, four 
questionnaires were to be completed by parents. None of the included measures were 
individualised. 
The reviews described above were not designed specifically to identity paediatric generic 
individualised PROMs, and therefore their search strategy could not retrieve any of these 
tools. In contrast, the unpublished literatures reviews described in section 2.4.1 as part of my 
Master of Science in Clinical Epidemiology at University of Alberta were more focused and 
were specifically performed to identify a validated paediatric generic individualised HRQOL 
tool. However, the search performed in 2011 was seven years old by the end of my PhD in 
2018 and therefore needed to be updated. In the below section (2.4.3) I have reported on this 
search update.  
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2.4.3 Updated search to identify Validation of Generic Individualized Paediatric 
Measures published since 2011 
To update the reviews performed as part of the MSc Clinical Epidemiology Thesis, 
summarised in the Section 2.4.1, a search in the PubMed database was conducted with the 
search strategy shown in Figure 2.1. To avoid missed studies, I also performed a SCOPUS 
search with the names of the generic individualised tools identified in my MSc systematic 
review, that is, PGI, SEIQOL-DW, SEIQOL, and MYMOP. Finally, I searched the six 
studies [81-83,87-89] included in the review of psychometric of the generic individualised 
tools, and relevant studies citing these since 2011 until August 2018.  
The purpose of these searches was to identify and review any psychometric or validation 
studies on: a) a new generic individualised HRQOL measure for children, or b) studies that 
may have validated the previously identified generic individualised tools used for children. 
Therefore, only studies of psychometric analysis conducted on a paediatric population were 





Figure 2.1 PubMed database search strategy  
 
  
(((health-related quality of life OR hrql OR hrqol OR qol OR quality of life OR 
health status OR functional status OR activities of daily living OR patient reported 
outcomes OR patient reported outcome OR patient reported outcome measures OR 
patient reported outcome instruments OR patient reported outcome instrument OR 
outcome assessment OR outcome measure OR outcome measures OR patient 
centered OR patient centred OR patient reported OR patient-reported OR patient 
oriented OR patient-oriented))  
AND (psychometrics OR psychometric OR measurement properties OR clinimetric 
OR validation study OR validation studies OR valid OR validity OR reliable OR 
reliability OR responsiveness OR cross cultural validity OR content validity OR 
content-validity OR face validity OR criterion Validity OR construct validity))  
 AND (patient generated OR patient generated outcomes OR consumer generated 
OR patient perspective OR individualized OR individualised OR individualized 
patient reported outcome measures OR individualized patient-reported outcome 
measures OR individualised patient reported outcome measures OR individualised 
patient-reported outcome measures OR individualized patient reported outcomes OR 
individualised patient reported outcomes OR personalized OR personalised) 




Figure 2.2 Inclusion and Exclusion Criteria  
 
The search yielded 1203 articles, which was reduced to 1194 after removal of duplicates. The 
titles and abstracts of these 1194 articles were screened to identify relevant studies. The full 
text of 29 articles was retrieved and screened to find studies reporting on evidence of 
psychometric analysis of a new or previously identified generic individualised HRQOL 
measure for their use in children (PGI, SEIQOL-DW, SEIQOL, MYMOP) [91-120]. Two 
articles reported their results at two different occasions from the validation of the same tools 
[109,110,114,115]. Conclusions from the full text screen were that none of the 29 identified 
studies reported a psychometric analysis or the development of any paediatric generic 




1. Validation studies on generic individualized measures  
2. Paediatric population (0-18 years) studies  
Exclusion Criteria  
1. Disease-specific PROMs  
2. Paediatric proxy completed PROMs  
3. Studies reporting on the psychometric properties of non-English PROM  
4. Studies on preference-based measures  








423 articles retrieved from search of 
citations and named generic 
individualised tools  
(PGI, MYMOP, SEIQOL) 
780 articles retrieved from the 
PubMed database search 
Title and Abstracts of  
1194 articles screened 
Screened articles with reasons for exclusion 
 
1. Barthel, 2017 German HRQOL instrument- KIDSCREEN 1  
2. Bertisch, 2017 CAT with PROMIS items plus neurological scale 2  
3. Devine, 2015 Child CAT German 1   
4. Dilek Ergin 2015 KINDL Scale Turkish version 1  
5. Dzuka, 2012 1 
6. Garratt, 2015 Adult PGI  3 
7. Jervaeus, 2013(Swedish KIDSCREEN 27 for cancer patients  
8. Kenzik, 2014 (comparison of four generic paediatric HRQL Tools) * 
9. Klosinski, 2015 1 
10. Kyte, 2015 (guidelines on the selection of PROMs in physiotherapy) * 
11. Landgraf, 2013 parent-proxy tool for infants 4 
12. Lloyd 2011 generic tool 5 
13. Lochting, 2014 3 
14. Maenner, 2013 Activities of daily living questionnaire 4 
15. Masquillier, 2012 KIDSCREEN generic  5 
16. Morley, 2014 (pediatric advanced care-quality of life scale) 5 
17. McDougall, 2013 5 
18. Mueller-Godeffroy, 2016 5 
19. Murphy, 2017 (Two publications on the same tool identified) 5 
20. Rodday, 2013, 7 item global HRQL scale 5 
21. Schacht, 2011 CHIP- CE tool in German language 1 
22. Thompson et al., 2011 5 
23. Tavernier, 2011 (Two publications on the same tool identified) 3 
24. Wasson, 2018 3 
25. Weeknink, 2014 6 
26. Williams et al., 2015 5 
27. Williams et al., 2012 5 
 
Notes: 1 Non-English; 2 Disease specific; 3. Adult population; 4 Proxy 
completed; 5. Non-individualised; 6. Not psychometrically evaluated; *Other 
Full text of 29 articles screened 
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2.5 Psychometric evidence on the individualised generic HRQOL tools 
previously used in paediatric populations   
Due to the absence of any validated paediatric generic PROMs it was decided to analyse the 
available psychometric evidence on the three generic individualised tools from psychometric 
studies conducted in adult populations. Instead of searching for primary studies on 
psychometric analysis of the identified tool, it was decided to focus on reviews summarising 
those studies. The reviews of outcome measurement instruments are important tools as they 
can provide a comprehensive overview of the quality of instruments and thereby can support 
evidence-based selection of the most suitable instrument for a population [83].   
A number of literature reviews on the measurement properties of these adult, individualised 
HRQOL and QOL measurement tools (PGI, MYMOP, SEIQOL-DW, SEIQOL) have been 
published [38, 121-124]. A review by Aburub evaluated the feasibility and psychometric 
properties of two individualised HRQOL tools, namely, the Patient Generated Index and the 
Schedule for the Evaluation of Individual Quality of Life (SEIQOL) and its short Form (the 
direct weighting SEIQOL-DW) in adult cancer patients [121]. This review reported that the 
tools were acceptable, feasible, and responsive to change; furthermore, that both the PGI and 
SEIQOL were able to identify QOL concerns not represented in other generic standardised 
HRQOL measures [121]. A systematic review by Wettergren evaluated the feasibility and 
psychometric properties of SEIQOL-DW [122]. The review included 39 studies that reported 
on psychometric properties of the tool and the use of the tool in research and clinical settings. 
It concluded that SEIWOL-DW was feasible and valid in a variety of populations including 
healthy and ill adults. An older review by Martin published in 2007 evaluated the feasibility 
and psychometric properties of the PGI [123]. Eighteen studies were included in the review, 
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and the PGI was found to be valid, with the evidence for reliability being stronger for the 
versions with a shorter Likert scale. There was no review on the quality of psychometric 
properties of the MYMOP. Given this, primary studies reporting on the psychometric 
properties of the MYMOP were retrieved from the literature and are summarised below.  
Four primary studies on the measurement properties of MYMOP use in adults were identified 
[76,77, 124,125]. Two studies reported on the content validity of the tool. The first study (all 
patients of complementary medicine) compared qualitative interviews of 20 patients with 
their scores on the MYMOP forms [76]. Revision of the MYMOP was performed, based on 
participants’ feedback [76]. The new MYMOP was named MYMOP2 and is the current 
version. The MYMOP2 was then applied to acupuncture patients (26-83 years) and in-depth 
interviews and focus groups were conducted to evaluate content validity [124]. No further 
revisions were made after the second study.  
Studies on construct validation of MYMOP2 reported on correlation of MYMOP score with 
‘self-perceived change in condition’ [77,125] and clinical outcomes measured by physicians 
[125]. It was hypothesised post hoc that MYMOP scores would have a significantly larger 
correlation with improvement (measured by patient self-perceived change in health 
condition) for acutely ill patients compared to chronically ill patients [77]. The expected 
correlation of the MYMOP scores of patients with their corresponding SF36 scores was also 
studied [77]. While evidence supporting these hypotheses was found in these studies [77, 
125], the fact that they were not postulated a priori is a limitation.  
 
Responsiveness was assessed by gradient change in the MYMOP scores on multiple 
applications across the spectrum of clinical change by physicians [125] and patients [77]. The 
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change in the MYMOP score of patients who described themselves as ‘a little better’ was 
compared with the change in scores of patients that reported being ‘about the same,’ by t-test 
[77]. However, this assessment of responsiveness was not in accordance with current 
guidelines/standards for evaluation of this measurement property [81, 77, 125] as the groups 
were intimately related to the outcome of interest.  
Proper scaling of responses is crucial for validity and clinical applicability of any HRQL 
measure. The MYMOP2 has a seven-point rating scale. This was found difficult to 
comprehend by older people, people with low literacy, and those with little confidence in 
completing forms [126,127]. Therefore, a faces scale was then introduced, which included 
faces alongside each number [126,127]. The row of faces represented a continuum of 
emotion of happiness at one end and worry at the other end. The measure has reported 
evidence of content validity, construct validity, and responsiveness for adults (see Table 2.1 
for a summary of evidence on psychometric properties of the MYMOP). 
In summary, none of the included generic individualised measures used to assess paediatric 
PROs were thoroughly validated for children. Both the PGI and SEIQOL-DW were 
complicated in their layout. Studies on the PGI have shown that the questionnaire was found 
to have poor validity in populations with a low education level [128-131], older ages 
[128,131-135], and for individuals who had physical or mental limitations [131,132,135]. 
SEIQOL-DW had negative results on content validation for children with diabetes under 12 
years of age, partly as children below 12 years could not understand the standard instructions 
to complete SEIQOL, and about 1/3rd had difficulty in completing the tool [80]. 
Overall, the MYMOP was the simplest generic individualised tool identified, and thus was 
chosen for adaptation for a paediatric population. Beside its simplicity, the other reason for 
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selecting the MYMOP was based on the experience at a paediatric clinical and research 
group, CARE Program for Integrative Health & Healing, Department of Pediatrics, 
University of Alberta’s complementary and alternative paediatric clinic. The MYMOP was 
used successfully in the complementary and alternative paediatric clinic of the CARE 
Program, with children, possibly as the tool was simple and avoided non-applicable 
questions to non-verbal and developmentally delayed children.   
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Table 2.1 Validation of MYMOP 
Measurement Property       Methods  Weaknesses/limitations 
Content Validity  
 
 
1. Qualitative interviews of 20 patients and 
comparison of this qualitative data to 
corresponding MYMOP scores (the 
current version MYMOP2 was developed 
as a result) [76]. 
2. Twenty-three patients of eight 
acupuncturists underwent: focus groups, 
in-depth interview/cognitive interviews 
[124]. 
Issues identified were: 
-  floor effect  
 
No revision of the tool was made after the 
2004 study [124] which identified that 
MYMOP had a floor effect (i.e. more than 
15% of patients reported the lowest possible 
score and if they got worse, no further change 
in their condition could be recorded); periodic 




-  inability to score episodic conditions 
- inaccurate measurement of medication 
change 
Construct Validity 1. Correlation between ‘perceived change in 
condition’ and MYMOP score was assessed 
[77,125] 
2. Correlation between MYMOP and 
physician-assessed clinical outcome [125] 
3. Known group comparison: MYMOP score 
in patients with acute conditions (< 4 
weeks) was compared to patients with 
chronic conditions. It was hypothesised that 
MYMOP score would have a significantly 
larger correlation with improvement for 
No a priori hypotheses were defined.  
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acutely ill patients compared to chronically 
ill patients [77]. 




1. Gradient change in MYMOP scores at 
repeat applications across perceived 
changes by clinicians and patients  
2. Standardised response mean  
3. Index of responsiveness 
4.  t-test conducted to compare the MYMOP 
scores of patients who reported being a 
‘little better’ to those who were ‘about the 
same.’ 
 
Statistics reported were not in accordance with 
the current guideline [81] 
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2.6 Characteristics of the MYMOP  
The Measure Your Self Medical Outcome Profile (MYMOP) is an individualised tool for 
adults, which is publicly available for clinical use [72]. It was specifically designed and 
evaluated for use in primary care. Most of the validation work was conducted in general 
practitioners’ offices.  
The current version of the MYMOP has two forms: the initial form, and a follow-up form. 
The initial form can be filled in by a patient with or without help; it addresses two symptoms, 
one activity affected by the named symptoms, overall well-being, and medication use. The 
follow-up form consists of scoring of the originally identified symptoms and activity 
limitation at the time of follow-up, with a third optional symptom. Each question, except for 
the medication questions, is scored on a seven-point scale (0-6). High scores indicate worse 
outcomes. A profile score can be calculated, being a mean of all nominated scaled scores 
[72]. 
Within this thesis, the aim of adapting the MYMOP for children was to assess the suitability 
of MYMOP to supplement clinical encounters through the use of an individualised patient-
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CHAPTER 3. PATIENT-REPORTED OUTCOME MEASURES 
(PROMS) IN CLINICAL CARE  
3  
3.1 PROMs: their utility in practice 
To introduce a new practice in the world of evidence-based medicine, a question that requires 
a satisfactory answer is: ‘how effective is a new practice, relative to standard care?’ 
Evidence-based medicine is the conscientious, explicit, and judicious use of current best 
evidence in making decisions about the care of individual patients [1]. Hence for PROMs to 
become an integral part of routine clinical care, PRO assessment is required to empower 
patients and produce a positive impact on future patient outcomes and/or the process of future 
healthcare delivery.  
3.2 Existing evidence on the use of PROMs in clinical care 
To examine the present-day use of PROMs in clinical care, a search was performed in the 
PubMed database to identify literature reviews evaluating the use of PROMs as an 
intervention to improve patient outcomes. The search terms used were: reviews, systematic 
reviews, meta-analysis, patient-reported outcomes, patient-reported outcome measures, and 
clinical care. The relevant systematic and narrative literature reviews were selected, their 
reference list was scanned, and relevant cross-references were reviewed. Only literature 
reviews (systematic and narrative) were included at this stage.  
The search identified 21 literature reviews [2-22] on the use of PROMs in adult populations 




The systematic review by Alsaleh [2], Boyce [4], and Chen [8] investigated PROM use in 
adult oncology patients in various settings. The Alsaleh review focused on the effectiveness 
of the use of QOL measures, in an oncology outpatient clinic, on patient management by 
examining published RCTs between January 1990 to December 2012. The review by Boyce 
investigated the use of PROM feedback for both patient and group level outcomes. The 
review by Chen investigated the impact of PROM collection among oncology patients on 
provider behaviour and organisational change. Five of the identified reviews [6, 12, 15, 16, 
18] were focused on the use of PROMs in mental health and two focused on palliative care 
[3,11]. The review by Carlier was reported in Dutch [7] and the review by Mitchell [20] was 
on screening for distress in cancer patients. The systematic review by Duncan and Murray 
was on routine outcomes assessment by allied health professionals [9]. A further review by 
Boyce included qualitative studies, only with no RCTs included [5]. The literature search did 
not identify any systematic or narrative reviews of paediatric studies on the use of PROs in a 
clinical setting. 
Of 21 identified reviews, seven literature reviews specifically focused on the effect of the 
presentation of patients’ PROM results to their healthcare providers [10,12,13,16,18,19,22]. 
These reviews are summarised in Table 3.1. All of the reviews identified differed in their 
aims, scope, and methodological quality; however all of them concluded that the current 
evidence on the use of PROMs in clinical care is equivocal. Therefore the evidence on the 






Table 3.1 Literature reviews evaluating the impact of presentation of results of PROMs to physicians 
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Regardless of the evidence of effectiveness on patient outcomes, the evaluation of PROs is in 
line with provision of patient-centred healthcare, as the assessment of PROs allows patients 
to present and thereby integrate their values, opinions and wishes into their clinical care 
[23,24]. Patients are the experts on their own health and well-being. Only they have the 
internal knowledge of their health problems, and they are the ones who, based on their social 
and cultural values, can decide what treatment options and lifestyle changes might work best 
for them. Without respecting and integrating patients’ values and desires, the healthcare 
provided to them will not be patient-centred, and therapies that may have been proved 
‘effective’ on average in a clinical trial setting may not work for an individual patient.  
Besides the indefinite conclusion of the identified adult literature reviews and absence of any 
literature reviews of paediatric studies on the use of PROs in clinical care, it was surprising 
that none of identified literature reviews evaluated the effectiveness of the use of PROMs as 
an intervention intended to support the representation of patient values and preferences in 
clinical encounters. Since systematic reviews of randomised controlled trials are considered 
to produce the highest level of evidence for the effectiveness of any intervention, it was 
therefore decided to perform a systematic review of randomised controlled trials with this 
aim, and to consider the evidence in a subset of paediatric studies. The review protocol was 
developed and registered with PROSPERO (registration number: CRD42016034182) [25]. 
The systematic review was performed as part of this PhD thesis and the Manuscript, as 
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Patient-reported outcome measures (PROMs) could play an important role in identifying 
patients’ needs and goals in clinical encounters, improving communication and decision-
making with clinicians, while making care more patient-centred. Comprehensive evidence 
that PROMS are an effective intervention is lacking in single randomised controlled trials 
(RCTs). 
Methods  
A systematic search was performed using controlled vocabulary related to the terms: clinical 
care setting and patient-reported outcome. English language studies were included if they 
were a RCT with a PROM as an intervention in a patient population. Included studies were 
analysed and their methodologic quality was appraised using the Cochrane Risk of Bias tool. 
The protocol was registered with PROSPERO (CRD42016034182). 
Results  
Of 4,302 articles initially identified, 115 underwent full text review resulting in 22 studies 
reporting on 25 comparisons. The majority of included studies were conducted in USA (11), 
among cancer patients (11), with adult participants only (20). Statistically significant and 
robust improvements were reported in the pre-specified outcomes of the process of care (2), 
and healthcare (3). Additionally; five, eight, and three statistically significant but possibly 
non-robust findings were reported in the process of care, health, and patient satisfaction 





Overall, studies that compared PROM to standard care either reported a positive effect or 
were not powered to find pre-specified differences. There is justification for the use of a 
PROM as part of standard care, but further adequately powered studies on their use in 
different contexts are necessary for a more comprehensive evidence base.  
Keywords: patient-reported outcome measures; PROMs; health-related quality of life; 







± PROM studies: studies that compared patient completion of a PROM with standard care in 
the control group 
PROM ± summary studies: studies in which all patients completed a PROM and compared 
the presentation of PROM summary scores to clinicians vs. no presentation of summary 
scores  
FDA: Food and Drug Administration 
HRQOL: health-related quality of life 
PRO: patient-reported outcomes  
PROM: patient-reported outcome measure 
QOL: quality of life 
RCT: randomised controlled trial 




4.3 Background  
According to the ISOQOL Dictionary of Quality of Life and Health Outcomes Measurement, 
a patient-reported outcome (PRO) is ‘a measurement of any aspect of a patient’s health that 
comes directly from the patient, without interpretation of the patient’s response by a 
physician or anyone else’ [1]. Patients’ experiential knowledge of the effects of any 
intervention is essential for the delivery of high quality clinical care. All patients in clinical 
care are unique and therefore may experience different benefits or side effects from the same 
treatment [2], which cannot be captured by the mere assessment of traditional physiological 
outcomes. It is therefore important to ask patients about their preferences and values to set 
self-directed health goals and promote compliance with treatment.  
The assessment of PRO requires instruments that are valid and reliable. These instruments are 
often termed PRO measures (PROMs). It is suggested that regular use of PRO instruments to 
collect patients’ health-related outcomes can affect the health and well-being of patients by 
improving patient-physician interaction, focusing the clinical encounter on patient-directed 
concerns, and by promoting shared clinical decision-making [3]. PROMs are commonly used 
in comparative effectiveness research, comparative safety analysis and economic evaluations 
to inform resource allocation [4,5], with contexts including the ongoing monitoring of PROs 
for patients with chronic diseases or in palliative care [6].   
The existing evidence on the effectiveness of regular assessment of PROs comes from a 
variety of sources including observational studies and individual randomised controlled trials 
(utilising qualitative, quantitative and mixed methods) and gold standard literature reviews of 
RCTs [7]. The effectiveness of PROMs has been explored in a number of literature reviews 




equivocal. There are several potential reasons for this ambiguity in the field, such as the 
attempt to aggregate heterogeneous tools under the umbrella term of PROM (which 
inappropriately considers them equivalent) [26], assessment of different RCT outcomes by 
various different methods and at different times, as well as a lack of standardised procedures 
for the provision of PROM results to healthcare providers and methodological issues with 
primary studies [27].   
The aim of this systematic review was to assess the evidence on the effectiveness of the use 
of PROMs as an intervention intended to support the representation of patient values and 
preferences in clinical encounters. This review of RCTs is not limited by disease, age of 
patient population, nor year of publication. In addition, this is the first systematic review to 
consider the statistical robustness of results reported, and differentiate between the use of 
PROMs with and without the formal presentation of completed PROMs to treating clinicians.  
4.4 Methods  
A detailed systematic review protocol outlining the search strategy; methods for relevance 
and full text screening; data extraction form; quality assessment method; plan for data 
analysis, synthesis, and statistical issues; sensitivity and subgroup analysis; publication bias, 
and any conflicts of interest was developed and registered with PROSPERO; registration 
number: CRD42016034182 [28]. 
4.4.1 Search strategy  
With the help of a health research librarian, a systematic search strategy was developed to 





The search was conducted using controlled vocabulary and keywords related to the terms: 
clinical care setting and patient-reported outcomes [28]. The search strategy for the Medline 
database is included in the Supplementary 1 and was modified to adapt to variations in 
indexing among the databases. Reference lists of relevant literature reviews [8-13, 21] were 
also screened to identify additional articles. Citation searches were performed in Scopus.  
4.4.2 Eligibility criteria  
A publication of a study was eligible for inclusion if it reported on a RCT that applied a 
PROM to patients with or without providing the patients’ PROM score 
(summary/profile/dimension) to healthcare providers as an intervention. The review was 
restricted to studies that were published and reported in English. There were no restrictions 
on types of PROM, the form in which the PROM was used as an intervention, the health 
condition being studied, the country or setting in which the study was conducted.  
Trials were excluded if they applied PROMs only for screening of psychological disorders 
such as depression and anxiety, were in the palliative care setting, compared one type of 
PROM to another type of PROM, compared only paper application to computer application 
of the same or different PROMs applied PROMs assessing specific constructs such as pain.  
4.4.3 Relevance and full text screening  
First: a title, abstract, and keyword screening of initially identified articles was performed. In 
order to pilot the inclusion criteria, (see review protocol [28]), two authors (SI and RN) 
initially screened a random 10% of the search results. Discrepancies were discussed and 
inclusion criteria were modified accordingly. Full text articles identified from this search 
were retrieved and discussed. Once agreement on the inclusion criteria was achieved, the 




same authors (SI, RN) independently applied the inclusion criteria to full texts of potentially 
relevant studies (n = 115) to identify studies for final inclusion. Any discrepancies were 
resolved through discussion. While it was initially planned to contact authors of studies 
where there was doubt concerning eligibility, this was not necessary as all doubts were 
resolved by discussion. PRISMA (Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses) guidelines were followed to ensure transparent and comprehensive reporting 
[29].  
4.4.4 Data extraction, analysis, synthesis, and statistical issues 
The primary author extracted data from all studies including characteristics of the study 
design, the nature of the PROM, method of intervention and study outcomes. 
Consistent with previous systematic reviews in this setting [9,11,12], study outcomes were 
classified into three categories: process of healthcare, health outcomes and satisfaction with 
healthcare. Outcomes relating to how the care was delivered (e.g. consultation time, 
discussion of quality of life (QOL)/health-related quality of life (HRQOL), return visit 
referral to other health practitioners, etc.) were classified as ‘process of care’; monitoring of 
changes in a patient’s QOL/HRQOL or in any symptoms were classified as ‘health 
outcomes;’ and finally outcomes relating to patients’ satisfaction with healthcare or 
feasibility were classified as ‘satisfaction with healthcare.’ Given the heterogeneous nature of 
the data (both for PROMs used and patient populations studied) it was not considered 
meaningful to perform a meta-analysis. 
Positive results (i.e. in favour of the PROM intervention) were considered ‘robust’ when 
statistically significant differences in a pre-specified outcome were reported for a study which 




an outcome that was not pre-specified and/or for which the study was not powered to 
determine were considered ‘non-robust’. 
4.4.5 Quality assessment 
Three authors (SI, RN/AS) performed methodological quality assessments of seven included 
studies independently using Cochrane’s Risk of bias tool [30]; any discrepancies were 
resolved by discussion. Thereafter, the primary author (SI) performed the quality assessment 
and discussed it with another team member (AS), both carefully considering the reasons for 
specified rankings.  
4.5 Results 
After removal of duplicates, 4,302 articles were identified from database searches of which, 
77 were found eligible for full text screening. An additional 36 articles (of which 4 were 
included) were identified from previous literature reviews, and two articles were identified 
from other sources. After full text screening of 116 articles, 22 RCTs met the inclusion 
criteria and were consequently included in this systematic review (Figure 4.1) [31-52].  
Table 4.1 summarises characteristics of included studies and Table 4.2 presents additional 
summary details of the RCTs, including the PROMs assessed, the intervention process, and 
whether training was provided for health providers and/or patients. Based on the nature of the 
intervention evaluated, articles are grouped into two panels in Table 4.2: 18 studies in which 
all patients completed a PROM and compared the presentation of the PROM summary scores 
to clinicians vs. no presentation of summary scores (labelled ‘PROM ± summary’ studies) 
[31-38,40,41,45-52]; 7 studies that compared patient completion of a PROM with standard 




Studies by Velikova [49] and Rosenbloom [44] compared more than two treatment arms and 
their data is thus represented in both tables and panels by specific comparisons. For example, 
the Velikova study (2004) RCT [49] compared PROM with presentation of results to 
healthcare providers vs. standard care, and PROM without presentation of results to 
healthcare providers vs. standard care.  
Publication dates ranged from 1989 to 2016. Most of the studies took place in the USA 
[31,32,34,35,38,40,44-46,48,51,52], followed by the UK [43,49,50], Netherlands [36,37,39], 
Australia [33,41], Ireland [42] and Norway [47]. More than half of the studies (55%) 
included cancer patients [31-33,35,37,39,41,42,44,47,49,52] and were performed in tertiary 
hospitals. Four studies [34,40,48,50] were performed in tertiary-care hospitals in sub-
specialties other than cancer, and the remaining studies took place in GP/internal 
medicine/family physician offices [36,38,43,45,46,51]. Six studies reported enrolling only 
new patients, five studies enrolled only patients who were previously known to clinicians, 
and the remaining 11 studies did not specify. Sample size calculations to detect a specified 
effect size for named primary outcomes were reported in 11 studies [31,32,35-37,40-44,49]; 
three studies reported sample size calculations but their named primary outcome had multiple 
sub-components with no subsequent P value adjustments for multiple comparisons 
[39,46,47]; and one performed only a post-hoc power calculation [40].    
A total of 23 PROMs were used in these 22 studies (Table 4.2). Reference to previous 
validation work for all PROMs was provided in the RCTs for each PROM in use. However, 
an evaluation of whether the PROM was a valid choice for the target population of the RCT 
in which it was in use was not reported. Cancer-specific (9) or generic tools (8) were most 
commonly applied; four studies used more than one PROM as an intervention [33,36,41,49] 




generic and diabetes-specific tools (1)); and one applied two arthritis-specific tools [40]. The 
most commonly utilised tool was the European Organization for Research and Treatment of 
Cancer, Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) (reported in three 
studies). The Beth Israel/UCLA Functional Status Assessment Questionnaire, the Hospital 
Anxiety and Depression Scale (HADS), the SF 36 and PedsQL-generic were used in two 
studies each. The remaining PROM interventions were applied in one study only (Table 4.2).  
In 18 studies [31-33,36-47,49-51], PROMs were self-administered by patients on paper (15) 
or via a computer touch screen (3); in three studies [34,35,48] PROMs were completed via 
telephone with  assistance, and one study[52] (on paediatric patients) varied the 
administration method according to the child’s age. In this latter trial; children younger than 7 
years were allowed a parent proxy PROM completion, children aged 7 to 13 years had 
combined child and parent proxy PROM completion and children >13 years self-
administered the PROM.   
PROMs were mostly completed in waiting rooms/clinics [32,33,37,38,40,41,44,47,49-51], 
followed by home/place of convenience [36,39,42,45,46], over the telephone [34,48], first in 
clinic then subsequently over the telephone [35], a mixture of clinic and telephone interview 
[52], computer/paper-based completion according to patients’ preferences [31], or 
unspecified [43].  
Of the 18 studies that compared presentation of PROM ± summary studies (completion of a 
PROM with presentation of results to clinicians vs. completion of a PROM alone), [34,36-
38,45-52] provided training to clinicians/patients about interpretation of PROM scores. One 
[42] of the five studies that compared completion of a PROM with no PROM provided 




sessions provided to physicians and patients concerning the interpretation of the PROM 
varied substantially between studies (Table 4.2).  
Table 4.3 summarises outcomes reported in the included studies classified into the three 
categories: process of care, health, and satisfaction with healthcare. Pre-specified primary 
outcomes of studies are italicised.    
In PROM ± summary studies: a process of care outcome was reported in nine studies 
[31,32,37-40,45-47,51], of which two were primary outcomes [32,37]. In both studies that 
specified a process of care primary outcome intervention, patients reported a significant 
increase in the discussion of HRQOL issues with their clinician [32,37]. Four studies 
[31,38,47,51] either did not report if their process of care outcomes were of primary or 
secondary interest, or claimed to power their study around a primary outcome that consisted 
of multiple sub-components. While these studies reported statistically significant results, their 
findings are considered non-robust due to the lack of adjustment for multiple comparisons.  
Health outcomes were reported in 13 PROM ± summary studies [31,33-37,40,41,45-
47,49,52], of which four were primary outcomes [31,36,41,49]. A significant improvement in 
HRQOL and psychosocial health was reported in the Basch [31] and De Wit [36] studies 
respectively, whereas Velikova et al. [49] reported no significant difference in self-reported 
HRQOL, and McLachlan et al. [41] reported that the intervention did not significantly reduce 
the need for patient information regarding psychological and other health conditions. 
McLachlan et al. [41] reported a significant decrease in the spiritual needs of intervention 
patients, but without power for this comparison it was thus considered non-robust (Table 4.4). 
Cleeland [35] and Ruland [47] reported on studies whose outcomes had multiple sub-




4.3). These effects were similarly considered non-robust given no p-value adjustments for 
multiple comparisons (of sub-components) were made. Another seven studies 
[33,34,37,40,45,46,52] reported health outcomes without adequate power calculations for 
these comparisons, of which four reported significant non-robust results. In total, seven 
significant results for health outcomes were considered non-robust.  
Satisfaction with healthcare was reported in seven [34,36,37,40,41,50,51] PROM ± summary 
studies as one of the outcomes of interest, with none of these studies explicitly specifying it 
as their primary or secondary outcome. Significantly more intervention patients were reported 
to be satisfied with their emotional support [37], overall care [36], and management of pain 
[51] (male patients only); with results categorised as non-robust. Three studies [34,40,41] 
reported no significant difference between the groups, and one [50] reported a greater (but 
non-significant) satisfaction with care in the control group.   
In ± PROM studies (PROM completion with or without presentation of scores to clinicians 
vs. Standard Care): four studies [42,44,49] reported on process of care variables as one of 
their non-primary outcomes of interest. Of those, only Velikova [49] reported significantly 
(but non-robust) greater discussion of intervention patients’ HRQOL issues.  
Health outcomes were reported in five ± PROM studies [42-44,49] as primary outcomes. 
Significant improvement in HRQOL of intervention patients was reported by Velikova [49]. 
Four studies did not report any significant differences in health outcomes [42-44]. Health 
outcome variables were reported as secondary outcomes in Mills [42] and Velikova [49]. 
Mills [42] reported non-significant (and non-clinically meaningful) poorer lung cancer-
specific QOL in the intervention group, whereas Velikova [49] reported non-robust 




in the intervention group. The study by Hoekstra [39] reported on change in the prevalence 
and severity of several symptoms, some of which were reduced significantly, but the lack of 
adjustment for multiple comparisons rendered them non-robust. 
Comparisons on satisfaction with care for ± PROM studies were reported in three 
publications of RCTs [42,44], none of which were positive or statistically significant, thus 
there was no significant evidence that intervention patients were more satisfied than their 
comparator group regarding the healthcare that they received. 
Feasibility data (including physician satisfaction) on acceptance and the perceived usefulness 
of the PROM intervention tools were collected in nine studies [32-34,37,40,45,49,50,52] with 
largely positive results (Table 4.3).  
Methodological quality was evaluated using the Cochrane Collaboration’s Risk of Bias tool 
[30], with detailed assessment reported in Supplementary 2. The potential for bias was 
assessed in the domains of random sequence generation, allocation concealment, detection 
(blinding of outcome assessment), attrition (incomplete outcome data), and reporting 
(selective outcome reporting). The risk of introducing systematic error was found to be high 
in two studies on random sequence generation [46,48], two studies on allocation concealment 
[46,48], none on detection bias, two on attrition bias [40,46], and six on reporting bias 
[34,40,46-48,50]. Some studies had missing information, noted by the categorisation of 
domains as uncertain. Information regarding the likelihood of detection bias (blinding of 
outcome assessors/data analyst) and allocation concealment was missing in a large number of 





We considered the potential for performance bias (blinding of participants and personnel) 
difficult to avoid due to the nature of the PROM interventions. However, in one study authors 
acknowledged that they were able to blind patients and staff to the study hypothesis [44], but 
not to the interventions, and as such were considered to have low risk of performance bias. 
Apart from performance bias, reporting bias was the most common domain, being present in 
six studies [34,40,46-48,50]. Of those two were conducted in the internal medicine units, one 
in each of an arthritis, obstetrics and gynaecology, and neurology clinic, and one in a tertiary-
care cancer hospital.  
4.6 Discussion  
This systematic review of results from RCTs evaluating the use of PROMs in clinical practice 
categorised the reported comparisons into two groups. While in the first group of 18 studies 
[31-38,40,41,45-52], the intervention participants completed the PROM and had their PROM 
results presented to the clinicians providing their clinical care (PROM+/- summary), in the 
remaining seven studies [39,42-44,49] participants in the intervention group were simply 
asked to complete the PROM (+/- PROM). Reported results were grouped in one of three 
outcome categories: process of care, health, and satisfaction with care (Table 4.4). Analysis 
of tabulated results led to the following findings: more positive results were reported for 
health outcomes, compared to those for the process of care or satisfaction with care; PROM 
interventions worked better when PROM results were provided to clinicians; and the 
inclusion of PROM training to clinicians prior to a trial commencement appeared to result in 




Reviewed studies focused predominantly on statistically significant results, without typically 
mentioning whether they were clinically meaningful. If the results were positive but non-
significant, there was no consideration in the publication of whether this may have been the 
result of a smaller than necessary sample size. Equally, when results were positive and 
significant, there was no discussion of whether this was possibly due to an inflated Type I 
error resulting from multiple comparisons. This concurs with results from the methodological 
quality assessment, indicating that the most common form of bias was that of reporting bias, 
regardless of the study context. Indeed, when considering characteristics of studies that may 
have been more prone to bias in any one (or more) domains, no one type of study appeared 
more prone. 
All positive results were reported in this systematic review, regardless of significance, with 
Table 4.4 presenting a summary of the results differentiated by robustness, which includes 
studies reporting no evidence of a difference in treatment groups. 
For the 18 studies classified as PROM+/- summary, six [31,32,36,37,41,49] were powered to 
detect an effect for their pre-specified primary outcome (two process of care [32,37] and four 
health outcome variables [31,36,41,49]), with the remaining studies either not pre-specifying 
a primary outcome, not reporting on power calculations for pre-specified outcomes, or 
reporting that power calculations were performed for outcomes with multiple sub-
components without evidence of this. Of the four studies with health outcomes as their 
primary focus, two reported significant results in favor of the intervention group [31,36]. 
Non-significant improvement was reported in one study for the intervention group [41] and 
for the control group in another study [49]. Comparing the characteristics of studies reporting 
significant versus non-significant effects, there were no identifiable differences in sample 




Among seven studies [39,42,44,49] in the group classified as +/-PROM, none reported a 
process of care primary outcome. Five studies [42-44,49] reported a health outcome of 
primary interest with only one [49] reporting results in favor of the intervention, three 
reporting no significant evidence of a difference [43,44] and one reporting a non-significant 
poorer effect in the intervention patients [42]. Studies that failed to show any significant 
difference or reported poorer effects in intervention patients either stated that they did not 
achieve their desired sample size [42,44] or did not state this but appeared to have a relatively 
small sample size [43]. 
A total of 15 comparisons (in all identified studies) were on HRQOL/health status/PROM 
score outcomes [31,33,34,36,37,42-46,49,52]. One key observation noted in over half of 
these studies was the lack of discussion on what constitutes a clinically important difference. 
A predefined ‘clinically important’ and statistically significant difference in HRQOL was 
reported in only three comparisons [31,49]. The Mills study [42] reported non-significant 
non-clinically important poorer HRQOL in intervention patients, but while the Detmar study 
[37] found no significant difference in health status measured by SF-36; a significantly larger 
percentage of people in the intervention group had clinically meaningful improved SF-36 
scores [53]. The Velikova et al. PROM +/- summary comparison did not find any significant 
and clinically important HRQOL differences [49]. The remaining studies (8/15) [33,34,36,43-
46,52], simply referred to P values to oppose or support the PROM intervention without 
reference to whether differences were considered to be clinically meaningful. While P values 
can provide important evidence of a difference in average outcome scores, they indicate only 
the probability that study findings such as those reported (or more extreme) could have 
occurred due to chance alone if there really was no difference in the two groups in the 




(in general) the difference really matters to their patients, that is, if it was clinically 
meaningful [54,55].  
There are a large number of validated PROMs available for use (generic and disease-specific) 
and their selection for a particular clinical population can be challenging [56]. The fact that 
different PROMs are often designed for and used in different populations means that the 
recommendation of one particular PROM over another in any given scenario is generally not 
possible. Given that studies in this review reported some positive and robust effects of PROM 
interventions, there is likely to be value in the use of PROMs in clinical care.  
Thirteen studies provided training sessions to clinicians (and patients/families in some cases) 
on the interpretation and understanding of the PROM [34,36-38,42,45-52]. Contrary to our 
expectation that clinicians would be more engaged in the use of the PROMs if training was 
provided [57-59], there appeared to be no obvious difference in positive outcomes when this 
took place. Some studies assessed the feasibility of PROM use, but none evaluated changes in 
clinicians’ perceptions before and after the intervention and thus the role of the clinician in 
the use of PROMs may require further study to be understood.  
Compared to the previous literature [6,8-25], this systematic review provides more 
contemporary evidence on the use of PROMs in RCTs and additional information about the 
use of PROMs in children, by including two RCTs with patients under 18 years old. The fact 
that only two paediatric studies [36,52] met the inclusion criteria and were included in this 
review highlights the fact that little has been done to understand the value of PROMs in this 
context. It is well documented that children often struggle to communicate their health issues 
with parents and clinicians, and so a rationale for the use of PROMs to provide a voice for 




perceptions of talking to doctors, and in parents’ understanding of their child’s feelings. 
Clinicians also found PROM reports by children provided useful and new information in 
many cases [52]. While the study by Wolfe [52] did not report significant effects on primary 
health outcomes from the PROM intervention, a post hoc analysis of survivors beyond 20 
weeks showed significant improvement in the emotional subscale of the PROM and in 
overall sickness scores. These findings were even stronger in children aged 8 years and older 
who were more likely to have completed the PROM without a proxy. Hemmingsson [60] 
recommended the use of self-reporting paediatric PROMs whenever possible, or observable 
components of HRQOL when parent-proxy assessment is unavoidable, e.g. for young 
children. The De Wit [36] study on diabetic adolescents also reported a positive effect of 
PROMs on patients’ HRQOL and patient satisfaction with healthcare. Also, provided that 
haemoglobin A1C levels were kept under control, a positive effect of PROMs on 
psychological outcomes was reported [36]. 
 Methodological quality was evaluated using the Risk of Bias tool [30]. Detection bias occurs 
when outcome assessors are not blinded to the group allocation and study hypothesis. 
Although the studies in this review are considered pragmatic trials, blinding of the data 
analyst could have been achieved relatively easily.  
This review has several methodological strengths. To minimise bias and to ensure that the 
systematic review was conducted in a transparent manner, a review protocol was submitted to 
PROSPERO. There are several benefits of developing a review protocol a priori as outlined 
in the PRISMA statement on reporting items for systematic review and meta-analysis 
protocols [61], and they include assurance that methods are replicable and in line with current 




performed to reduce the possibility of missing relevant studies. An especially wide time 
frame, age range of target population, and disease type was considered.  
We acknowledge that there are some limitations of this review. Firstly, the inclusion criteria 
were restricted to studies published in the English language only. While this means we may 
have missed some important studies, it is unlikely that our conclusions would change given 
that previously documented systematic reviews included articles in multiple languages (in 
French, German, Italian, Russian, or Spanish) and yielded similar results [9,10]. Secondly, 
the relevance-screening was performed by a single author, and data were extracted by the 
same author, but the title, abstract, and keywords of a random 10% of the search were 
independently screened and inclusion criteria was modified after discussion with a second 
author (RN) and a more cautious (inclusive) approach was taken when screening. We 
acknowledge that single data extraction could result in missed items, and thus could affect the 
conclusions of a review. However, in an effort to minimise issues with interpretation, double 
extraction for the quality assessment and risk of bias analysis was performed. Thirdly, unlike 
previous systematic reviews, we excluded trials that claimed to use PROMs for screening of 
psychological conditions. Studies on psychological and mental health conditions were 
excluded from our systematic review. Patient-reported outcomes in these contexts are 
typically used for the purpose of diagnosing psychological or mental health conditions. Given 
that our focus was on the use of PROMs to effectively incorporate patient values and 
preferences in clinical encounters, these studies did not meet with the aim of our systematic 
review. Therefore, despite a much larger time frame for inclusion, there were fewer studies in 
this review compared to previous systematic reviews [6,9-22]. Our justification for this 
decision was our interest in the use of PROMs as a behavioural intervention and not as a 




part of a process to identify a disease at an earlier stage for secondary prevention, and thus 
identify patients who require follow-up, their use in this context is not optional. Hence, the 
use of PROMs as part of diagnostic tools for mental health disorders is different from 
proposing their use to inform patient-centred decision-making related to the choice of 
approach to care or treatment, and thus does not add to our evidence base. 
4.7 Conclusions 
Overall, positive findings in favor of the PROM intervention were reported on 21 occasions 
but the reported effects were robust in only five cases, i.e. statistically significant and 
adequately powered. Despite explicit CONSORT guidelines [27], many trials on PROM 
interventions failed to pre-specify their primary and secondary outcomes and/or adequately 
power their comparisons for clinically meaningful differences. Despite this, the combined 
evidence appears to support the use of PROMs to improve communication and decision-
making in clinical practice. It is vital that future trials on PROM interventions follow 
CONSORT guidelines and continue to contribute robust evidence on the use of PROMs in 
clinical practice.  
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4.9 Addendum: Elaboration of methodological issues identified in the 
included RCTs not included in the systematic review manuscript accepted 
for publication 
A sample size calculation for a predefined primary outcome was reported in only half of the 
included RCTs in the systematic review. Explicit reporting of sample size calculations and 
power calculations (and their underlying assumptions) is required by the CONSORT 
statement [27] and provide basic requirements to authentically accept or reject a hypothesis 
on the effectiveness of an intervention. In the included RCTs, results were highlighted if they 
were statistically significant and positive. The reported statistically significant and non-
significant positive results were not examined for their clinical significance in the majority of 
the included RCTs. Consideration of clinical significance was even more relevant to 15 
comparisons (in 12 RCTs) that reported comparisons on HRQOL/health status/PROM score 
outcomes [31,33,34,36,37,42-46,49,52], more than half of which did not report on what 
constituted a clinically important difference in their PROM outcome scores.  
The achievement of statistically significant differences in HRQOL/health status/QOL scores 
might look impressive for publication purposes (leading to publication bias—the most 
common type of bias found in the RCTs included in the systematic review), but if changes 
reported are not clinically meaningful, they are unlikely to provide enough evidence to bring 
change in clinical practice. A change in average PROM scores that is considered important 
by clinicians in consultation with experts on PROMs (i.e. considered clinically significant) is 
often needed to convince the healthcare industry for formulary and reimbursement decisions, 
clinicians to include PROM results in clinical consultations, patients to complete PROMs and 




resource allocation to support the regular use of PROMs in healthcare. Given that only 50% 
of the included 22 RCTs were adequately powered to find a pre-specified difference in a 
primary outcome, it is possible that studies reporting positive non-significant results were not 
achieve statistical significance because of their inadequate sample size. In addition, the 
reported positive significant results may have been achieved due to a lack of appropriate 
adjustment for the multiple comparisons that were made. These findings of the lack of 
specified clinically meaningful differences that were adequately powered and selective 
reporting of significant findings when multiple comparisons were made were not context 
specific as they appeared unrelated to study characteristics.    
Randomised controlled trials when performed rigorously can provide gold standard evidence 
on the effectiveness of an intervention. However, the absence of reporting of a sample size in 
RCTs affects the quality of the trial and makes its results less reliable. The importance of 
explicit reporting of sample size calculations and how its absence can affect conclusions of an 
RCT were highlighted first in 1994 by Moher et al. The authors concluded that the appraised 
RCTs not in favour of the intervention results did not have a sufficient sample size in 25% to 
50% of the cases [62]. Future RCTs performed on the effectiveness of PROMs or using 
PROMs as a primary outcome should include explicit sample size calculations for the main 
outcomes and the assumptions behind these which include statement of a difference that is 
considered clinically significant/meaningful.  
Since the use of PROMs in randomised controlled trials conducted for medical products 
development and labelling has been encouraged by the Food and Drug Administration (FDA) 
[63], a >500% increase in the use of PROMs in pre-market submissions to the Centre for 
Devices and Radiological Health over a period of six-years (2009-2015) has been observed 




difference would be considered clinically significant for a PROM as an intervention in the 
majority of RCTs considered in the Chapter 4 systematic review report it would be interesting 
to audit these pre-marketing submissions to analyse if their use of PROMs in the clinical 






Table 4.1. Characteristics of studies 
Publication 
ID 







sample size of 
healthcare 
providers  
Patient Population (sample size, age 
(years), condition/disease) 

















Sample size of 
healthcare 
providers was not 
reported 
Cancer patients  
n = 766 (C 42.42%) 
C mean age (range) 62 (26-88), I mean 
age (range) 61 (30-91)  
Sample size calculation was reported 










clinical team at 
the hospital   




n = 660 (C 49.54%) 
C mean age (range) 54 (18-86), I mean 
age (range) 54 (18-89) 





outpatient clinic at a 
tertiary-care hospital  
Australia 
Oncologists 
n = 4  
Oncology outpatients  
n = 80 (C 47.5%) 






internal medicine unit  
USA 
Four teams of 
internal medicine 
physicians  
n = 60 (C 47%) 
Patients with functional disability  
n = 497  
mean age of all participants at baseline 
59 









clinic at University of 





Sample size of 
healthcare 
providers was not 
reported 
Patients with primary lung cancer or 
lung metastasis  
n = 100 (C 52%) 
C mean age (SD) 60.9 (11.8), I mean 
age 59.2 (13.6) 
Sample size calculation was reported 
but there were multiple outcomes and 
P-values were not adjusted for the 
comparisons 
Not reported 
De Wit et al. 
2008 [36] 




n = 13 (C 46%) 
Patients with diabetes   
n = 80 (C 49%) 
C mean age (SD) 14.9 (1), I mean age 
(SD) 14.8 (1.1)  
Sample size calculation was reported 






n = 10 






Netherlands  n = 214 (C 47%) 
C men age (range) 55(24-81), I mean 
age (range) 58 (25-84) 




training clinic of Texas 




n = 27 (C 48%) 
Patient with at least one diagnosed 
chronic disease  
n = 62 
C mean age (SD) 66.9 (9.2), I mean 
age (SD) 70.3 (8.7) 










Rheumatologists  Arthritis patients  
 
Centre 1:356 I, 176 attention-placebo, 





 Centre 2: 614 I, 306 attention-placebo, 
and 290 C.  
Average age (centre 1=56, centre 2= 
57) 
Post hoc power calculation  
McLachlan 
2001 [41] 









n = 450  
Median age of all participants (range) 
61 (18-92)  













n = 76 (C 49%) 
N = 649 (C 50%) 
Sample size calculation was NOT 
reported 





1995 [46]  
University Primary 
Care Clinic Community 
internal medicine 




house officers  
n = 73 (C 45%) 
Primary care patients  
n = 557 (C 45%) 






inpatient clinics of a 





Sample size of 
healthcare 
providers was not 
reported 
Patients starting leukemia or 
lymphoma treatment  
n = 145 (C 48%) 
Sample size calculation was reported 
but there were multiple outcomes and 







Gynecology at Scott 




n = 7 
Prenatal patients  
n = 58 visits (C 47%) 
















n = 28 
Cancer patients 
n = 214 (C 33%) 
Mean age of all participants 54.9 SD 
(12.52) 









n = 2 
Epilepsy patients 
n = 163 patients (C 23%)  
210 clinical encounters (C 21%) 
C mean age (SD) 45(16),  I mean age 
(SD) 43(13) 









Three large urban 
health maintenance 
organizations internal 
medicine clinical sites  
USA 
Internists (n = 41) 
and nurse 
practitioners (n = 
=15) 
n = 56 (C 48%) 
Internal medicine patients 
n = 1522 











n = 69 
Progressive, recurrent, or 
nonresponsive cancer patients were 
included  
n = 104 (control 49%) 




PROM completed vs. PROM not completed  
Hoekstra 
2006 [39] 
Two hospitals in the 
Amsterdam region and 
general practitioners in 
the catchment area 
caring for cancer 
General 
practitioners 
n = 89 
Non-curable cancer with life 
expectancy of 1-12 months as judged 
by their physician 





patients in their 
palliative phase 
Netherlands  
C mean age 64.6, I mean age 64.1 
Sample size calculation was reported 
but there were multiple outcomes and 







Not reported Inoperable lung cancer patients 
n = 115 (C 50%)  
I age strata (n): <60 (21), 61-70 (18), 
70+ (18) 
C age strata (n): <60 (20), 61-70  (18), 
70+ (20) 
Sample size calculation was reported 
Not reported  
Qureshi 2001 
[43] 
Single primary care 
clinic with mix 




Sample size of 
healthcare 
Participants in the general 
practitioners’ list for 2 years 
n = 100 (C 50%) 




providers was not 
reported  
C mean age (range, median) 
43.14(30.75-53.5, 45.5) 
I mean age (range, median) 44.96 (36-
53,48) 
Sample size calculation was reported 
Rosenbloom 









Sample size of 
healthcare 
providers was not 
reported 
Advance lung, breast, or colorectal 
cancer  
n = 144 (C 49.3%) 
C mean age 60.4, I mean age 60.2 













Sample size of 
healthcare 
Advance lung, breast, or colorectal 
cancer  
n = 140 (C 51%) 
Mean age of all participants 59 















n = 28 
 
Cancer patients 
n = 142 (C 50%) 
Mean age of all participants 54.8 SD 
(12.52) 











n = 28 
 
Cancer patients 
n = 216 (C 33%) 
Mean age 54.9 SD (12.52) 
Sample size calculation was reported 
New patients 


















PROM completed and presented to clinicians vs. PROM completed without presentation to clinicians 
Basch [31] STAR Cancer specific Patients were randomised to control 
and intervention arms with 
stratification by ‘computer 
experienced,’ (CE) vs ‘computer 
inexperienced’ (CIE) groups. 
Self-
administered 
No training was 
provided  
Berry [32]  ESRA-C Cancer specific Patients were randomised to control 
and intervention groups after 
second application of PROM. 
Clinicians of intervention group 
patients received a summary of 




No training was 
provided  




Each time an intervention group 
patient completed the survey a 
Self-
administered 







summary graphical representation 
of anxiety and depression scores, 
list of debilitating physical 
symptoms in the past week, and 
supportive care needs plus 
management strategies was 
generated. Summary scores were 
added to patient charts  
Calkins [34]  FSQ Generic FSQ was applied to all patients. 
Summary report was only provided 
to intervention group physicians  
Phone A two-hour seminar 










MDASI Cancer specific On the occurrence of one or more 
symptom threshold in intervention 
group email with PROM response 
was sent to the surgical team’s 
advanced practice nurse  












Disease-specific HRQOL was monitored with 
PedsQL generic and PedsQL 
diabetes specific completed before 
3month appointment AND HRQOL 
scores were discussed with patient 
during the appointment; 




Training to interpret 
and discuss HRQOL 
scores  




Cancer specific  Intervention patients’ responses to 
QLQ-C30 were scored and printed 
as a graphical summary and were 
given to physicians and patients 
immediately before consultation; 




physicians had 30 min 
educational session on 
interpretation of QLQ-
30 summary score.  
Patients in the 
intervention group 
received a similar 
explanation via mailed 






explanation of the 
summary.  
No specific guidelines 
were provided for the 







Generic SIP scores were provided to the 
intervention group family 




The intervention group 
(n = 14) physicians 
received a one-hour 
introduction and 
written instructions on 
using SIP in clinical 
setting 
Kazis [40] AIMS, 
MHAQ 
Disease-specific Intervention consisted of 
application of PROMs followed by 
sending health status summary to 
clinicians on a quarterly basis over 
a 1-year period;  
Self-
administered 








A self-reported questionnaire was 
completed and summary reports 
Self-
administered 














were available immediately for 
consideration during clinical 
consult. Study coordination nurse 
discussed the summary with patient 









Generic Questionnaire was applied to all 
patients; a 1-page summary report 
resembling laboratory test result 
was provided only to physicians of 




I group physicians 
attended a single two-












Generic  Both the experimental and control 
groups completed the questionnaire.  
The experimental group physicians 
were given functional status 
summary reports and management 
guidelines regarding patient deficit 
attached to the front of each new 
patient's medical record  
Self-
administered 
The I group physicians 
attended an initial and 







Ruland [47] ITPAs Cancer specific All patients completed baseline 
questionnaire and a choice 
Interactive Tailored Patient 
Assessment (ITPA). Summary of 
intervention group patients added to 




Training provided, but 
details were not 
reported  
Street [48]  SF-36 
 
Generic All patients completed SF36 over 
phone 1-2 days before the 
consultation.  
Experimental group’s information 
was included to in their medical 
record  
Phone I physicians were 
educated about the 
PROM report structure 
and told that it would 












Cancer specific Both groups completed PROM 
questionnaires on a touch screen 
computer program and the graphic 






about interpretations of 
PROM scores, and to 
review examples of 
HRQOL and clinical 




They were asked to 
review and use the 
HRQOL results, unless 




displayed in clinics.  
No recommendations 
for specific responses 
were made. 
Wagner [50] SF-36 Generic Baseline SF36 was completed by all 
patients (no feedback was provided 
at that time), At 6 months f/u the 
health status profiles of intervention 
group were printed and handed to 




Two 1-hour training 
sessions were 
conducted by principal 
investigator and a 
nephrologist with 
previous experience of 
using health status 





Another session to 
discuss the experiences 
of physicians was 
conducted three 
months after the start 
of I arm. 
Wasson [51]  COOP charts  Generic  COOP charts were applied to 
intervention group patients, who 
were instructed to hand the results 
to their clinicians 
Self-
administered 
I group clinicians were 
educated about the use 
of PROM in a 10 















generic,   
PQ-MSAS is 
cancer specific 
Summary report was provided to 
families immediately after 
completion, and to clinicians before 
the clinic visit; email alerts were 
sent to oncologist, nurse, and 
psychosocial clinician, the 
palliative care service, and when 
pain was reported to pain service.  




PROM report was 
provided to families at 
enrolment and 
annually to healthcare 
providers. 
No training was 




providers about how to 
respond to email alerts. 







Cancer specific  The Symptom Monitor was 
completed by intervention group 
only and patients were encouraged 
to take the questionnaire to the 













Cancer specific EORTC-C30 plus related lung 
cancer module LC13; patients could 
share their diary information to 




Basic training on 
layout of diary was 
provided 
Qureshi [43]  Family 
history 
questionnaire  
Generic Family history questionnaire was 
applied to the intervention group 
patients. They were told that the 



















Cancer specific Intervention patients completed 
PROM at baseline and 1, 2, 3 and 6 
months and their PROM scores 
were shared with treating nurses 
before consultation with patients.  
Self-
administered 













Cancer specific Intervention patients completed 
PROM at baseline and 1, 2, 3 and 6 
months; PROM scores were shared 
with treating nurses, and a 
structured interview (by a trained 
interviewer) about the patients’ 
responses was conducted at 
baseline, 1, and 2 months.  
Self-
administered 










Cancer specific Intervention group completed 
PROM questionnaires on a touch 













Process of healthcare Health outcomes Satisfaction with healthcare 
PROM completed and presented to clinicians vs. PROM completed without presentation to clinicians 
Basch [31]  Intervention patients had 
significantly fewer emergency 
visits at 1 year (p = 0.02).  
Intervention patients received 
significantly longer duration of 
palliative chemotherapy  
(p = 0.002)  
There was moderate evidence of 
a smaller proportion of 
intervention patients hospitalised 
at 1 year (45% vs. 49%; p = 
0.08) 
Clinically meaningful 
HRQOL (evaluated by EQ-
5D) improved in the I Vs. C 
21% Vs. 11% (p = 0.0059) 
At 1 year, quality adjusted 
survival was significantly 
different between I vs. C 
(mean of 8.7 vs. 8.0 months) 
p = 0.004  
73% of I participants completed the PROM at 





No significant difference in the 
number of nursing calls to 
patients during participation  
Berry [32]  Intervention patients had 
increased likelihood of SQLI, 
that were reported problematic 
at first, being discussed  
(p = 0.032).  
No significant difference in the 
average length of clinic visit.  
Not reported Of enrolled clinicians, 43.1% completed 
questionnaire on PROM usability.  
Clinicians found PROM useful in: identifying 
appropriate areas of SQLI (67.8%), guiding the 
interview (64.3%), promoting communication 





Not reported Intervention patients 
reporting debilitating 
symptoms at visit 2 were 
significantly less likely to 
report debilitating symptom 
at visit 3 (P = 0.04), and 
reported significantly lower 
mean depression scores  
(p = 0.02). 
Patients found PROM easy to complete, a good 
way for doctors to get patients’ well-being 
information and were willing to complete the 
PROM at each visit. 
Oncologists felt that the feedback was useful, 





Intervention patients reported 
non-significant reduction in 
mean anxiety scores, in 
number of patients classified 
as clinically anxious or 
clinically depressed or with 
moderate or high 
psychological needs . 
Half (n = 2) of the oncologists felt that the 
discussion of feedback report with their patients 




Not reported FSQ subscales: 
Intervention patients had 
significantly fewer bed days 
(p < 0.05). 
Intervention patients had non-
significant improvement in 
restricted activity days, basic 
activities of daily living, 
intermediate activities of 
daily living, mental health, 
Intervention patients were non-significantly 





and quality of interaction; and 
work performance.  
Intervention patients had non-




Not reported Intervention patients had 
significant reduction in the 
number of symptom threshold 
events (pain, distress, sleep, 
shortness of breath, 
constipation) p = 0.003.  
Intervention patients were significantly more 
comfortable with the PROM reporting system  
(p = 0.03) and rated the system easy to use  
(p = 0.01). 
 
De Wit et 
al. [36] 
Not reported Significant improvement in 
HRQOL at follow- up 
compared to baseline in I 
patients CHQ-CH87  
(p = 0.006), vs C 
I vs C no significant 
difference on physical health 
(CHQ-CH87), family conflict 
At 1 year f/u:  
I vs C significantly more satisfied with their care 




(DFCS), or depression (CES-
D) 
I vs C no significant 
difference in Hb A1C level  
Note: baseline A1C level had 
confounding effect on 
psychosocial summary scale. 
For lower A1C level patients, 
psychological outcome 
significantly improved in the 
intervention group and 
remained stable for controls. 
Whereas, at highest A1C 
level >9.5 there was no 
difference in the baseline and 
f/u scores of I &C. 
Detmar [37]  HRQOL issues were discussed 
more frequently in intervention 
group. Significant differences in 
discussion of fatigue (p = 0.02), 
No significant difference in 
any of the SF-36 scales. 
Intervention patients had significantly greater 
satisfaction with the degree of emotional support 




dyspnea (p = 0.02), and social 
functioning (p = 0.05)  
Intervention patients received 
more counseling on managing 
their health problems (p < 0.05); 
No significant differences in 
medication prescription, 
ordering of tests, referral to 
other providers and mean 
duration of visits   
Larger percentage of I vs C 
showed improvement of 0.5 
SD* or more in mean health 
(43% vs. 30% p =0.04) and 
role function (22% vs. 11%  
p = 0.05) 
*a change of 0.5 SD is 
considered a clinically 
important difference. 






No significant difference in 
return visits to the family 
physician; referrals to other 
physicians or allied health 
professionals or to social or 
community services. 
Not reported Not reported 
Kazis** 
[40] 
AIMS study group (one of the 
centres): Intervention patients 
had non-significant decrease in 
Intervention patients in the 
MHAQ group had non-
No significant differences in patient satisfaction 






the number of visits to doctors in 
the previous three months. 
Intervention patients had non-
significant increase in the drug 
category change over one year, 
and more referrals to other 
arthritis health professionals 
over one year.  
MHAQ group: Intervention 
patients had non-significant 
reduction in the number of visits 
to doctors in previous three 
months, and referrals to other 
arthritis health professionals 
over one year.  
Intervention patients had a non-
significant increase in drug 
category change over one year 
significant increase in 
compliance  
Control group had non-
significantly better 
compliance in AIMS group. 
 
Physicians found PROM report helped in patient 
management (79%), had moderate to substantial 
value (55%), contributed to doctor-patient 
relationship (no percentage reported) 
2/3rd physicians always examined the report and 
filed them in on patient chart, 50% discussed it 
with patients most of the time, 38% never 








Not reported Intervention patients had non-
significant reduction in their 
psychologic and health 
information needs 
Intervention patients had 
significant reduction in 
spiritual needs at 6 months 
(P<0.02). 





No significant difference in the 
number of office visits to 
physicians; hospitalisations; 
contacts with nurses, physical 
therapists, or other health 
professionals; new medications 
started; medical equipment 
purchased; or new diet or 
exercise regimens 
Intervention patients non-
significantly improved on 
three subscales of PROM 
questionnaire (Intermediate 
Activities of Daily living, 
Frequency of social contact, 
and Sexual satisfaction).  
Control group non-
significantly improved on 
eight subscales. 
Physicians found the PROM accurate and useful 
(97%), felt that it would improve patient health 
and physician-patient communication (43%), 












Intervention patients were more 
likely to have a specific 
treatment plan for their 
symptoms  
(p = 0.05), had more medical 
and functional status problems 
listed in the visit notes (p < 
0.01), were more likely to be 
identified as having physical, 
psychological, social or 
functional status problems (p < 
0.05), and had more diagnosis of 
depression (p < 0.05) and 
anxiety (p < 0.001) 
Intervention patients had 
significantly better Mental 
Health scores (p < 0.03), and 
Social Activities scores for 
people >70 years (p = 0.03). 
Intervention patients’ scores 
for Basic Activities of Daily 
Living, Social Activities, and 
Work Performance improved 
non-significantly.  
Control group had non-
significant improvement in 
the Intermediate Activities of 
Daily Living. 
Not reported 
Ruland [47]  Significantly increased number 
of symptoms addressed by 
physicians and nurses in the 
inpatient and outpatient records 
Intervention patients had 
significantly reduced 








of intervention patients  
(p < 0.05)  
 
concentration/memory, 
activities of daily living/self-
care, and worries/concern 
(P<0.01); bleeding/infection 
and sexuality (P<0.05). 
Control patients had 
significant reduction in 
symptom distress in 
worries/concern (p = 0.03)  
Street* [48]  
 
Not reported Not reported Non-significant increase in intervention patients’ 




parison 1)  
 
Not reported No significant difference was 
found in the emotional well-
being, physical well-being, 
functional well-being, and 





Control patients had non-
significant improvement in 
HRQOL 
40% Intervention patients had 
clinically meaningful 
improvement, whereas 32% 
of controls.  
Wagner 
[50] 
Not reported Not reported Physicians reported that availability and 
discussion of PROM: resulted in change in 
therapy (12.3%), was at least moderately useful 
for communication with patients (14.2%), and 
helped with patient management (8.4%).  
Physicians indicated the PROM result 
lengthened 67% of the encounters. 
Intervention patients’ perception that their doctor 
considered how they felt emotionally and 
considered their usual daily activities when 




Control patients showed non-significant increase 
in patients’ satisfaction with clinical encounter, 




Female Intervention patients had 
significant increase in the 
ordering of tests and procedures 
(p<0.001).   
Male Intervention patients had 
non-significantly increased 
ordering of tests and procedures  
 
 Not reported Male Intervention patients significantly reported 
receiving greater help with functional problems 
related to pain (p = 0.016 
Male Intervention patients were significantly 






 Not reported No significant change in 
average scores of PQ-MSAS, 
PedsQL4.0, or Sickness 
scores during 20 weeks f/u 
Post hoc analysis: survivors 
beyond 20 weeks I vs. C 
PedsQL4.0 emotional score 
52% children, and 71% parents found reports 
easy to understand.  
28% children and 54% parents thought reports 





(by an average of +6 points) 
and overall sickness scores 
(average -5.3 points) 
significantly improved. 
Post hoc analysis: Children 
>= 8 years.  
I vs. C PedsQL4.0 emotional 
score (by an average of +8.1 
points) and overall sickness 
scores (average -8.2 points) 
significantly improved. 
 
75% parents agreed that PROM reports helped 
them understand their child’s feelings. 
21/34 providers completed satisfaction survey. 
50% found reports useful when speaking to their 
patients and did not cause increase in 
consultation time. 
Reports provided new information (61% on 
psychosocial issues; and 22% physical 
symptoms).  
Reports contributed at least sometimes to their 
decision to initiate a psychosocial (56%), pain 
(34%), social work (33%), or palliative care 
(29%) consult and to discuss goals with families 
(36%). 




Not reported Intervention patients had 
significant reduction in the 
prevalence of constipation 





 (p<0.01); and a non-
significant reduction in 
fatigue, pain, lack of appetite, 
shortness of breath, 
sleeplessness, nausea, and 
diarrhea.  
Intervention patients had non-
significant increase in the 
prevalence of cough.  
Intervention patients 
displayed reduced severity of 
all reported symptoms, except 






No significant associations at 2 
and 4 months regarding the 
discussion of patient problems 
with healthcare professionals 
Intervention patients QOL 
declined non-significantly 
(and non-clinically 
meaningful) (p = 0.14);  





47% Intervention vs. 32% 
controls had clinically 
meaningful declined QOL; 
this difference was non-
significant. 
52% Intervention vs. 26% 
controls had clinically 
meaningful* decline in lung 
cancer specific QOL  
(p = 0.03) 
*a difference of 6 or more is 
considered clinically 
meaningful.   
Qureshi 
[43] 
Not reported No difference in anxiety 
scores at three months 
The only significant difference in the perception 
of self-health was found in response to the 
question ‘what do you think is your risk of 
developing something wrong in the future?’ 26% 




patients gave a negative response to this 
(Fisher’s exact test, two-tailed, p = 0.025). 
There was no significant difference in having 





No significant difference in 
clinical treatment changes 
between the groups  
There was no significant 
difference in HRQOL across 
the groups  
No significant difference in general satisfaction, 




parison 2)   
No significant difference in 
clinical treatment changes 
between the groups  
There was no significant 
difference in HRQOL across 
the groups  
No significant difference in general satisfaction, 




parison 2)  
 
Not reported Intervention patients had 
significant improvement in 
HRQOL (p = 0.01), physical 
well-being (p = 0.003). 
No significant difference was 
found on emotional well-





and social or family well-
being   
32% of Intervention patients 
and 24% of control patients 
showed clinically meaningful 
improvement in HRQOL  
Velikova 
[49] (com-
parison 3)  
 
Intervention patients had 
significantly more HRQOL 
symptoms mentioned during the 
clinical encounter (p = 0.03). 
No significant difference was 
found in the number of other 
symptoms discussed, and length 
of clinical encounter, medical 
decisions, and non-medical 
decisions. 
Intervention patients had 
significant improvement in 
HRQOL (p = 0.006), 
emotional well-being (p = 
0.008), physical well-being  
(p = 0.006), functional well-
being (p = 0.03).  
No significant difference was 
found in social or family 
well-being.  
40% of Intervention patients 
and 24% of control patients 
Physicians explicitly mentioned/referred to 
HRQOL data in 64% of intervention encounters, 
43% found HRQOL information clinically very 
useful, 28% found it somewhat useful, 21% 
found it a little useful, and 9% found it not 
useful.  
Physicians found that HRQOL data provided an 
overall assessment of patients (69%), additional 
information (33%), identified problems for 
discussion (27%), and contributed to patient 
management (11% encounters).  
Oncologists did not use the HRQOL information 




showed clinically meaningful 
improvement in HRQOL  
encounter or irrelevant to patients’ major 
problems.’  
Notes: AIMS: Arthritis Impact Measurement Scales, CHQ-CF87: 87-item child report version of the Child Health Questionnaire, 
CES-D: 20-item Center for Epidemiological Studies scale for Depression, C: Control group, DFCS: Diabetes Specific Family 
Conflict Scale, HRQOL: health-related quality of life, I: intervention group, MHAQ: Modified Health Assessment Questionnaire, 
PEQ-D: Patient Evaluation of the Quality of Diabetes Care, PedsQL4.0: Pedatric Quality of Life Inventory, STAI: Spielberger 
State Trait Anxiety Inventory, PQ-MSAS: PediQUEST Memorial Symptom Assessment Scale, PCQ: Psychological consequences 
questionnaire, PROM: Patient-reported outcome measure, QOL: Quality of life, SD: Standard deviation, SQLI: Symptoms and 
quality-of-life issues, FSQ: Functional Status Questionnaire, Hb A1C: Haemoglobin A1C, EQ-5D: EuroQoL 5D, HRQOL: health-
related quality of life 
Sections are italicised when pre-specified primary outcomes of studies were detailed 
*No sample size calculation was reported 
**A post-hoc power calculation was performed, no pre-specified primary outcome 
***No pre-specified primary outcome 
****Sample size was calculated but was not achieved for the comparison 






Table 4.4. Summary of reported results for comparisons in both panels 
 
 1. PROM results to clinician vs. no PROM 
results to clinician (n = 18) 

























Processes of care 3 4 2 3 1 0 
Health outcomes 4 7 2 4 1 1 
Satisfaction 4 3 0 3 0 0 
Note: Reported effects were considered ‘robust’ if they were statistically significant and pertained to a single reported comparison 
or there was evidence that the study was adequately powered for more than one comparison. Other positive effects were classified 

















































c Records identified 
through database 
searching after removal 
of duplicates  
(4302) 








other sources (2) 
Records excluded on relevance-screen 
(title, abstract, and keywords) 
(4225) 
Records excluded, 
with reasons  
(Total 94) 
1. PROM was not 
the intervention 
(22) 






5. Pain Measure 
(1) Records included on full 
text screen (22) 
Full-text articles assessed 
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4.11 Supplementary 1: Search Strategy 
Primary care.mp OR General practi*.mp OR Primary health*.mp OR Family practice.sh OR 
family practice.mp OR Family physicians.sh OR family physician*.mp OR Family 
practice.mp OR Family medicine.mp OR general medical setting*.mp OR  medical 
inpatients.mp OR (clinical oncology adj2  practice).mp OR (oncology adj2 clinical 
practice).mp OR routine oncology practice.mp OR outpatient oncology practice*.mp OR 
outpatient adj2 oncology clinic*.mp OR cancer outpatient clinic*.mp OR cancer center.mp 
OR cancer centre.mp OR cancer centres.mp OR oncology department.mp OR cancer 
survivors.mp OR cancer survivor.mp OR (general adj3 medicine clinic).mp OR neurology 
patient*.mp OR community practice*.mp OR emergency department.mp OR (inpatient OR 
inpatients).mp OR (palliative phase.mp AND cancer.mp) OR (feedback adj3 
oncologist*).mp. OR patient-reported cancer need*.mp 
AND  
patient-reported outcome*.mp OR treatment intention*.mp OR functional assessment 
instrument.mp OR functional status questionnaire*.mp OR intention to treat.mp OR 
(awareness adj3 clinicians).mp OR health personnel attitude.xm OR attitude of health 
personnel.mp OR patient referral.mp OR physician patient relations.xm OR physician patient 
relations*.mp OR self report* questionnaire*.mp OR (self administered adj3 
questionnaire*).mp OR (self administered adj3 interview).mp  OR self report screening.mp 
OR screening questionnaire*.mp OR self-assessed health status.mp OR self rating scale*.mp 
OR patient satisfaction.xm OR patient satisfaction.mp OR physician satisfaction.mp OR 
consumer satisfaction.xm OR consumer satisfaction.mp OR physicians prescription 




OR (health status report OR health status reports OR health status questionnaire*).mp OR 
symptom monitor.mp OR cancer related pain.mp OR (communication adj5 patient 
problem*).mp. OR attention towards symptom*.mp 






4.12 Supplementary 2: Risk of bias assessment 
Author’s name Basch [31] 




Low Randomisation was conducted via a computer 
system using randomly permutated blocks 
Allocation concealment  Low The patients in each subgroup were 
independently allocated to self-reporting 
versus usual care 
Performance: blinding 
participants and patients 
Not 
applicable 
Non-blinded, randomised, controlled trial of 
web-based self-reporting of symptoms 
Pragmatic trial 
Detection bias: blinding of 
outcome assessment   
Not 
applicable 
Not applicable  
Attrition bias: incomplete 
outcome data 
Low Sensitivity analyses were performed to justify 
assumptions about missing data 
Reporting bias: selective 
outcome reporting 
Low Pre-specified outcomes (primary and 
secondary) were reported  
Other sources of bias Low Judged based on overall RCT methods 
Author’s name Berry [32] 







Low After second assessment patients were 
randomly assigned automatically by the 
ESRA-C application to study groups (1:1) 
Allocation concealment  Low Automated assignment 
Performance: blinding 
participants and patients 
Not 
applicable 
Not possible to blind the clinicians (recipient 
of intervention e.g. summary PROM scores); 
no report of blinding patients and outcome 
assessors  
Pragmatic trial  
Detection bias: blinding of 
outcome assessment   
Uncertain  Not reported   
Attrition bias: incomplete 
outcome data 
Low Patients were randomised at second  
application of PROM and outcomes were 
assessed by audio recording of the session. No 
missing data 
Reporting bias: selective 
outcome reporting 
Low One primary and two secondary outcomes 
were pre-specified and reported 
Other sources of bias Uncertain Judged based on the overall RCT methods 
Author’s name Boyes [33] 




Low Participants were alternately allocated, by the 





Allocation concealment  Low Computer assisted allocation to groups 
Performance bias: blinding 
participants and personnel 
Not 
applicable 
No description reported; pragmatic trial   
Detection bias: blinding of 
outcome assessment 
Uncertain Not reported 
Attrition bias: incomplete 
outcome data 
Low Similar proportions missing in intervention and 
control groups.    
Reporting bias: selective 
outcome reporting 
Low Reported both positive and negative results 
Other sources of bias Uncertain Judged based on overall RCT methods 
Author’s name Calkins [34] 




Uncertain  We selected up to eight patients at random 
from each physician’s panel.  
Allocation concealment  Uncertain   Same as above  
Performance bias: blinding 
participants and personnel 
Not 
applicable 
Not reported if the participants (patients) were 
blinded.  
Not possible to blind physicians as only the 
intervention group physicians were offered 




report was handed to and added to the medical 
record of intervention physicians only.  
Pragmatic trial  
Detection bias: blinding of 
outcome assessment 
Uncertain   Not reported  
Attrition bias: incomplete 
outcome data 
Low Similar proportions missing in intervention and 
control groups.    
Reporting bias: selective 
outcome reporting 
High  Non-significant results were also reported, 
however no primary or secondary outcomes 
were pre-specified 
Other sources of bias Uncertain  Judged based on overall RCT methods 
Author’s name Cleeland [35] 




Low Random assignment was completed 
electronically by  
M.D Anderson’s System Inventory  
Allocation concealment  Low Same as above  
Performance bias: blinding 
participants and personnel 
Not 
applicable 
Not reported  





Detection bias: blinding of 
outcome assessment 
Uncertain  Not reported  
Attrition bias: incomplete 
outcome data 
Low Similar proportions missing in intervention and 
control groups.    
Reporting bias: selective 
outcome reporting 
Low Pre-specified primary and secondary outcome 
were reported in results section 
Other sources of bias Uncertain Judged based on overall RCT methods 
Author’s name Detmar [37] 




Low The physicians were initially assigned, at 
random, to either the intervention or control 
condition.  
Allocation concealment  Uncertain Not reported  
Performance bias: blinding 
participants and personnel 
Not 
applicable  
Pragmatic trial  
Detection bias: blinding of 
outcome assessment 
Low Coding was performed by 3 trained raters who 
were blinded to group assignment 
Attrition bias: incomplete 
outcome data 
Low Similar proportions missing in intervention and 
control groups.    
Reporting bias: selective 
outcome reporting 
Low One primary outcome, and four secondary 
outcomes were specified a priori 





There was a buffer period of two months before 
the physicians were switched to the other group 
Author’s name De Wit [36] 




low Cluster randomization of four centers: two 
intervention and two control  
Allocation concealment  Not 
applicable 
Not Applicable 
Performance bias: blinding 
participants and personnel 
Uncertain Not reported 
Detection bias: blinding of 
outcome assessment 
Uncertain Not Reported  
Attrition bias: incomplete 
outcome data 
Low Similar proportions missing in intervention and 
control groups.    
Reporting bias: selective 
outcome reporting 
Low Outcomes were predefined and all of them 
were reported in the results section 
Other sources of bias  Uncertain  Judged based on overall RCT methods 
Author’s name Qureshi [43] 




Low A block randomization process was used. This 
involved allocating patients to one of the three 




and the first 26 females were selected from 
each stratum. Within each of these six groups, 
patients were allocated at random to 
intervention or control group. The allocation 
occurred prior to recruitment  
Allocation concealment  Uncertain  Not reported  
Performance bias: blinding 
participants and personnel 
Not 
applicable   
Clinic staff was unaware of the purpose of the 
study 
Not possible to blind as only intervention group 
patients completed the questionnaire 
Pragmatic trial  
Detection bias: blinding of 
outcome assessment 
Uncertain Not reported  
Attrition bias: incomplete 
outcome data 
Low Similar proportions missing in intervention and 
control groups.    
Reporting bias: selective 
outcome reporting 
Low One primary and two secondary outcomes were 
specified in the methods. 
Other sources of bias Uncertain   Judged based on overall RCT methods 
Author’s name Goldsmith [38] 




Low The providers were first stratified into four 




then randomly assigned to experimental and 
control groups so that each group had 
approximately equal number of faculty, first, 
second, and third year residents.  
Allocation concealment  Uncertain Not reported   
Performance bias: blinding 
participants and personnel 
Not 
Applicable 
Pragmatic Trial  
Detection bias: blinding of 
outcome assessment 
Low A retrospective chart review of patients 
participating in the study was conducted by the 
principal investigator ‘blinded’ to the patient’s 
group 
Attrition bias: incomplete 
outcome data 
Uncertain Not reported 
Reporting bias: selective 
outcome reporting 
Uncertain Not reported 
Other sources of bias Uncertain  Judged based on overall RCT methods 
Author’s name Hoekstra [39] 




Low  All patients who had given informed consent 
were randomised to either the intervention or 
the control group. Randomization took place 




all patients who were subsequently included by 
this GP were allocated to the same group 
Allocation concealment  Uncertain Not reported 
Performance bias: blinding 
participants and personnel 
Not 
Applicable 
Pragmatic trial  
Detection bias: blinding of 
outcome assessment 
Uncertain Not reported  
Attrition bias: incomplete 
outcome data 
Low Similar proportions missing in intervention and 
control groups 
Reporting bias: selective 
outcome reporting 
Uncertain No outcome (s) identified as primary  
Other sources of bias Uncertain  Judged based on overall RCT methods 
Author’s name Velikova [49] 




Low The random assignment was unbalanced 2:1:1 
in favour of the intervention group and 
stratified by site of cancer in random permuted 
blocks (block size was 8). Random assignment 
was carried out by telephone, by the 
Administrative Office at Cancer Research UK 
Centre (Leeds).  




Performance bias: blinding 
participants and personnel 
Not 
applicable   
 Pragmatic trial  
Detection bias: blinding of 
outcome assessment 
Low Coding was performed directly from the audio 
taped by three raters, blinded to patient identity  
Attrition bias: incomplete 
outcome data 
Low  Similar proportions missing in intervention and 
control groups (slightly more in control arms. 
Reporting bias: selective 
outcome reporting 
Low Two primary and five secondary outcomes 
specified.  
Other sources of bias High  Several outcomes - could lead to cherry picking 
significant results 
Author’s name Mills [42] 




Low Patients were randomly assigned to 
intervention or control groups using block 
randomization with computer generated 
random numbers  
Allocation concealment  Low Patient were randomised with a computer 
program  
Performance bias: blinding 
participants and personnel 
Not 
Applicable 
Pragmatic trial   




Completion of a mailed QOL questionnaire 




of the trial, and therefore blinding of outcome 
assessor was not applicable  
Attrition bias: incomplete 
outcome data 
Low  Similar proportions missing in intervention and 
control groups 
Reporting bias: selective 
outcome reporting 
Low One primary outcome identified in the methods 
and reported in the results section 
Other sources of bias High  Several secondary outcomes  
Author’s name Kazis [40]  




Low In the BU component of the study, 710 RA 
patients from 12 community practices were 
randomised into three groups within each 
practice. The VU component involved 1210 
RA patients from 15 practices, also randomised 
into three groups within each practice. 
Allocation concealment  Uncertain Same as above 
Performance bias: blinding 
participants and personnel 
Not 
Applicable 
Pragmatic trial   
Detection bias: blinding of 
outcome assessment 
Uncertain Not reported  
Attrition bias: incomplete 
outcome data 
High Multi-center study: 80% of patients completed 




center. No comparison was made between the 
completers and non-completers  
Reporting bias: selective 
outcome reporting 
High  No primary outcome identified at the start of 
the study  
Other sources of bias Uncertain  Judged based on overall RCT methods 
Author’s name McLachlan [41] 




Low Computer-generated randomization charts were 
prepared for each clinic and held in the 
statistical office  
Allocation concealment  Low Same as above  
Performance bias: blinding 




Detection bias: blinding of 
outcome assessment 
Uncertain  Not reported 
Attrition bias: incomplete 
outcome data 
Low Similar proportions missing in intervention and 
control groups 
Reporting bias: selective 
outcome reporting 
Low  Two primary outcome variables were specified 
a priori. 
Other sources of bias High  Secondary outcomes mentioned but not 
specified a priori; many secondary outcomes 
could have led to cherry picking 








Low ‘After signing informed consent, patients were 
randomly assigned to one the three condition.’ 
Random assignment of participants was 
stratified by primary cancer diagnosis to ensure 
balance across treatment arms. 
Allocation concealment Uncertain Same as above 
Performance bias: blinding 
participants and personnel 
Low  The author acknowledges in the discussion 
that they were able to blind the patients and 
staff to the study hypothesis but they could not 
be blinded to group assignment 
Detection bias: blinding of 
outcome assessment 
Uncertain Not reported  
Attrition bias: incomplete 
outcome data 
Low  Patient did not complete assessment due to 
worsening illness (10) or death (46). Logistic 
regression analysis indicated that type of cancer 
and baseline quality of life scores were 
associated with study dropout. Dropout was not 
random, and therefore analysis was performed 
to account for the dropouts. 
Reporting bias: selective 
outcome reporting 
Low Primary outcome identified in the methods 
section.  




Author’s name Rubenstein [45] 




Low  Physicians and their patients were randomised 
to the experimental or the control group. 
Physicians in the group practices whose 
partners were in the study were randomised 
together.  
Allocation concealment  Uncertain  Not reported  
Performance bias: blinding 
participants and personnel 
Not 
Applicable 
Pragmatic trial  
Detection bias: blinding of 
outcome assessment 
Uncertain Not reported 
Attrition bias: incomplete 
outcome data 
Low  Similar proportions missing in intervention and 
control groups 
Reporting bias: selective 
outcome reporting 
Low  Primary outcome was pre-specified 
Other sources of bias High  Multiple secondary outcomes  
Author’s name Rubenstein [46] 




High  (Non-random) allocation was stratified by 
gender and by medical education program 




medicine). Patients were alternatively assigned 
to the modules according to the order in which 
they called the clinic. The experimental module 
was determined by coin toss.  
Allocation concealment  High  Probably high as the random sequence 
generation is high 
Performance bias: blinding 
participants and personnel 
Not 
Applicable 
Pragmatic trial  
Detection bias: blinding of 
outcome assessment 
Low  Medical records were reviewed by a non-
physician abstractor, and were over-read by a 
physician; both were blinded to group 
allocation  
Attrition bias: incomplete 
outcome data 
High  Only 190/309 experimental, and 152/248 
control group patients completed the study. The 
non-completers were significantly younger, 
more disabled, more socially isolated, and more 
financially distressed at enrolment that were the 
completers  
Reporting bias: selective 
outcome reporting 
High  Multiple outcomes, primary outcome not 
specified  
Other sources of bias Uncertain  Judged based on overall RCT methods 
Author’s name Ruland [47] 







Low  patients were randomised into the intervention 
or control group via a computer-generated 
minimization algorithm that equalized the 
groups on gender and type of treatment 
Allocation concealment  Low Same as above  
Performance bias: blinding 
participants and personnel 
Not 
Applicable 
Pragmatic trial   
Detection bias: blinding of 
outcome assessment 
Low  Two raters blinded to patients’ study group 
assignment conducted independent chart audits  
Attrition bias: incomplete 
outcome data 
Low Similar proportions missing in intervention and 
control groups 
Reporting bias: selective 
outcome reporting 
High  Multiple outcomes, no pre-specified primary 
outcome  
Other sources of bias Uncertain  Judged based on overall RCT methods 
Author’s name Street [48] 




High The study design was implemented by 
assigning patients and physicians to the control 
condition for the first 2 weeks of the month and 
to the experimental group for the remainder of 
the month.  




Performance bias: blinding 
participants and personnel 
Not 
Applicable 
Pragmatic trial   
Detection bias: blinding of 
outcome assessment 
Uncertain Not reported  
Attrition bias: incomplete 
outcome data 
Uncertain  Not reported  
Reporting bias: selective 
outcome reporting 
High  No primary or secondary outcome pre-
specified  
Other sources of bias Uncertain  Judged based on overall RCT methods 
Author’s name Wagner [50] 




Low  Patients were randomly assigned to two groups 
using a random number table  
Allocation concealment  Uncertain  Not reported  
Performance bias: blinding 
participants and personnel 
Not 
Applicable 
Pragmatic trial   
Detection bias: blinding of 
outcome assessment 
Uncertain  Not reported 
Attrition bias: incomplete 
outcome data 
Low  Similar proportions missing in intervention and 
control groups 
Reporting bias: selective 
outcome reporting 
High  Primary outcome not specified 




Author’s name Wasson [51] 





Low A sample of participating clinicians were 
studied prior to start of study. Clinicians were 
then blocked in the proportion of patients for 
whom they reported multiple reasons for office 
visit and were randomly assigned to the 
experimental conditions within blocks 
Allocation concealment  Uncertain  Not reported  
Performance bias: blinding 
participants and personnel 
Not 
Applicable 
Pragmatic trial   
Detection bias: blinding of 
outcome assessment 
Low  Reasons for visit were coded by one member of 
the research staff who was blinded to the 
patient study group using the international 
classification of primary care 
Attrition bias: incomplete 
outcome data 
Uncertain  No mention of missing data 
Reporting bias: selective 
outcome reporting 
Uncertain  Primary outcomes not specified  
Other sources of bias Uncertain  Judged based on overall RCT methods 
Author’s name Wolfe [52] 










Low  Random sequence assignment was computer 
generated and integrated into the PediQUEST 
system 
Allocation concealment  Low The random assignment was concealed to 
researchers, patients, and provider 
Performance bias: blinding 
participants and personnel 
Not 
Applicable 
Author acknowledges that blinding was not 
feasible. Pragmatic trial  
Detection bias: blinding of 
outcome assessment 
Low Author acknowledges that blinding was not 
feasible 
Attrition bias: incomplete 
outcome data 
Low  Of 51 intervention and 53 control patients 49 
from each group completed at least one f/u and 
were included in the analysis  
Reporting bias: selective 
outcome reporting 
Low  Primary outcomes were predefined and were 
reported in the results section  
Other sources of bias Uncertain  Judged based on overall RCT methods 
BU: The Boston University Arthritis Centre, RA: Rheumatoid arthritis, RCT: randomised 
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Patient/client/respondent: used interchangeably  
HRQOL: Health-related quality of life 
ISOQOL: International Society of Quality of Life Research  
MYMOP: Measure Yourself Medical Outcome Profile   
MYMOP2: Current adult version of the Measure Yourself Medical Outcome Profile  
P-MYMOP: Paediatric MYMOP 
Research Team: the PhD student and supervisory panel 







Background and Objectives 
A systematic review to identify validated paediatric generic individualised HRQOL measures 
confirmed the absence of any such tools. The Measure Yourself Medical Outcome Profile 
(MYMOP) was identified as one of the adult individualised tools used for children without 
any evidence of validation in this setting. Individualised instruments are patient-specific 
rather than disease-specific and therefore can be applied across various different diseases or 
health conditions. This study aimed to adapt and subsequently content validate the MYMOP 
for use in paediatric clinical encounters of children 7-11 years old. 
Methods 
There were four iterations of the adaptation and validation process: 1) an online survey of 
local paediatricians and paediatric trainees, 2) a focus group discussion with paediatricians, 3) 
an online survey with paediatric research experts and paediatricians across Australia, and 4) 
interviews with child-parent pairs at the General Medicine and Diabetes/Endocrine 
Outpatient clinic of a local Children’s Hospital. Analysis of the interview data was performed 
according to Braun and Clarke (2006) guidelines on thematic analysis. An inductive, 
interpretative approach with realist epistemology was used. 
Results 
Four paediatricians completed the first survey, five paediatricians participated in the focus 
group, and four paediatric HRQOL research experts completed the second survey. Several 
changes were recommended to the wording and layout of the MYMOP by the expert groups. 




old completed the draft paediatric MYMOP (P-MYMOP) and were interviewed afterwards.  
Data from the completed P-MYMOP and interviews demonstrated that the majority of 
participating children were able to identify their own problems and activity limitations, and 
all children in the study understood the 7-point faces scale. Most parents and children 
perceived that the P-MYMOP would be useful to complete before clinic appointments.  
Conclusions 
The P-MYMOP is the first content-validated generic individualised HRQOL measure for 
children. The wording, layout, and scale of the P-MYMOP has been successfully adapted for 
children 7-11 years old. Given that validation is an iterative process, further research to assess 






5.2 Introduction  
Health-Related Quality of Life (HRQOL) is a multidimensional, subjective, patient-reported 
outcome defined as ‘a measure of the value assigned to the duration of life as modified by 
impairments, functional states, perceptions and opportunities – as influenced by disease, 
injury, treatment and policy [1 pp. 1325-1326].’ HRQOL measurement during or before 
clinical encounters is reported to improve patient outcomes [2]  and has several additional 
benefits. In the current era of evidence-based, patient-centred medicine, assessing HRQOL is 
encouraged as essential practice in physicians’ offices, clinical trials, and for resource 
allocation (where HRQOL is often thought to reflect patients’/clients’ satisfaction with a 
healthcare intervention).  
There are various methods reported in the literature to assess HRQOL. The construct can be 
assessed by generic or disease-specific questionnaires that can be standardised—consisting of 
pre-determined domains, or individualised—allowing each individual patient to choose what 
is important to them. Each approach to HRQOL measurement has strengths and limitations. 
While standardised measures of HRQOL provide easy comparisons between different 
populations, these instruments have been criticised for a lack of patient-centredness [3,4]. 
Studies by Bowling and Clinch [5,6] demonstrated that standardised measures often miss 
aspects of life that are comparatively more important to patients. Individualised measures on 
the other hand are superior in picking up individual patient needs, values, and goals. 
However, they cannot be used for economic evaluations [5,6]. Hence the choice of a 





A systematic review (2011, unpublished MSc thesis, University of Alberta, S. Ishaque) to 
identify paediatric individualised HRQOL measures confirmed the absence of any such 
validated tool for use in children. This search was updated in September 2018 and it was 
confirmed that to date no generic individualised tool had been validated for paediatric use. 
The details of the search update are reported in Chapter 2, section 2.5.2. In the systematic 
review (2011, unpublished MSc thesis, University of Alberta, S. Ishaque), the Measure 
Yourself Medical Outcome Profile (MYMOP) was identified as one of the adult 
individualised tools being used for children without any published evidence of validity for 
this cohort. In addition to the lack of the availability of a validated paediatric tool, the 
MYMOP was also found suitable for validation in a paediatric population based on the 
personal experience of a paediatric clinical and research group, CARE Program for 
Integrative Health & Healing, Department of Pediatrics, University of Alberta. The tool was 
used successfully with children in the Program, as it was simple and avoided non-applicable 
questions to developmentally delayed children.   
The current version of the MYMOP available for use in adult populations is called MYMOP2 
[7]. It is a simple one-page tool that has three individualised questions for the patient to name 
two of their most important symptoms, and one activity which is limited to the identified 
symptoms. After the individualised questions, it enquires about the feeling of overall well-
being, and medication usage by the patient. The tool is publicly available free of cost, but the 
developer has asked to be informed about any usage [7].  
This study, therefore, was designed to adapt and validate the MYMOP2 tool for use in a 
paediatric population of children aged 7-11 years old, by consultation with paediatric health 
practitioners (first and second iteration), paediatric researchers (third iteration), and child-




selected in view of the anticipated relative ease of most children of this age group in 
completing such a tool themselves, and the well-established homogeneity in cognitive 
abilities [8-10] of children in this age bracket. The participant groups to be recruited for 
consultation were selected as they were considered suitable stakeholders in the application, 
usage, and integration of a paediatric PROM to a clinical setting.  
5.3 The current study  
The adaptation of the MYMOP2 was conducted by a research team that consisted of a PhD 
student (S. Ishaque), and her supervisory panel. This team will subsequently be referred as 
the ‘Research Team’. 
The adaptation of the MYMOP2 to make it suitable for children 7-11 years old used a mixed-
methods research design combining quantitative and qualitative sub-studies, referred as 
iterations henceforth. This approach is considered appropriate for instrument adaptation [11]. 
As per the recommendations of the COSMIN criteria for content validation of measurement 
tools [12], it was deemed essential to check the relevance of included items to the construct 
of interest and context of use. The four iterative stages were: 1) an online survey of local 
paediatricians and paediatric trainees; 2) a focus group discussion with paediatricians; 3) an 
online survey with paediatric research experts and paediatricians across Australia; and 4) 
interviews with child-parent or child-guardian pairs at the outpatients department of a local 
children’s hospital (Figure 5.1). After each iteration, Research Team meetings were held to 





5.3.1 Sampling Logic 
As the paediatric MYMOP (P-MYMOP) was being adapted for use in a clinical setting, the 
Research Team, paediatricians, paediatric researchers and stake-holders were consulted to 
ensure relevancy. First, a local group of paediatricians with whom the researcher had some 
previous contact was consulted to ensure that the changes suggested by the Research Team to 
the response options, recall period, wording, and comprehensiveness of the key concepts for 
inclusion in the P-MYMOP were appropriate. This group was consulted via an online survey 
followed by a focus group of an available subset of the local group that not only provided 
more open responses, but also helped clarify some of the responses given in the online survey 
and resulted in a refined version of the P-MYMOP. In the next iteration the intension was to 
widen the sample by including Australia-wide paediatricians and paediatric researchers from 
a quality of life special interest group to comment on the current P-MYMOP and provide 
comment on any further refinements. The sample for the last phase was drawn to test that the 
further refined P-MYMOP had appropriate content to use with children and parents in a 
clinical setting. In this phase it was necessary that participants were key stakeholders in the 
adaptation process, i.e. child-parent pairs at the Women’s and Children’s hospital, who were 
also provided with the opportunity to suggest any changes to the content if needed and this 
resulted in the near final version of P-MYMOP (seen in Appendix 5.6).  
The methods and results of the iterations are separately described below followed by an 





5.4 First iteration: Online survey of paediatricians and paediatric 
trainees  
5.4.1 Methods 
Ethics approval for the first online survey and the focus group with local paediatricians 
(Second iteration) was obtained from the Women’s and Children’s Health Network Human 
Research Ethics Committee (HREC/16/WCHN/8).  
The potential participants were doctors working in the Department of General Medicine at 
the Women’s and Children’s Hospital (WCH), Adelaide. The survey was distributed to 10 
paediatricians at the WCH through staff email addresses. 
To develop the first online survey using SurveyMonkey, several Research Team discussions 
were held and changes were suggested in the wording and layout of the MYMOP2 to make it 
suitable for children 7-11 years old. The Research Team also considered the addition of a 
‘faces scale’ to promote and assist self-completion of the paediatric PROM. As a previous 
version of MYMOP2 had included a faces scale [13,14] for use in older adults (Pictorial 
version of MYMOP), use of the same faces in the P-MYMOP was considered. However, the 
methods of content validation of the Pictorial Version of MYMOP were not clearly reported 
[13,14]. In addition, the number of faces in the Pictorial Version of MYMOP was not 
consistent with the numerical rating scale of the MYMOP2 and the faces scale had tears 
shown on it, which are not considered suitable for use in children [15]. The corresponding 
author of this study [13] was contacted to provide additional details of methods that may not 
had been published and the developer of MYMOP2 (Dr Charlotte Paterson) was also 




scales were searched for and considered to be included in the P-MYMOP. A relatively simple 
set of seven faces [15] was selected. The Research Team’s suggested changes to the 
MYMOP2 were incorporated to develop the first online survey (see Appendix 5.1).  
5.4.1.1 Statistical analysis  
The data were analysed using descriptive statistics using basic counts and qualitative 
responses of the participants were analysed via a summative approach to qualitative content 
analysis [16]. As per this approach the principal researcher (SI) started with identifying and 
quantifying certain words in the participants’ text responses to explore usage and interpreted 
their usage via discussion with the Research Team. 
5.4.2 Results  
There were four responses (4/10) to the first online survey by paediatric consultants at the 
WCH. All respondents agreed to the suggestion of changing the word ‘symptoms’ to 
‘problems’ as it was perceived that the word ‘symptoms’ may be difficult for children 7-11 
years old to understand. After Research Team discussion, the term was refined to ‘health 
problems.’ Three respondents did not agree with the replacement of the word ‘bother’ by 
‘bug,’ therefore the word ‘bother’ was retained.  
There were four different responses to the selection of the most appropriate time interval for 
the P-MYMOP. One respondent suggested to keep it unchanged, that is, ‘over the last week,’ 
another suggested changing it to ‘over the past few days,’ a third to change it to ‘today,’ 
whereas the fourth respondent did not have a preference, but mentioned that the time interval 
would depend on the acute or chronic nature of the problem identified on the P-MYMOP. 




the last few days,’ with the decision to test this change in the next stage of the adaptation 
process by asking respondents if they agreed or disagreed with it, and to give a reason. 
There was complete agreement on the deletion of words ‘physical, mental, or social’ from the 
activity question in MYMOP2, as well as to substitute the word ‘activity’ with ‘thing,’ 
although this was later changed to ‘something’ after Research Team discussion. The well-
being question was retained after changing the word ‘symptom’ to ‘problem.’ There was a 
50/50 split among respondents on the use of a ‘faces scale’ for P-MYMOP, and it was 
therefore decided by the Research Team to leave the faces scale for discussion for the next 
stage of the study.  
All respondents agreed that the medication questions would be challenging for children to 
complete, and therefore it was suggested that this section be offered to primary caregivers 
(i.e. parent/guardian) of the children for completion. The P-MYMOP draft Tool (Appendix 
5.2) was prepared based on the first online survey responses.  
5.5 Second iteration: Focus group discussion with paediatricians  
5.5.1 Methods  
Results of the first online survey were used to facilitate a focus group discussion with 
paediatricians at the Department of General Medicine WCH before a usual weekly staff 
meeting. Five paediatric consultants from the Department participated in the focus group 
discussion, which was held for approximately 20 minutes.  
The focus group aimed to discuss the results of the first online survey with paediatric 
consultants, facilitate discussion concerning the use of P-MYMOP in the hospital setting, and 




based on the first survey responses was presented to the focus group participants for 
discussion, along with a summary of first online survey responses. Some questions to guide 
the focus group discussion, as approved by the Ethics Committee are attached as Appendix 
5.3.  The focus group data were also analysed using the summative approach to qualitative 
content analysis [16].    
5.5.2 Results  
Five paediatricians participated in focus group discussion. As a result of the focus group 
discussion, the well-being question was simplified to ‘how you have been feeling?’ rather 
than ‘rate your general feeling of well-being.’ The medication question was changed from 
‘are you taking any medication?’ to ‘are you taking any therapy or treatment?’ and the word 
‘medicine’ was preferred over ‘medication.’ After Research Team discussion on the focus 
group responses, the medication question was changed to ‘do you take any tablets, medicine, 
or treatment?’ and was open to further validation in the next iterative stage.  
Use of a large font and more spaces for writing were suggested to make the layout more user- 
friendly. Participants of both the online survey and the focus group agreed that it would be 
best for the P-MYMOP to be completed in a waiting room, before a scheduled appointment 
with a paediatrician.  
5.6 Third iteration: Online survey of paediatric research experts and 
paediatricians across Australia 
Ethics approval for this iterative stage was obtained from the University of Adelaide’s 





After further modification of the P-MYMOP informed by the opinions of local paediatricians 
via the online survey and focus group, a second online survey (Appendix 5.4) was designed 
to enable consultation with paediatric research experts and paediatricians across Australia.  
The survey was circulated to the Australian members of the International Society of Quality 
of Life Research (ISOQOL)—Child Health Special Interest Group as a representative body of 
researchers interested in child HRQOL/QOL (n = 22), and to paediatricians via the monthly 
Newsletter of the Paediatric and Child Health Division of the Royal Australian College of 
Physicians. One reminder was sent to potential participants. The data were analysed via the 
same methods reported in section 5.4.  
5.6.2 Results  
The second online survey was designed to gather opinions of paediatric research experts and 
paediatricians in Australia. Unfortunately, only four responses were received, with all 
respondents being paediatric researchers. There were no additional responses to the reminder 
included in the next Newsletter and it was decided to close the survey.    
Of the four respondents, three agreed to asking children to name their ‘health problems’ as 
the opening question on P-MYMOP, and confirmed that the time interval of ‘over the last 
few days’ was suitable for children 7-11 years old. In addition, the replacement of the word 
‘activity’ with ‘something’ was considered acceptable for the target population.  
All respondents confirmed that the ‘faces scale’ would be a beneficial addition to the 
paediatric tool to help elicit meaningful responses from the children. One of the respondents 




instead of asking children to circle a face, asking them to cross it out might be simpler. In the 
Research Team meeting, it was decided to keep the tool as it was, let the children fill it out, 
and then re-visit this concern based on their observed ease of circling the faces. The Research 
Team also changed the term ‘health problems’ to ‘problems’ on the P-MYMOP, to be tested 
with child-parent pairs, because ‘health problems’ was thought to be too narrow to capture 
issues that may be important for young children.   
5.7 Fourth iteration: Child-parent interviews at the Women’s and 
Children’s Hospital’s Paediatric Outpatients Department  
Ethics approval for the child-parent interviews was obtained from the WCH Network Human 
Research Ethics Committee (HREC/17/WCHN/36).  
5.7.1 Methods  
Content validation of the P-MYMOP involved interviewing children 7-11 years old and their 
parent/guardian visiting the Department of General Medicine and Diabetes/Endocrine 
Outpatient clinic at the WCH Adelaide. A child-parent or child-guardian pair was eligible to 
participate in the study if: 1) the child was 7-11 years old; 2) the parent/guardian and the 
child could speak and read English; and 3) child was able to name their own issues. Potential 
participants (7-11-year-old children and their parent/guardian) were identified by the 
Paediatric Outpatients Department’s Clinic nurse, or by reception staff, who provided them 
with a study information leaflet. This leaflet sought permission to be approached later by the 
principal researcher (SI). Once the parent of an eligible child-parent/child-guardian pair 
granted permission to be approached by the researcher (SI), a detailed information sheet was 




for themselves and on behalf of their child. The researcher (SI) then asked the 
parent/guardian to complete a short demographic information form (Appendix 5.5) followed 
by both child and parent/guardian together completing the P-MYMOP (Appendix 5.6). After 
completion of the demographic information form and the P-MYMOP, a semi-structured 
interview was conducted about the wording, layout, willingness of the pair to complete the P-
MYMOP as a routine task before their clinic appointment, and the benefit they perceived of 
completing the Tool.  The interview questions for children 7-11 years old and their parents 
are attached as Appendix 5.7. Data from this session included: demographic information, the 
completed P-MYMOP, the interviewer’s observations, and the semi-structured interview. The 
session was audio recorded and later transcribed by the researcher (SI). 
This iteration was a mixed-methods study that collected information from multiple sources as 
described above to adapt the contents of the MYMOP2 for children 7-11 years old. The 
demographic form and P-MYMOP provided both quantitative and qualitative data, whereas 
the interviewer’s observations and transcribed interviews were the qualitative components of 
the iteration. These methods were found suitable for content validation of patient-reported 
outcome measures [12,17-20]. Inclusion of parent’s/guardian’s and children’s views in the 
adaptation of MYMOP is in line with current recommendations to consult the target 
population for the development of PROMs. Participants were recruited until saturation was 
reached [21]. Saturation was defined as the emergence of no new information from three 
consecutive interviews of child-parent pairs, and this was achieved for both of the clinic sub-
groups (i.e. for patients from the Department of General Medicine and Diabetes/Endocrine 
Outpatient clinics).   
Analysis of the interview data were performed according to the Braun and Clarke (2006) 




epistemology was used. Thematic Analysis is defined as ‘a method for identifying, analysing, 
and reporting patterns (themes) within data [22].’  
5.7.1 Results  
This phase of the study ran for 12 weeks (three days/week) in the Department of General 
Medicine Outpatient clinic and for 4 weeks (2 days/week) in the Diabetes and Endocrine 
Clinic. A total of 25 child-parent pairs participated. One participant was a non-verbal child 
whose mother completed the P-MYMOP for him. As the aim of the P-MYMOP is 
identification of issues by children through self-completion, the data for the non-verbal child 
was excluded from subsequent analyses. The participating children’s ages were 
representative of the target population: 7 years (6), 8 years (10), 10 years (6), 11 years (3). 
Demographic characteristics of these children are presented in Table 5.1. Of the 24 children, 
20 were native English speakers. Sixteen children were from the General Medicine Clinic and 
eight children were from the Diabetes and Endocrine Outpatient clinic.  
The completion of the P-MYMOP was followed by the semi-structured Interview. An 
important aspect of the process of the P-MYMOP completion was to observe if the children 
appeared to understand the concepts represented on the tool. Six themes were generated from 
the coded data collected during the interaction of the researcher with child-parent pairs:  
1. children’s understanding of the concepts represented on the P-MYMOP (i.e. 
‘problems,’ duration of problems, and ‘faces scale’)  
2. reading and writing on the P-MYMOP 
3. perceived value in using the P-MYMOP 
4. approach to the medication questions 
5. suggested changes to P-MYMOP, and  




These themes are reported below and their supporting codes from the data are presented in 
Table 5.2.  
5.7.1.1 Theme 1 Children’s understanding of the concepts represented on the  
P-MYMOP (i.e. ‘Problems,’ Duration of problems, and ‘Faces scale’)  
Theme 1 had three sub-themes: 1) child named their problem; 2) the child’s understanding of 
the ‘faces scale’; and 3) understanding of the duration of the problem. The ability of children 
to identify their own problems and the time period for which they have these is crucial in the 
completion of an individualised PROM. In addition, the selection of faces on the ‘faces scale’ 
by children, with little or no help from their parent, is crucial for the P-MYMOP to yield 
meaningful outcomes.   
Information about a child being able to name his/her problem and their understanding of the 
‘problem duration’ came from the Interviewer’s observation of the completion of the  
P-MYMOP form by the child-parent pair. Data on understanding of the ‘faces scale’ was 
both observational and in response to the direct question asked to the children about their 
impression of the ‘faces scale.’  
Twelve children from the General Medicine (12/16) and six children from the 
Diabetes/Endocrine cohort (6/8) were able to name their problem and then measure the effect 
of it using the ‘faces scale’. Of the participating children, some children were not able to 
readily identify their own problems, in which case parents/guardians either provided them 
with some examples or reminded them of recent issues that the child had discussed with 
them. With this small amount of help, the majority of participating children were able to 




Of the six children (4 General Medicine, 2 Diabetes/Endocrine) who did not name their 
problems, four were attending the Clinic for follow-up appointments and had no presenting 
complaints. In two cases (1 General Medicine, 1 Diabetes/Endocrine), parents chose the 
problems on their own without confirming with their child; but proceeded to ask the child to 
score these problems on the ‘faces scale’. 
The ‘faces scale’ was unanimously accepted as helpful by all participating children and 
parents in the study. All of the children appeared to understand the duration of the problem 
question on the P-MYMOP.  
The new paediatric tool, the P-MYMOP, was self-completed by most of the participating 
children with limited exceptions where the parents took over and named the most important 
problems for their child. Overall, most of the participating children were able to understand 
the concepts presented on the P-MYMOP. The data therefore provided positive evidence for 
the content validation of the tool in our target population. 
5.7.1.2 Theme 2 Reading and writing on the P-MYMOP  
There were three sub-themes under the main theme of ‘reading and writing on the  
P-MYMOP’: 1) who wrote the individualised items on P-MYMOP; 2) who read the P-
MYMOP; and, 3) completion of the ‘faces scale’ on the paper form.  
Most data about the reading and writing of the P-MYMOP was gathered through observation 
of how the child-parent pair completed the tool. No issues were identified with the reading of 
the P-MYMOP questions, as it was permissible for either the child or parent to read them. 
Regardless of who read the tool, the wording appeared to be understood by all participating 




MYMOP, but was able to understand it when their father read it to them. Direct code from 
the interview of this child is included in Table 5.2. Similarly, writing individualised problems 
into the space provided on the P-MYMOP was not an issue. The participating children, in 
some cases, needed help with spelling which was readily provided by their parents. Overall, 
children were able to read and complete P-MYMOP with some support from their 
parent/guardian.  
To explore how the faces were selected to score the questions on the P-MYMOP, 
participants’ completed paper forms were examined. Of the 24 participant responses, three 
children had ticked the faces they wanted to select, one had filled in their selected face with 
ink, one had marked their selected face with a cross, one underlined their selected face, and 
another child chose to circle and tick a few of the faces. These responses demonstrated that 
the children understood the idea of selecting a face by making a mark on them. Therefore, it 
was decided to keep the instructions about the selection of the faces of the measurement scale 
as they were, as it appeared to be intuitive for children to do as they felt comfortable.  
5.7.1.3 Theme 3 Perceived value in using the P-MYMOP  
There were two sub-themes under the main theme of ‘value in using the P-MYMOP’:  
1) interested in completing in future (as routine practice); and, 2) statements on child’s voice 
in consultation. 
Of the 24 child-parent pairs who participated, most perceived the use of the P-MYMOP as 
beneficial for routine clinical practice. It was believed by the parents/guardians that the P-
MYMOP would help their child to identify and remember important issues to be discussed 




where it was often less likely for them to do so. Parents also appeared to show an interest in 
using the tool during future clinic visits as part of usual clinical practice. 
Three parents, two from the Endocrine/Diabetes Clinic and one from the General Medicine 
Clinic did not see any value in using the P-MYMOP for their children. A common feature of 
these interviews (1 Endocrine/Diabetes and 1 General Medicine) was that the children 
involved were visiting the Clinic as a follow-up appointment and had no presenting 
complaints. The majority of the study participants perceived the completion of the P-
MYMOP as valuable, and were willing to complete the tool before their clinic appointments.  
5.7.1.4 Theme 4 Approach to the medication questions  
The medication questions were completed by the parents of 12/16 General Medicine patients. 
All parents mentioned that their children were not taking any prescription, although two o 
stated that their child had been taking some over-the-counter and/or herbal remedies that they 
did not consider as ‘medication.’ No parents from the General Medicine cohort considered 
the medication questions as irrelevant (Table 5.2).  
In the Diabetes/Endocrine Clinic, one parent did not complete the medication section on the 
form. Of the five parents who completed the tool, one clearly mentioned that the section was 
not relevant for patients with diabetes, and the rest of the parents also had concerns, as is 
evident in the data codes (Table 5.2). 
Indeed, examination of the medication questions of the P-MYMOP, as currently written, 
suggest that these are not relevant for children with diabetes, as these questions ask if patients 
would like to stop taking their medication—which is not possible for patients with type 1 




help with capturing information about any alternative therapies/herbs/over-the-counter 
medicines that they might be taking.  
5.7.1.5 Theme 5 Suggested changes to P-MYMOP 
Three parents from the Diabetes/Endocrine Clinic, and one from the General Medicine Clinic 
suggested some changes to the P-MYMOP form as presented for completion. The children 
from the Diabetes/Endocrine and General Medicine Clinic whose parents suggested changes, 
did not have any presenting complaints and therefore left the first two questions about 
problem-1 and problem-2 on the P-MYMOP blank. The changed suggested were: increased 
slots for number of problems, change the P-MYMOP to ask more disease-specific questions, 
and to change the word ‘problem’ with ‘worry’ or ‘concern.’ Specific interview codes in this 
regard are presented in Table 5.2. 
One parent from the Diabetes/Endocrine Clinic, whose child enthusiastically completed the 
questionnaire, and who mentioned that P-MYMOP would be a good form to complete as it 
would help with organising thoughts before any clinic consult, suggested that they would like 
to see more space to describe the problems they had to discuss. They also showed the 
Interviewer the list of issues that they had prepared before coming to the Clinic for 
discussion. Another parent from the Diabetes/Endocrine Clinic did not like the P-MYMOP 
and found it too generic, suggesting alternative questions to be asked and mentioning their 
own experience on developing questionnaires.  
Inspection of the P-MYMOP for eight participants who self-completed the questionnaire 
during the study, showed that the spaces provided for children to write their own issues were 
not enough to easily allow for the size of their handwriting.  The written responses to 




current P-MYMOP. Therefore, a decision was made to provide increased space to answer the 
three individualised questions. Other changes suggested in the Diabetes/Endocrine clinic 
were parent-centred and therefore were not incorporated into the adaptation of P-MYMOP.  
5.7.1.6 Theme 6 Connecting activity limitation with identified problems 
The third question on the P-MYMOP asks respondents to identify a relative activity 
limitation due to their identified problem(s). This theme specifically articulated whether 
children were able to connect the activity limitation question with their self-identified 
problems or not.  
Of the 24 included children, five did not mention any activity limitation on the questionnaires 
and that column was subsequently left blank. Two children specifically wrote that there was 
no activity limitation by writing ‘no,’ and ‘doesn’t stop me.’ Of the 19 children who 
mentioned some activity limitation, three were unable to understand that the activity 
limitation had to be connected to the problems that they had identified.  
One parent said that the activity question was completed by the child without considering the 
problems that the child mentioned, and that as a result parent and child response were 
completely unrelated to each other. Another parent advised a change to the activity question 
from ‘now look at the faces below and circle the face that shows how hard it has been to do 
over the last few days’, to ‘now look at the faces below and circle the face that shows how 
hard it has been for you not to be able to do this.’ Based on this helpful comment, the 
Research Team decided to change the wording of the activity question accordingly. Overall, 
children were able to connect the activity question to their identified problems. In cases 
where the mentioned activity was separated from the identified problems, it was obvious 




5.8  Discussion  
In this study an adult individualised questionnaire, the MYMOP2 [7], was adapted for 
children 7-11 years old. The results provide early evidence of content validation of the P-
MYMOP in such children in General Medicine and Endocrine/Diabetes Outpatients 
populations. The content validation was achieved by simplifying the tool’s wording, layout, 
and scaling method by several iterative stages that started with an online survey of local 
paediatricians; this was followed by a focus group discussion with local paediatricians, a 
second online survey of paediatric researchers; and finally, through testing the simplified 
language and layout with child-parent pairs in relevant Outpatient clinics by asking dyads to 
complete the P-MYMOP. The participating child-parent pairs were also interviewed about 
their experience of completing the P-MYMOP. In this study, children as young as 7 years old 
were able to understand and select faces to rate their named symptoms without any help from 
parents. Most children were also able to name their own problems with some help from 
parents. 
Based on the direct observation of the children’s completion of the MYMOP questionnaire 
and the interview responses of the participating children and parents, it was evident that most 
children could understand the concept of Problems, the P-MYMOP’s recall period, and the 
faces scale. The medication questions were completed by the participating parents/guardians 
and they were able to complete it without any difficulty. After the expert feedback from the 
thesis examiner the medication question was changed to include inquiry on herbals as well as 
alternative therapies because patient’s use of these is important information for their 




HRQOL is a subjective construct, so assessment may vary according to whose perception is 
sought. Parents/caregivers are often asked to provide an assessment of paediatric health 
outcomes, including measurement of subjective symptoms such as pain, anxiety, and 
depression. When children are non-verbal or pre-verbal, parents, caregivers, or healthcare 
providers may be an acceptable proxy for deriving paediatric outcomes; however, self-
assessment of HRQOL should be encouraged whenever possible, given evidence that proxy 
ratings of childrens’ HRQOL by their parents/caregivers are systematically different from the 
child’s self-rated HRQOL [23-26]. Indeed, considerable discordance between children’s and 
parents’ ratings of HRQOL, psychological functioning, and physical functioning has been 
reported in children with chronic diseases [23-26]. The new tool, the P-MYMOP, is simple 
and is designed to support self-rating of HRQOL in children 7-11 years old.   
Valid self-completion of individualised HRQOL instruments requires respondents to identify 
their own specific issues and then measure them with a scale. For this to occur using the P-
MYMOP it was important that children could either read the tool themselves or at the very 
least understand the questions when read to them by their accompanying adult. With the 
adapted wording and layout of the P-MYMOP, most participating children in this study were 
able to name their own problems, with occasional help from parents/guardians. It is of note 
that some participating children did not have any ‘problems’ on the appointment day and 
therefore they left the P-MYMOP ‘Problems’ column blank. The participating children were 
asked in the interview if they could understand all the questions on the P-MYMOP and they 
confirmed it. The adapted paediatric version of MYMOP is shown in Appendix 6.   
In addition to the use of simple wording and layout, to promote self-completion of the P-
MYMOP by children, a faces scale was incorporated to the P-MYMOP. Comparative use of 




‘faces scale’ have been studied in relation to the measurement of pain in children [26-28]. 
The reason to include the ‘faces scale’ in the P-MYMOP was ease of its use in children over 
numeric rating scales [27,28,30]. The use of faces as a measurement scale for children is 
known to improve self-reporting [28] and has been found to be successfully understood by 
children as young as 4 years old [28]. The change from numeric rating scale to the ‘faces 
scale’ was further supported by the data collected during the child-parent interviews, and the 
observation that children as young as 7 years old were able to understand and appropriately 
respond to the ‘faces scale’ to rate their named symptoms without any help from parents. 
When calculating the score for the P-MYMOP, the ‘faces scale’ is intended to convert back 
to the 0-6 numeric-scale of the MYMOP2. Similar to the MYMOP2, the profile score will be 
calculated by adding the score from each response and is then interpreted in parallel with the 
individual item scores (because an increase or decrease in the overall profile score at different 
clinic visits may occur due to changes in one or more of the patient’s issues). 
As has occurred in areas of paediatric research [31], development of a generic individualised 
HRQOL measure for children has lapsed behind adult measure development. The adult 
MYMOP, also known as MYMOP2, was developed in 1996 [32] and has been adapted for 
adult cancer patients [33-37], mental health outcomes [38-42], elderly patients undergoing 
acupuncture [13,14]; and has been translated into 12 languages [7]. The MYMOP2 offers a 
simple and patient-centred approach to the measurement of HRQOL. The adaptation of this 
tool for children may enhance their clinical care using self-assessment of paediatric HRQOL 
which integrates their values and preferences.  
Development of the P-MYMOP is an essential precursor to the first generic individualised 
assessment of paediatric HRQOL. Validity and reliability (or sound psychometric properties) 




developed [15,16]. Accordingly, development of tools for disease-specific populations and 
age-specific groups is a weighty task to undertake. Alternatively, generic individualised 
questionnaires can provide measurement of patient-specified domains or symptoms and is 
encouraged by the recent establishment of Patient-reported Outcomes Information System 
(PROMIS) [42]. As stated by PROMIS researchers, domain-specific measures are the way 
forward, as the presence of a particular disease alone is not likely to define the experience of 
fatigue, headache, sleep difficulty, anger, sadness, etc. [43]. In the current study, P-MYMOP 
was tested for the suitability of its content with children with a variety of health conditions. 
Despite differences in parent-reported diagnoses, children were able to complete the 
questionnaire successfully, and to provide positive feedback when interviewed.  
As with any measurement approach to HRQOL, there are some limitations to using 
individualised instruments for this purpose. Scores on individualised measures represent 
measurement of unique patient issues, and thus these scores cannot be used to discriminate 
between individual patients or patient groups, or for economic evaluations [4-6, 44-46]. 
Furthermore, since the patients nominate the individualised domains or symptoms that are 
important to them, changes in the importance of certain domains or symptoms over time may 
limit the evaluative properties of these tools in longitudinal fashion [4-6, 44-46]. Some may 
argue that this would limit measurement properties of individualised instruments [47]. 
However, there are reasons to consider that this does not affect their validity in the context of 
their use to inform clinical practice. Change in nominated symptoms for evaluation, for 
example, can inform clinicians that the patient’s experience and priorities have changed over 
time; and hence clinicians should now focus on other aspects of life that are important to their 
patient. These limitations, moreover, are shared by all individualised questionnaires and are 




As the P-MYMOP allows child-parent pairs to complete the tool together, another potential 
limitation of the tool could be that parents select the symptoms/problems without confirming 
that these are important with their child. In the current study, it was decided that the 
interviewer would not interfere as the child-parent pair completed the questionnaire. During 
the study, most children completed the P-MYMOP on their own with some help from 
parents. Nonetheless, two participating parents were reluctant to let their child name their 
own issues. Therefore, acknowledging that potential proxy completion is a weakness of the 
questionnaire and could have contributed to an under-representation of parents who wished to 
provide parental help when not required, explicit instructions are now included for parents on 
the P-MYMOP that the questionnaire is for their child to complete with parental help only 
when necessary.  
Similar to any study where consent must be gained, there was potential for selection here 
which might have resulted in more parents agreeing to participate if they were willing to 
allow their children to nominate their own problems. We believe that this was however 
minimal as the first point of contact was made with parents of potential participants by clinic 
nurses, who asked for parental permission to be approached by the researcher. At the point of 
first contact, the parents did not know what was involved with regard to children’s 
participation into the study and none of the parents declined to be approached by the 
researcher. After the parental agreement the researcher handed the study Information Sheet to 
the caregiver and answered any questions that were asked. At this point, only one parent 
declined to participate in the study.  
It can be argued that the P-MYMOP was developed through a top-down approach where the 
starting point was an adult questionnaire that underwent several rounds of adaptation through 




from scratch to develop a tool specifically for children [48,49]. There are limitations to this 
approach especially when this is applied to tools with predetermined dimensions/domains, as 
the adoption of a top-down method may mean that dimensions pertinent to the target 
population (children 7-11 years-old in case of the P-MYMOP) are be missed. The P-
MYMOP however has no predetermined dimensions/domains. Each respondent (child) is 
given an opportunity to identify the domains/areas of life that are important to them on the 
day of P-MYMOP completion and an opportunity to quantify their impact using the faces 
scale. The participant child-parent/child-guardian pairs were given opportunities to provide 
feedback on the wording, layout, response options, and recall period of the tool in the fourth 
iteration of the adaptation study. Moreover, additional interviews and/or focus groups with 
parents and children could have been undertaken to explore issues further in the feasibility 
study but while this would be crucial for the effective adaptation of standard PROMs, it is 
less helpful for individualised PROMs. 
 
A limitation of our approach to validation of P-MYMOP is acknowledged due to no 
responses being received from paediatricians to the second online survey. Fortunately, 
however, the opinions of this group of users were collected via the first survey and focus 
group discussion with the local paediatricians. According to the guidance on validation of 
PROMs it is not necessary to sample a large group of service providers for validation [12,17].   
Assessing HRQOL may improve physician-patient communication and thus help achieve 
better health outcomes [2]. However, integrating HRQOL assessment into routine clinical 
care can be challenging. Individualised measures that are short, straightforward and quick to 




P-MYMOP is the first paediatric generic individualised HRQOL measure which offers a set 
of brief and easy-to-complete questions that can be used to assess variation in patient-
concerns, regardless of their diagnosis. The P-MYMOP may also provide a useful source of 
information to assist in the understanding of inevitable heterogeneity of treatment effects. 
Given the global initiatives advocating patient-centred research and outcomes [42,52-55], and 
a better understanding of the limited application of evidence from a group of patients in 
clinical trials to individual patients [55]; P-MYMOP can also help provide more 
comprehensive data from paediatric patients’ perspective. Individualised outcome assessment 
tools such as P-MYMOP hold much promise, as personalised medicine approaches to tailor 
conventional therapies from a patient-perspective gain momentum.  
The P-MYMOP is the first generic individualised HRQOL questionnaire adapted for use in a 
paediatric population [56-61]. Individualised instruments can be beneficial in clinical 
consultations in primary, secondary, and tertiary-care settings, N-of-1 trials, as well as in 
randomised controlled trials to better understand heterogeneity of the treatment effect and 
derive individual level recommendations [62]. Importantly, individualised HRQOL measures 
can help patient and healthcare provider to tailor healthcare according to the patient’s needs, 
values, and preferences.  
5.9 Conclusions  
The P-MYMOP is the first generic individualised HRQOL measure created for children. The 
tool can be a starting point for individualised measurement of paediatric HRQOL. The 
wording, layout, and scale of the P-MYMOP has been successfully adapted for children 7-11 




iterative process, further research to assess its feasibility, reliability, and construct validity is 











Words replaced: symptom with 
problem, ‘bother’ with ‘bug.’ 
Time interval changed to ‘today 
or right now.’  
Rating scale changed from 
numeric to faces.  
Parenthesis containing ‘physical, 
mental, or social’ omitted 
from activity questions.  
Research Team discussions 
(were held before and after 
each iteration to implement 
the results of previous 
















1) Online survey of 
paediatricians and 
paediatric trainees 
Well-being question changed to 
‘how you have been 
feeling.’ 
Word ‘medication’ changed to 
‘tablets, medicine, or 
treatment.’ 
Use of large fonts and more 
space to write on the 
printed form.   
2) Focus group discussion 





interviews at a 
paediatric outpatients 
department of a 
tertiary hospital 
‘Health problems’ 






Change in the 
time interval to 
‘over the last 
few days’ 
agreed.  
Theme 1: Children’s 
understanding of the 
concepts represented 
on P-MYMOP (i.e. 
‘problems,’ duration of 
problems, and faces 
scale). 
Theme 2: Reading and 
writing on P-MYMOP 
Theme 3: Value in using 
P-MYMOP.  
Theme 4: Parental 
influence on 
completion.  
Theme 5: Medication 
question. 
Theme 6: Suggested 
changes to P-MYMOP. 
Theme 7: Completion of 


















Problem 1 Problem 2 Activity  
GM1 7 M Mother English 
Behavioural 
problems 
Happy Not sure Left blank 
GM2 10.5 M Mother English Sleep apnoea 
Not getting work 
done 
People calling me 
names 
Get 200 tasks done 
GM3 8 M Mother English 
Auditory processing 
disorder & dyslexia 
Sore toe 
Learning, auditory and 
sensory processing 
diagnosed 3 months;1 
year ago had for at 
least 1-5 years 
No 
GM4 8 M Mother English 
Obesity & behaviour 
issues 
Being blamed for 
things he hasn’t 
done 
When things are hard 
to do 





GM5 10.5 F Mother English 
Enlarged liver, raised 
liver function, 
increased IgE level 
Bullies at school 
Bullies get rewarded 
for bad behaviour 
Swimming because 
of my eczema 
GM6 8 F Mother English Follow-up 
Not allowed to 
have too much 
lollies 
When I fall down and 
scratch myself 
I can’t play on the 
monkey bars 
GM7 7 M Mother English Asperger’s 
My sister annoys 
me 
I want to have a 
normal break at school 
Playing on Xbox 360 
GM8 8 F Mother English 
Diagnosis of small 
height and weight 
Noise issues Left blank Doesn’t stop me 
GM9 8 F Mother English Migraines Left blank Left blank Left blank 
GM10 10 M Mother English Autism 
Getting off the 
internet 
Going to school and 
doing work 
Is to find it easy to 
learn 
GM12* 10 F Mother English Cerebral Palsy Cutting my hair Go to sleep School 
GM12a
* 




GM13 7 M Mother English Left blank School Stomach Football 
GM14 8 M Mother English 
Mozaki 
Chromosomes 
Fight Mum hard at act Stop getting angry 
GM15 10 F Mother English 
seizure of unknown 
cause 
My mum getting 
angry with me 
Dying Feeling happy 
GM16 7 F Mother Malayalam 
Follow up after 
neurosurgery 
Left blank Left blank Left blank 
Endo1 11 F Mother English Growth delay Left blank Left blank Left blank 
Endo2 8 F Mother 
English 
(non-native) 
Left blank Scared Left blank 
Jumping into the 
water 
DM1 10 M Mother Arabic Type 1 diabetes 
Coming here and 
missing school 
Staying away from my 
family for a long time 
Make a new kind of 
pump 
DM2 7 M Father Punjabi Type 1 diabetes Insulin injections Reading/studies 
Can’t eat sweet stuff 
like ice cream 
DM3 8 F 
Foster 
mother 




DM4 8 F Mother English Type 1 diabetes 
Getting interrupted 
in school 
Always having to 
check by readings 
Left blank 
DM5 7 F Father English Type 1 diabetes 
Erin (older sister) 
has got to eat 
sweets 
Sweets Eat sweets 
DM6 8 F Mother English Type 1 diabetes 
About my friends 
arguing at school 
One of my friends 
does not like to play 
with my other friends 
Make a friendship 
club 







Table 5.2 Themes and codes  
Themes Themes & subthemes 
defined 
Subthemes  Codes  
1) Children’s understanding 
of concepts represented on 
P-MYMOP (i.e. 
‘Problems,’ ‘Duration of 
problems,’ and ‘Faces 
scale’) 
If children are able to 
name their problems, 




of his/her problems 
tells us that they can 
understand the P-
MYMOP and hence 
provide positive mark 
to the content validity 
of our questionnaire 
1. Child named their 
own problem 
 
C: (thinking…and then wrote down something on the form -
observation) is that it?’ 
 
M: What do you think, what your problem would be? 
C: Hmmmm you can write… 
M: You can write it down. Come on (handed the pen to child) 
Observation: Child is completing questionnaire on her own. 
Getting help with spelling  
M: (helping with spelling) u i n g. 
 
Example when parent named the problem for child: 
GM3: Mother: to do you want to fill out this? This is like a 
visual way for us instead of using words.  





Mother: No no no, you just write on the smiley faces. You 
show me, show the lady how good or how bad it is you 
finding learning, reading, and writing at the moment. 
  1. Children’s 
understanding of 
the faces scale  
DM3: M: Now look at the faces below and circle the face that 
shows how bad that problem has been over the last few days. 
C: Hmmmm 
M: So how bad it has been over the last few days. Have you 
thought about food lots, not a lot, or (pointing to faces) 
C: Hmmm what do you think? 
M: No this is your question. 
C: Hmm I think this one. 
DM5: F: now, look at the faces below and circle the face that 
shows how you have been feeling over the last few days.’  
Observation: child selects a face 
  1. Understanding 
of the duration 
of problem  
 
DM2  
F: How long have you had problem 1. How long this problem 
(pointing to questionnaire). 
C: Since a year. 





DM3:C: How long have you had problem 1 either all the time 
or on and off please circle (reading the duration question) 
C: I have had it for five years 
M: How long have you had problem with food? 
C: Five years  
M: Over five years 
C:N, five years’ 
2) Reading and writing on  
P-MYMOP  
This theme included 
observational data if 
the participating 
children were able to 
read and write on the 
P-MYMOP.  





Example of getting help with spelling: 
GM3: Child: how do I spell sore? 
Mother: You tell me how you spell sore?  
Child: s o r?  
Mother: Hmmm (affirming) and e .hmm 
 
DM5: F: You can tell daddy if you want him to write. 
C: I want to write. 
 









Interviewer: Could you understand the questions when you 
were reading them or when your dad was reading?  
C: Indicated no (observation) 
I: No? Was it confusing? 
C: No I just can’t read but I know what daddy said. 
 
3) Circle/cross to 
Select a face on 
the paper form 
 
 
3) Perceived value in using P-
MYMOP 
 Value in using P-
MYMOP 
GM15:’ Mother: yeah for sure. Yes absolutely which I guess 
for children often parent is the one who does talking so I 
guess this is an easy way to get them to be able to comment 
without having to may be face to face with the doctor. 
 
GM3: So this questionnaire, and I really like the visuals 
(referring to faces scale) because that is something they really 
can use and often in learning you use visuals in every element 




learning difficulties that you rely on visual stimulus a lot and 
that’s really handy. 
It’s a great scale and a great questionnaire for GP but for 
specialists ... a specialist or a paediatricians for longer term 
care they might not necessarily understand that there may be 
even an issue and therefore a questionnaire for parent might 
be a better thing. As I said when we were at (hospital) with 
his broken arm I loved the fact they talked to him about his 
body (referring to his son) and as a parent often I find that 
very refreshing. 
And they hate, kids hate being talked about. [Name] coz she 
really have had a life time of medical appointments about her. 
She really really hates being talked about in her presence and 
I often, if I can get to see the therapist by making appointment 
to see them (Interviewer: Before?) before to meet with them 
to discuss it so that I don’t have to say it in front of her. 
 
GM3: Still a good scale to use, I do love ... I love the use of 
visuals. Any part of you know teaching kids or 





GM5: M: Also it is a very good idea, isn’t it? (asking child) 
It’s about the emotional side of how they are feeling as well 
as physical. I: So do you see value in that? 
M: oH yeah. Yeah I do a lot for sure. 
 
Interested in 
completing in future 
 
GM14: M: I reckon, it should be done. Because like 
sometimes you forget what you forget stuff that you wanted 
to ask and if the kids can it themselves it will make it a lot 
easier for all of us. 
 
Statements on child’s 
voice in consultation 
DM3: M: Well it is (P-MYMOP) beneficial. We actually see 
someone else outside of here for these problems so for the 
doctors to know the problems that are going on. ... I think 
would help. 
 
M: Do you like this? Being able to give this to Dr (name) or 
would you rather tell Dr (name)? 
C: Give it to Dr (name) 




C: so she knows what I am saying. 
C: Coz it will be difficult to explain it to her. 
M: Yeah ... 
C: …very difficult ‘ 




on the paper form and 
any particular issues 
raised about the 
medication questions 
in the interview 
  
DM1: M: (medication) with this one I believe it wasn’t much 
relevant to the insulin because they are all type 1(diabetes). In 
their case it’s all type 1.  
All attending the hospital are type 1 and they are taking 
insulin so it was a bit confusing. 
 
DM2: ‘: ok this is about the medications if he is taking 
anything. He is taking insulin obviously but is taking 
anything else? 
F: No 
I: OK then just leave this out. 
F: It’s not applicable. 
 





DM6: M: Is avoiding it … It’s quite important that she takes 
it. .... Not important  
 
5) Suggested changes to P-
MYMOP 
  As observed by the researcher from the P-MYMOP forms, 
the children from the Diabetes/Endocrine and General 
Medicine Clinic whose parents suggested changes, did not 
have any presenting complaints. 
DM1: M: yeah. If you can please give us more space to write 
down that we are here to see the educator, the doctor and seek 
guidance and speak to this and this. Aaah … couple of issues. 
 
DM2: F: I have done this thing in my own masters. I have 
done an MBA so I have done this research program and sort 
of thing.  
If you … If you make this questionnaire related, more 
specific towards diabetes. For example, are you ... are you 
happy? First of all you need to tell this kind of faces, how 
happy you are with your diabetes ... You will you will 
understand from kids point of view whether kid is happy with 




(observation: child pointed to a face) 
F: See this is a specific answer. I didn’t tell him anything. 
This is first question. Second question is OK the way you are 
taking insulin, is that insulin is helping you control your Hbgl 
levels. So what other help you need in terms of controlling it.  
 
Endo1: M: I guess. With it says ‘problem’, it’s kind of like, I 
don’t know. This doesn’t really make sense. Yeah. 
I: What would make sense? Can you suggest a different 
word? 
M: I don’t know. Any worries or concerns I guess. May be. I 
don’t know.  
 
GM6: M: (reading the activity question to point out the place 
of confusion for her) Look at the faces below and circle the 
face that shows how hard it has been to you. I think there is 
something wrong with the instructions there coz I got 
confused.  
How hard it has been to you. … I think has been for you, for 





6) Connecting activity with 
identified problems 
The theme is about 
the completion of the 
activity question on 
the P-MYMOP, and 
any issues raised in 
the interview about 
the particular 
question. 
 DM 1: M: No, he separated the problems from what he really 
wants to do. So we believe that this question is separated, 
totally separated from the second question. When he 
expressed his feelings here about the problems he didn’t 
believe that this problem would stop him from (I: doing 
anything) doing anything.  
 
DM6: M: OK choose something you really want to do but 
find it hard because of your problems. I think it’s about these 
problems right. So what did you want to do that is hard? 
C: Writes down something 
M: Hmm that is tricky 
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5.11.1 Appendix 5.1 First online survey 




 Trainee/medical resident  
 Other 
 Please specify      
We would like to adapt the wording of the current Measure Yourself Medical Outcome 
Profile (MYMOP), which is an adult questionnaire, for use in paediatric patients.  
The first four questions of the adult MYMOP ask for a score on a seven-point scale and the 
rest ask for qualitative information (i.e. there is no scale). 
The adult MYMOP questionnaire starts by asking patients to name two symptoms (symptom 
1 & symptom 2). The exact wording of the first two questions on the adult version of 
MYMOP is as below: 
Choose one or two symptoms (physical or mental) which bother you the most. Write them on 




your chosen number. 
SYMPTOM 1: ................              0          1          2          3          4          5          6 
 As good as it As bad as it 
 could be could be 
 
SYMPTOM 2: ................           0          1          2          3          4          5          6 
 As good as it As bad as it 
 could be could be 
 
We have drafted some changes to the above statements to make them easier for children 
(aged 7-11 years) to understand and respond to.  
Drafted wording for item 1 on the paediatric MYMOP:  
Choose one or two problems which bug you the most. Write them on the line (or ask 
someone to write them for you). Now look at the faces below and circle the face that shows 






1) We have replaced the word ‘symptoms’ (in the adult MYMOP) with ‘problems’. Which 
of them do you prefer? 
Symptoms 
Problems 
Other (please specify) 
2) We have changed the time interval from ‘over the last week’ (in the adult MYMOP) to 
‘today or right now.’ Which of the recall intervals do you think is appropriate for 7-11 
year old children?  
 Right now  
 Today 
 Today or right now    
 Over the last week 
 Other (please specify)      
3) We have replaced the word ‘bother’ (in the adult MYMOP) with ‘bug.’  Which of them 
do you prefer? 
Bother   
Bug  
Other (please specify) 
4) Please suggest any other changes to this item that might aid in the understanding of a 





The next item on the adult MYMOP is about an activity that the patient/responder identifies 
as important. The exact wording of the question on the adult version of MYMOP is as below: 
Now choose one activity (physical, social or mental) that is important to you, and that your 
problem makes difficult or prevents you doing. Score how bad it has been in the last week.  
ACTIVITY: ................              0          1          2          3          4          5          6 
 
 As good as it As bad as it 
 could be could be 
  
Draft wording for activity item on the paediatric MYMOP:  
Choose one activity that you really want to do but find it hard because of your problem. Write 
this on the line (or ask someone to write it for you). Now look at the faces below and circle 
the face that shows how hard it is to do right now or today 
 
5) We have deleted the parenthesis containing (physical, social or mental). Do you agree 
with this change? 




6) Please suggest any other changes to this item that might aid in the understanding of a 
child aged 7-11 years so they can respond in a meaningful way. 
After the responder identifies two symptoms and one activity in the adult MYMOP, they are 
asked about their overall feeling of well-being. The question on well-being is worded as 
follows: 
Lastly how would you rate your general feeling of well-being during the last week? 
        0          1          2          3          4          5          6 
 As good as it As bad as it 
 could be could be 
  
Draft wording for the well-being item on paediatric MYMOP:  
Look at the faces below and circle the face that shows how you are feeling today. 
 
Do you agree with this change? 
 Yes   
 No   





No other questions on the adult MYMOP are scored.  
After the well-being question, the respondent is asked about the length of time they have been 
experiencing symptom 1. The exact wording of the question (on the adult MYMOP) is as 
below: 
How long have you had symptom 1, either all the time or on and off?  Please circle:  
0-4 weeks 4-12 weeks 3 month-1 year 1-5 years over 5 years 
Do you think that the above question (with ‘problem’ rather than ‘symptom’) would be useful 
for the paediatric MYMOP? 
 Yes      
 No     
Other (please specify)       
7) Would you suggest any more changes to the above question? 
The last section on the adult MYMOP is about medication usage for the problem (symptoms) 
identified. The exact wording of this section (on the adult MYMOP) is worded as below: 
Are you taking any medication FOR THIS PROBLEM? Please circle:  YES/NO 
IF YES: 





2. Is cutting down this medication: please circle: 
Not important  a bit important  very important not applicable 
IF NO: 
Is avoiding medication for this problem:  
Not important  a bit important  very important not applicable 
8) As it might be difficult for children (aged 7-11 years) to respond about medication use, it 
has been suggested that the medication questions are answered either by a primary 
caregiver or by relevant health practitioners. Do you agree? 
 Yes      
 No     
Other (please specify)       
The adult MYMOP has a seven-point interval scale to score the named symptoms. We would 
like to retain the seven-point format; however, as seen in the previous questions, we plan to 
introduce faces along the seven points to improve children’s understanding of the scale. The 






9) Do you think these faces would help to elicit a meaningful response in children aged 7-
11?  
 Yes   No    Other (please specify) 
10) Do you think the use of faces is more appropriate than numbers for paediatric patients? 
 Yes   No    Other (please specify):       
 
11) Are there any other changes you believe should be made to the adult version of MYMOP 
to make the tool more suitable for a paediatric population?      
 Yes   No    Other (please specify): 
12) This first administration of MYMOP for adults usually takes place within a medical 
consultation or in a waiting room. The follow-up questionnaire can be administered by 
post if needed. Do you think an adapted version of the MYMOP would be a useful tool 
for paediatric use in a similar context? 
 Yes   No    Other (please specify): 






Thank you for taking the time to complete this survey, it is greatly appreciated, 
If you wish to be informed about the progress of this study, please share your contact 
information  
Name      
Email Address    






5.11.2 Appendix 5.2 Paediatric MYMOP Draft as prepared after the First online survey 
 
Full name         
Date of birth          
Address and postcode 
            
             
Today’s date        
Practitioner seen        
 
Choose one or two problems which bother you the most. Write them on the line (or ask 
someone to write them for you). Now look at the faces below and circle the face that shows 
how bad that problem has been over the last few days.   
 






PROBLEM2:        
 
Choose something that you really want to do but find it hard because of your problem. Write 
this on the line (or ask someone to write it for you). Now look at the faces below and circle 
the face that shows how hard has been to do over the last few days 
 
Thing that I really want to do:       
 
 
Look at the faces below and circle the face that shows how you have been feeling over the 






How long have you had Problem 1, either all the time or on and off? Please circle:  
0 - 4 weeks  4 - 12 weeks  3 months - 1 year 1 - 5 years over 5 years  
 
Following questions may be completed by a primary caregiver or medical practitioner.  
Is your child taking any medicine(s) FOR THIS PROBLEM ? Please circle: YES/NO  
 
IF YES:  
1. Please write in name of medication, and how much a day/week     
            
             
2. Is cutting down this medication: Please circle:  
Not important  a bit important  very important  not applicable  
 
IF NO:  
Is avoiding medication for this problem:  





5.11.3  Appendix 5.3 Focus group preparation and potential questions 
 
1. Take copies for all focus group participants of i) consent form, ii) information sheet, iii) 
Paediatric MYMOP, and iv) recorder. 
2. Start by introducing yourself to new members, present info from the information sheet 
(highlight potential risks and benefits, and that the discussion will be recorded).  
3. Get signatures on consent forms 
4. Play the recorder 
Potential questions: 
 It was mentioned by one team member that some questionnaires are used regularly in 
Hospital Palliative care unit. Can I please get the names of the questionnaires used in 
WCH currently?  
o How is your experience with them? 
o What do you like/dislike about them? 
 In which patients do you think the MYMOP could be used?  
 How do you envisage the MYMOP being used in these patients?  
 How might the use of MYMOP change clinical practice and improve patient 
outcomes in different patient groups? 
 
 *If the child is unable or unwilling to complete the questionnaire, who do you think 
would be best to complete the questionnaire? Parents? Nurse?   
 What do you think about the language/words used in the current version? (Comment 




 What do you think about the current wording of the question on medication use? (For 
medication question, it was suggested that the word ‘medication’ is changed to 
‘medicine’) 
 What are your thoughts about the formatting i.e: text size on paper questionnaire and 
the space provided to write down the name of problem? 
 Discussion about the current 7-11 year cohort at the Hospital was made. There are 
kids with diabetes (mostly don’t have symptom, their complaints can be around 
restricted diet and taking medicine), cystic fibrosis, epilepsy, ADHD (not so 





5.11.4 Appendix 5.4 Second online survey  
1) Are you a member of 
 International Society for Quality of Life Research (ISOQOL) 
 Paediatric & Child Health Division, Royal Australian College of Physicians 
 Both 
Other  
 Please specify      
 






 Trainee/medical resident  
 Other 





3) If you are a physician, which age of children do you usually treat? 
 0-2 years 
 2-5 years 
 5-7 years 
 7-11 years 
 Not applicable 
 Other 
 Please specify      
 
We would like to adapt the wording of the current Measure Yourself Medical Outcome 
Profile (MYMOP), which is an adult questionnaire, for use in paediatric patients.  
The first four questions of the adult MYMOP ask for a score on a seven-point scale and the 
rest ask for qualitative information (i.e. there is no scale). 
The adult MYMOP questionnaire starts by asking patients to name two symptoms (symptom 
1 & symptom 2). The exact wording of the first two questions on the adult version of 





Choose one or two symptoms (physical or mental) which bother you the most. Write them on 
the lines. Now consider how bad each symptom is, over the last week, and score it by circling 
your chosen number. 
SYMPTOM 1: ................              0          1          2          3          4          5          6 
 As good as it As bad as it 
 could be could be 
 
SYMPTOM 2: ................           0          1          2          3          4          5          6 
 As good as it As bad as it 
 could be could be 
 
We have drafted some changes to the above statements to make them easier for children 
(aged 7-11 years) to understand and respond to.  
Drafted wording for item 1 on the paediatric MYMOP:  
Choose one or two problems which bother you the most. Write them on the line (or ask 
someone to write them for you). Now look at the faces below and circle the face that shows 
how bad that problem has been over the last few days. 





4) We have replaced the word ‘symptoms’ (in the adult MYMOP) with ‘health problems’. 
Which of them do you prefer? 
Symptoms 
 Health problems 
Problems 
 Other 
 Please specify      
 
5) We have changed the time interval from ‘over the last week’ (in the adult MYMOP) to 
‘over the last few days.’ Which of the recall intervals do you think is appropriate for 7-11 
year old children?  
 Over the last few days  
 Over the past few days 
Over the last week     
 Today  
 Other  






6) Please suggest any other changes to this item that might aid in the understanding of a 
child aged 7-11 years so they can respond in a meaningful way. 
 
The next item on the adult MYMOP is about an activity that the patient/responder identifies 
as important. The exact wording of the question on the adult version of MYMOP is as below: 
Now choose one activity (physical, social or mental) that is important to you, and that your 
problem makes difficult or prevents you doing. Score how bad it has been in the last week.  
ACTIVITY: ................              0          1          2          3          4          5          6 
 As good as it As bad as it 
 could be could be 
  
Draft wording for activity item on the paediatric MYMOP:  
Choose something that you like doing but find it hard because of your health problem. Write 
this on the line (or ask someone to write it for you). Now look at the faces below and circle 





The thing that I really like doing:       
 
 
7) We have replaced the word ‘activity’ (in the adult MYMOP) with ‘something.’ Which of 




(Please specify)      
 
8) Please suggest any other changes to this item that might aid in the understanding of a 
child 7-11 years so they can respond in a meaningful way. 
After the responder identifies two symptoms and one activity in the adult MYMOP, they are 
asked about their overall feeling of well-being. The exact wording of the question (in the 







Lastly how would you rate your general feeling of well-being during the last week? 
        0          1          2          3          4          5          6 
 As good as it As bad as it 
 could be could be 
  
Draft wording for the well-being item on paediatric MYMOP:  
Look at the faces below and circle the face that shows how you have been feeling over the 
last few days. 
 
9) Do you agree with this change? 
 Yes  
 No   
(Please explain)     
 
No other questions on the adult MYMOP are scored.  
After the well-being question, the respondent is asked about the length of time they have been 





How long have you had symptom 1, either all the time or on and off?  Please circle:  
0-4 weeks 4-12 weeks 3 month-1 year 1-5 years over 5 years 
 
10) Do you think that the above question (with ‘health problem’ rather than ‘symptom’) 
would be useful for the paediatric MYMOP? 
 Yes      
 No     
(Please explain)       
 
11) We would like to know your opinion on deletion of ‘either all the time or on and off,’ 
from the above wording of the adult MYMOP. Do you agree with the change? 
 Yes      
 No     
(Please explain)       
 
12) Would you suggest any more changes to the above question? 





The last section on the adult MYMOP is about medication usage for the health problem 
(symptoms) identified. The exact wording of this section (on the adult MYMOP) is as below: 
Are you taking any medication FOR THIS PROBLEM? Please circle:  YES/NO 
 
IF YES: 
Please write in name of medication, how much a day/week    
Is cutting down this medication: please circle: 
Not important  a bit important  very important not applicable 
 
IF NO: 
Is avoiding medication for this problem:  
Not important  a bit important  very important not applicable 
 
Drafted Wording for the medication question on paediatric MYMOP: 







Please write in the name of the therapy/treatment       
   
Is reducing this therapy: please circle: 
Not important  a bit important very important not applicable  
 
IF NO 
Is avoiding therapy for this problem: 
Not important  a bit important very important not applicable 
 
13) Do you agree with the above change? 
 
 Yes     
 No     





The adult MYMOP has a seven-point interval scale to score the named symptoms. We would 
like to retain the seven-point format; however, as seen in the previous questions, we plan to 
introduce faces along the seven points to improve children’s understanding of the scale. The 
proposed faces are replicated below:  
 
14) Do you think these faces would help to elicit a meaningful response in children aged 7-
11?  
Yes      
 No     
(Please explain)       
      
15) Do you think the use of faces is more appropriate than numbers for paediatric patients? 
Yes      
 No     





16) Are there any other changes you believe should be made to the adult version of MYMOP 
to make the tool more suitable for a paediatric population?      
Yes      
 No     
(Please explain)       
 
17) This first administration of MYMOP for adults usually takes place within a medical 
consultation or in a waiting room. The follow up Questionnaire can be administered by 
post if needed. Do you think an adapted version of the MYMOP would be a useful tool 
for paediatric use in a similar context? 
Yes      
 No     
(Please explain)       
 
18) Which 7-11 years disease group do you think the paediatric MYMOP would be most 
applicable (select all that apply)? 
Children with diabetes  
Asthma 
Attention deficit hyperactivity disorder (ADHD)  
Cystic fibrosis 
Autism 




19) Are there any other comments you would like to make? 
 
         
Thank you! 
Thank you for taking the time to complete this survey, it is greatly appreciated, 
If you wish to be informed about the progress of this study, please share your contact 
information below.  
Email Address 





5.11.5 Appendix 5.5 Demographic information used in the fourth iteration  
 
Child’s age        
Parent/Guardian’s highest level of education (please tick one) 
 High school diploma or equivalent 
 Some college degree  
 Trade/technical/vocational training 
 Bachelor’s degree 
 Master’s degree 
 Doctorate degree  
Your relationship with the child         
Language spoken at home          
Home postcode           
Name of physician seen today         
Primary/main diagnosis (if any)         
Presenting complaint (problem for which you saw doctor today) 





5.11.6 Appendix 5.6 P-MYMOP (as it was presented to the child-parent/child-guardian 
pairs in the fourth iteration of the adaptation study) 
Choose one or two problems which bother you the most. Write them on the line (or ask 
someone to write them for you). Now look at the faces below and circle the face that shows 
how bad that problem has been over the last few days.   
 
 PROBLEM 1:         
 
 
PROBLEM2:        
 
 
Choose something that you really want to do but find it hard because of your problem (s). 
Write this on the line (or ask someone to write it for you).  




Now look at the faces below and circle the face that shows how hard has been to do over the 
last few days 
 
 
Look at the faces below and circle the face that shows how you have been feeling over the 
last few days. 
 
 
How long have you had Problem 1, either all the time or on and off? Please circle:  
0-4 weeks 4-12 weeks 3 months-1 year 1-5 years over 5 years  
 
The following questions may be completed by a primary caregiver  
1. Do you take any tablets, medicine, or treatment? Please circle: YES/NO  
 




a. Please write in name of medication, and how much a day/week     
            
           ______ 
  
b. Is cutting down this medication: Please circle:  
Not important  a bit important  very important  not applicable  
 
IF NO:  
c. Is avoiding medication for this problem:  





5.11.7 Appendix 5.7 Interview questions 
Interview questions to child-parent/child-guardian pair after the parent had completed the 
demographic information form and the child had completed the P-MYMOP 
I am going to ask you to complete a form with the help of your parent. After you are done, I 
would like to know what you think about the questions on the form. 
 
Parent/guardian and child’s Interview Schedule: 
Note: Now I have a few questions. There is no right or wrong answer- I just want to know 
what you think because you are the expert on you, not me. Listen carefully to each question 
and if you have any problem understanding, let me know and I’ll try to ask them in a 
different way. Do you have any questions before we start? 
Interview questions for child: 
1. How easy were the questions on the form to understand? 
2. How easy were the faces on the form to understand?  
3. When you were selecting faces, the questionnaire asked to circle a face. Was it easy to 
circle a face or would you rather prefer crossing a face?  
4. Do you have any ideas about how to make the form better for children? 
We hope to use a form like this so that doctors know more about how children think about 





5. Do you think this form would help your doctor to know more about your problems? 
6. Would you like to fill in a form like this every time you see the doctor? 
 
Interview questions for parent: 
Thank you for completing this process with your child. I have a few questions for you before 
we finish this session. 
7. Do you have any additional thoughts about the form that you completed with your child? 
8. Do you have any suggestions to make it more child friendly? 
As explained previously, the purpose of this form is to assess the health-related quality of life 
of your child and to help your doctor to know more about your child from their own 
perspective. It also provides you and your child with an opportunity to highlight important 
health issues.   
9. With this is mind, would you find it helpful to complete this form each time you see a 
doctor for your child? 
 





5.11.8 Appendix 5.8 P-MYMOP (as it was presented to the child-parent/child-guardian 
pairs in the fourth iteration of the adaptation study) 
Choose one or two problems which bother you the most. Write them on the line (or ask 
someone to write them for you). Now look at the faces below and circle the face that shows 
how bad that problem has been over the last few days.   
 
 PROBLEM 1:         
 
 
PROBLEM2:        
 
 
Choose something that you really want to do but find it hard because of your problem (s). 
Write this on the line (or ask someone to write it for you).  




Now look at the faces below and circle the face that shows how hard has been to do over the 
last few days 
 
 
Look at the faces below and circle the face that shows how you have been feeling over the 
last few days. 
 
 
How long have you had Problem 1, either all the time or on and off? Please circle:  
0-4 weeks 4-12 weeks 3 months-1 year 1-5 years over 5 years  
 
The following questions may be completed by a primary caregiver  
2. Do you take any tablets, medicines, or treatments including any over-the-counter, herbal, 





IF YES:  
a. Please write in name of medication, and how much a day/week     
            
           ______ 
  
b. Is cutting down this medication: Please circle:  
Not important  a bit important  very important  not applicable  
 
IF NO:  
c. Is avoiding medication for this problem:  






CHAPTER 6. LINKING CHAPTER BEFORE FEASIBILITY 
STUDY  
Integration of patient-reported outcome measures (PROMs) into routine clinical practice has 
the potential to enhance patient-centred care, which may lead to better health outcomes [1,2]. 
Clinical indicators such as lab reports and radiographic imaging might not have much 
relevance to the day-to-day functioning of patients with chronic diseases. Often the most 
important patient-centred assessment of the effectiveness of any treatment or intervention for 
patients with chronic conditions is change in health-related quality of life, symptom severity, 
or physical and mental functioning. Data from PROMs can be used along with other clinical 
indicators (e.g. lab reports, imaging studies, and clinical history) for optimal patient 
management. Routine collection of patient-reported outcomes (PROs) can help monitor 
treatment effect on health-related quality of life (HRQOL)/quality of life (QOL)/health status 
[3,4], and detect previously unrecognized problems [5,6]. In particular, alongside clinical 
indicators, the detection of increased or reduced QOL or HRQOL with a validated PROM 
can provide clinicians with a holistic picture which will allow clinical decision making to be 
more patient-centred [3-6]. 
Validation of a PROM is a prerequisite to their use in research and clinical settings [7-11]. 
However, sound psychometric properties such as validity and reliability of a PROM are not 
sufficient to ensure its successful integration into busy clinical routine practice [12,13]. There 
are a number of practical and methodological challenges identified in the literature that must 
be managed as best as possible to enable the successful implementation of PROMs in clinical 
care [14-17].  Some of the identified barriers are: cost and limited resources, lack of agreed 
upon methods among healthcare management for integration of PROMs into routine clinical 




priority given to PROMs in busy clinic environments, a lack of requisite technology (to 
enable electronically completed PROMs), and knowledge of how to interpret PROM data 
clinicians [14-17]. Similarly, knowledge of facilitators in the literature is essential for 
successful implementation. Some of the facilitators as identified in the literature are: firm but 
sensitive leadership that encourages the use of PROMs while managing any fear-related 
beliefs of healthcare providers being judged about quality of care provided based on patients’ 
PROM results, continuous involvement of and feedback to clinicians and clinic staff on the 
use of a selected PROM, ongoing organisational and technical support, education of 
clinicians around evidence of the use of PROMs in clinical practice, and selection of a 
suitable PROM as per the needs of a clinical practice [14, 17-20]. The barriers and facilitators 
identified in the literature are context-specific and therefore it is likely that previously 
unidentified barriers and facilitators are discovered when a PROM is applied in a new setting 
[21,22]. While the process of identifying these barriers and facilitators is often iterative and 
takes time and patience, this ultimately leads to better integration of the PROM in practice 
and an enhancement of the patient experience as well as to the literature in this field.  
The previous Chapter described how an adult generic individualized tool was adapted and 
content-validated for use in a paediatric population. The next Chapter reports on a pilot 
feasibility study of the integration of the newly content-validated paediatric tool (Paediatric 
Measure Yourself Medical Outcome Profile—P-MYMOP) into the same setting whereon it 
was content-validated. The methods of the Feasibility Pilot Study were informed by the 
results of Chapter 4 (Systematic Review). For instance, given that PROM interventions had 
more positive results in RCTs in which PROM scores were presented to clinicians, this pilot 
feasibility study planned to ensure this took place. Similarly, given that the systematic review 




associated with more positive results, it was planned that the participants (nurses and doctors) 
of the feasibility study would be advised to discuss the completed PROM with their patient, 
but no special training on the integration of PROM scores into clinical consultation would be 
provided.  
In the context of this pilot feasibility study, it was also important to be mindful that the P-
MYMOP was only content-validated and that further validation of the tool requiring 
recruitment of a large sample of child-parent pairs is necessary. Once the feasibility of the 
tool in a clinical context is studied and there is evidence that it can be adopted in this setting, 
this will strengthen the ethical argument (thus facilitating obtaining ethical approval) for the 
necessary recruitment of a larger sample of child-parent pairs to assess the construct 
validation and responsiveness of the P-MYMOP. This later stage was considered beyond the 
scope of the research required for this PhD  but provides motivation for the pilot feasibility 
study that was undertaken. The feasibility pilot study was conducted to: a) understand the 
barriers and facilitators to the routine use of the P-MYMOP in a tertiary-care outpatients 
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Introduction: The measurement of patient-reported outcomes (PROs) is a means of 
including opinions and values of patients, who are the key stakeholders of the healthcare 
system, in the process of clinical decision making regarding their care. This study was 
designed to identify the barriers and facilitators to the routine use of the Paediatric Measure 
Yourself Medical Outcome Profile (P-MYMOP) in a tertiary hospital outpatient clinic, and to 
inform further validation processes.  
Methods: The study required participating clinic nurses to introduce the P-MYMOP to 
eligible child-parent pairs attending their clinic and recommend that they take the completed 
tool to their clinic consultation. Participating doctors at the clinic were asked to discuss the 
completed P-MYMOP form with child-parent pair if the patient wished. Nineteen nurses and 
11 doctors consented to participate in the study. Six participants, (three nurses and three 
doctors) were subsequently interviewed about their experience of the process. The resulting 
data was analysed qualitatively using deductive content analysis. 
Results: The study ran for 19 afternoons in the Department of General Medicine Outpatient 
Clinic. Over the study period, 129 children of 7-11 years old were booked to attend the clinic 
and 77 of these presented on the day. Forty-two forms were distributed and approximately 
70% patients (n = 29) who received the P-MYMOP completed it. Participating nurses were 
able to distribute the forms to relevant children and stated that they would be willing to do so 
in future. Clinic doctors found the P-MYMOP simple and straightforward, also stating that 
they would be willing to use it in future. The barriers identified to the implementation of the 
P-MYMOP were: misunderstanding of patients and clinic nurses about necessary processes 




completed forms at reception, parent proxy completion of the P-MYMOP, impact of the busy 
clinic workload on nurses’ ability of distribute the P-MYMOP, and that children 7-11 years 
old constituted only a small fraction of the total clinic population with some potentially 
eligible children overlooked by nursing staff. Some facilitators identified were: identification 
of a clinic leader to the successful implementation of the P-MYMOP, marking of the 
potentially eligible patients on the appointment lists by clinic nurses, and printed copies 
available for distribution. During the study a decision was made to recruit all outpatient clinic 
doctors on duty in the study on a particular day.  
.  
Conclusions: This feasibility study collected evidence on the barriers and facilitators of 
implementing the P-MYMOP in a clinical practice. Both participating nurses and doctors 
were able to implement the tool within their routine clinical consultations with relative ease. 
Ensuring opportunities for meaningful engagement with doctors and clinic staff prior to study 
start is a potential facilitator identified in this study and this information will be invaluable in 





7.2  Abbreviations/Acronyms  
Clinicians:  This term includes both nurses and doctors 
Doctors:  Specifically used only for physicians 
HRQOL:  Health-related quality of life 
MYMOP:  Measure Yourself Medical Outcome Profile 
PRO:   Patient-reported outcomes 
PROM:  Patient-reported outcome measures   







The measurement of patient-reported outcomes (PROs) provides an opportunity of including 
opinions and values of patients in process of clinical decision making regarding their care. 
PROs allow patients to share their views and priorities about what is important for them in 
accordance with their lifestyle and social system. Doctors as the ‘experts’ of treatment 
options may have more knowledge about the biological state of a patient’s body and how it 
might physically respond to a treatment, but it is the patient who is the expert in what 
healthcare choices they can practically implement in their life in accordance with their 
priorities [1,2]. As patients are living and experiencing their disease and wellness within the 
socio-cultural system they are part of, it is therefore invaluable to include them in the 
preparation of a healthcare plan that incorporates their lived experiences.    
The Paediatric Measure Yourself Medical Outcome Profile (P-MYMOP) is a generic 
individualised tool that has been adapted and content-validated for use in children 7-11 years 
old. The adult MYMOP questionnaire [3] has been adapted and content-validated for use in a 
paediatric population [see Chapter 5] in consultation with paediatric health practitioners, 
paediatric researchers, and volunteer child-parent/child-guardian pairs at the Department of 
General Medicine Outpatient clinic Women’s and Children’s Hospital (WCH), Adelaide. The 
current version of the P-MYMOP is considered to have appropriate content for children 7-11 
years old.  [The details of the adaptation process are reported in Chapter 5 of this thesis.]  
According to current recommendations for construct validation of PROs [4-7], the P-
MYMOP needs to be applied to a sample of 50-100 children along with the application of an 
external tool for comparison purposes (another questionnaire or clinical consultation record). 




ethically and methodologically appropriate to check the feasibility and acceptability of 
incorporating the P-MYMOP into clinical care, with staff including clinic clerks, nurses, and 
practicing doctors at a paediatric outpatients department of a tertiary-care hospital. 
While the use of PROMs in routine clinical care has been shown to benefit patients in some 
contexts [8], the focus to date has been primarily on adults, overlooking individuals 
ordinarily less able to communicate their health priorities, such as children, with rare 
exceptions [9,10]. Besides having sound psychometric properties, PRO tools intended for use 
in paediatric populations need to be easy to understand and supportive of self-completion 
[11-14]. Given the context in which they are likely to be implemented, paediatric PRO tools 
also need to be short and succinct for their swift inclusion into routine clinical care, not least 
as their inclusion may mean more work for nurses, unit clerks, and paediatricians [15,16]. 
Furthermore, successful implementation of PROMs in clinical care can only occur when 
clinicians involved in PROM distribution, interpretation, and implementation perceive 
PROM use as an important and useful adjunct to their clinical practice [17-19]. This may 
require some training of clinic staff prior to using PROMs to collect patients’ health-related 
quality of life (HRQOL), but current evidence on the value of this is weak. Thus, clinicians’ 
views on their experience of implementing a PROM in their clinical practice may provide 
evidence on the value of PROMs in clinical practice and inform improvements to the 
implementation of PROMs in clinical practice.  
The process of integrating PROMs into clinical practice is complex as it includes several 
interacting components such as: distribution of a PROM by clinic staff to patients with some 
introduction, completion of the PROM by the child with or without help from their parent, 
presentation of PROM results to doctors, discussion of PROM results between patient and 




patients’ health records [20]. In addition, [as noted in Chapter 6], there are common issues 
reported with the literature, including cost and limited resources, lack of consensus among 
healthcare management regarding methods for integration of PROMs into routine practice, 
difficulties in the selection of a suitable PROM for a particular clinical setting, continuous 
involvement of and feedback to clinicians and clinic staff on the use of a selected PROM, and 
ongoing organisational and technical support [15,17-19,21-25]. Barriers and facilitators for 
these interacting components will vary across clinical settings. Therefore, a thorough 
understanding of the factors associated with the implementation of the P-MYMOP is needed 
to inform the integration of the P-MYMOP with clinical practice.  
This feasibility study was designed to: a) understand the barriers and facilitators to the routine 
use of the P-MYMOP by testing the implementation process of introducing the P-MYMOP to 
child-parent pairs in an outpatient clinic waiting room, documenting any perceived changes 
in the workload of unit clerks nurses and paediatricians and length of time needed for 
consultation; and b) help in the planning of the further validation work on the P-MYMOP. 
This study will also explore the impact of the P-MYMOP on clinical consultations in terms of 
healthcare decisions made, and report additional observations that will support or hinder the 
integration of the P-MYMOP in clinical settings such as an outpatient clinic.  
7.4 Methods 
The process for this study was as follows: a 7-11 year old child (with parent/s) arrived at the 
Outpatient clinic for their appointment; the clinic nurse introduced the P-MYMOP (Appendix 
7.5) to child-parent pairs, asking them to complete the tool and take it to their doctor if they 




children who were considered able to name their own concerns. However, child-parent pairs 
were not the participants for this study and their completed P-MYMOP Forms were not 
reviewed by the researcher (SI). Completed P-MYMOPs were intended to be taken to the 
child’s clinical consultation, and after the consultation to be added to their patient health 
record. The intended flow of the activities is shown in Figure 7.1.  




Nurses and doctors (who had not  
already consented) introduced to study  
and consent obtained 
Eligible patients identified on the booked 
patients’ list for the day 
P-MYMOP distributed to patients 
Patient-completed forms discussed during clinical consultation 




7.4.1 Participants  
Potential participants of this study were unit clerks, clinic nurses, and doctors working in the 
Department of General Medicine Outpatient clinic at the WCH, Adelaide.  
The primary plan was to recruit both clinic nurses and clerks for distribution of the P-
MYMOP to patients, however, it was not possible to meet clerks in the nursing staff meeting 
because they did not attend the meeting. As a result, only clinic nurses were recruited for 
handing the P-MYMOP to eligible patients. Other target participants of this study were 
doctors working in the Department of General Medicine Outpatient clinic. The study was 
introduced to this group of potential participants during their weekly staff meeting by the 
Researcher (SI). 
7.4.2 Procedure  
This pilot feasibility study was approved by the WCH Network Human Research Ethics 
Committee (HREC/17/WCH/186). Consenting participants were informed that they were free 
to withdraw at any time.  
7.4.2.1 Recruitment of nurses and doctors  
Nurses were introduced to the study during regular biweekly meetings. The researcher (SI) 
provided a brief introduction to the study and an Information Sheet (Appendix 7.1) to nurses 
and answered any questions. Signatures on the Consent Form (Appendix 7.2) were sought 
from the nurses who agreed to participate in the study on the day of their shift at the 
Department of General Medicine Outpatient clinic. All nurses approached in the Outpatient’s 
Clinic agreed to participate so selection bias was not a concern. Doctors working in the 




meeting, provided with an Information Sheet (Appendix 7.1) to read, and the researcher (SI) 
answered any questions they had. Signatures on the Consent Form (Appendix 7.2) were 
sought from interested doctors at that time.  
Although ethical approval for the study was obtained to recruit all doctors from the 
Department of General Medicine, the Departmental Head (and author 4) noted that registrars 
and residents (trainees at the Department) were unlikely to be interested in being recruited to 
the study due to workload. Therefore, six consultant paediatricians and one senior registrar 
(six years training) were recruited. However, as the clinic is generally staffed by two 
consultant paediatricians and four paediatric trainees, some patients who received and 
completed the P-MYMOP were scheduled to see a doctor who had not consented to 
participate in the Study. This would mean that the opportunity to observe the role of P-
MYMOP in the clinical consultation was missed and patient issues mentioned on the P-
MYMOP may have remained unaddressed. To avoid this where possible, it was decided that 
all doctors staffing an Outpatient clinic on a particular day would be asked for their consent 
to participate in the study on that day, and if this was not provided, their patients would not 
be handed the P-MYMOP Form. However, when approached, no doctors declined to 
participate. 
The Department of General Medicine Outpatient clinic runs for 3.5 hours per day, three days 
per week. On average, each week 140 patients are booked for consultation with 
approximately 20% of these patients between the ages of 7-11 years, the age group of focus 





Participating nurses and doctors were informed that they could be interviewed about their 
experience at a later date. At the time of consent, all participants were given the opportunity 
to provide contact details, only used to schedule this interview.   
Participating nurses completed an Impression Form for Nurses (Appendix 7.3) after their 
clinic shift and were interviewed later about their experience. Consenting doctors were asked 
to discuss the P-MYMOP with patient if their patient wished and then to complete an 
Impression Form for Doctors (Appendix 7.4) after consultation with patients who had filled 
in the P-MYMOP (Appendix 7.5).  
7.4.2.2  Analysis  
Data for the study came from the nurses’ and doctors’ completed Impression Forms and 
subsequent interviews. Interviews were audio recorded and summarised directly following 
the interview session. Interview recordings were not transcribed verbatim, but direct quotes 
were extracted where necessary. Data were analysed using a qualitative content analysis that 
involved a directed deductive approach [26,27]. Recruitment continued until saturation of 
data were achieved [28], with saturation defined as the ‘emergence of no new information 
from participants’ completed Impression Forms and interviews. This occurred after 
interviewing three nurses and three doctors working in the Department of General Medicine 
Outpatient clinic.  
7.5 Results   
The study ran for 19 afternoons in the Department of General Medicine Outpatient’s Clinic, 
with 129 children of 7-11 years old were booked to attend during this time. On average, 40% 




total of 77 patients of this target age group attending. Of the 77 children 7-11 years old, who 
attended their appointments about 45% received a P-MYMOP form from a clinic nurse (n = 
42). Approximately 70% patients (n = 29) who received the P-MYMOP completed it, with 
the remaining either declining to complete the P-MYMOP or returning the P-MYMOP to the 
reception desk rather than to their doctor. The flow of patients during the study period is 
presented in Figure 7.2. 
Nineteen nurses and 11 doctors working in the Department of General Medicine Outpatient 
clinic consented to participate in the study.  Six of the participating nurses completed the 
Impression Form (Appendix 7.3), and three of them were subsequently interviewed. Of the 
11 consenting doctors, four provided a completed Impression Form (Appendix 7.4) and three 
of them were interviewed about their experience. 








129 patients booked 
77 attended their appointment 
13 P-MYMOP Forms 
either declined or 
completed and placed 
on the reception (thus 
unable to be referred 
to in clinic 
consultation) 
42 P-MYMOP Forms were distributed 
29 P-MYMOP completed and taken  




7.5.1 Opinions of Nurses about the study and the P-MYMOP  
From the Impression Forms completed by the six participating nurses and subsequent 
interviews of three of those nurses, there was agreement that the training and information 
provided to the nurses about the distribution and use of the P-MYMOP was sufficient and the 
nurses felt comfortable introducing the P-MYMOP to child-parent pairs. Two direct quotes 
from the Impression Forms in this regard were ‘Yes I felt comfortable and confident while 
introducing the questionnaire to patients after reading the information pamphlet,’ and ‘I had 
not engaged with many patients previously, but all were happy with the explanation of the 
study.’ One nurse who confirmed that she was comfortable while introducing the P-MYMOP 
to patients wrote on the Impression Form that ‘[the P-MYMOP] feels broad to me, I would 
like to see the questions more focused, e.g. ‘do you like coming to the appointment,’ ‘what 
you do or don’t like about it.’ This comment demonstrated that further clarification about the 
aim of the P-MYMOP implementation in the Clinic would have been helpful for this nurse. 
The remaining five nurses did not provide comments indicating a lack of understanding of the 
study.  
Two reasons for not distributing the P-MYMOP to eligible patients as mentioned on the 
Impression Form were: being busy (n = 2) and patients not attending their appointments (n = 
4). When explored further during the interviews, nurses indicated that if the printed P-
MYMOP Forms were added to the start of the patient file where weight and height 
measurement forms are kept, it would be a useful cue to distribute the P-MYMOP and would 
have been a useful reminder ahead of children’s presentation to the clinic. Another nurse 
mentioned that if the P-MYMOP is introduced as an ongoing process it will require ongoing 
involvement of staff, further noting in interview that ‘I would have liked to distribute more 




at the reception, it would help as a reminder.’ A barrier identified by one participant on the 
Impression Form was ‘language barrier.’ As some patients coming to the Outpatient clinic 
needed an interpreter, they could not complete the P-MYMOP on their own. However, this 
nurse was not available for an interview and further exploration of this issue was not possible.  
When asked about how the distribution and introduction of the P-MYMOP affected time 
management along with the other tasks of the day, five nurses noted on the Impression Form 
that they did not find the task noticeably affecting their time management. Interview quotes 
in this regard were: ‘just took a few extra minutes with each patient to explain questionnaire,’ 
‘not really, generally steady flow of patients today.’ In contrast, however, one nurse noted 
that the distribution of the P-MYMOP was time consuming and said ‘it made the interaction 
with parents longer as the questionnaire requires an explanation.’ 
When asked about the distribution rate and on average what proportion of booked eligible 
patients it was feasible to hand the P-MYMOP to on a given day, five nurses noted on the 
Impression Form that they could achieve an 80% or above distribution rate, though one noted 
that the distribution rate was only 20%, due to the Clinic being very busy (15 patients of 7-11 
years were booked that day). Being busy with other clinic tasks was provided as one of the 
reasons for missing patients by the nurse who estimated distributing 80% of the Forms, ‘I got 
a little busy at one stage and that is when I missed a patient.’  
When asked about their impression of child-parent pairs’ acceptance of the P-MYMOP, all 
felt that there were no negative comments about having to complete the P-MYMOP from 
parents. One nurse did mention on the Impression Form that ‘parents question motives of the 
questionnaire. I think a short letter explaining what the questionnaire is for and how the 




any feedback from the children or parents about the P-MYMOP,’ ‘there were no negative 
comments but no real feedback either.’  
Overall, the participating nurses helped identify some barriers to the implementation of the P-
MYMOP (i.e. busy clinic schedule and need of reminders for nurses). It was perceived that 
the tool distribution had a negligible impact on their time management, and one nurse showed 
interest in seeing the results of the study. However, one of the five nurses was not clear about 
the purpose of the P-MYMOP, indicating that training about the role of the P-MYMOP in 
clinical consultations and ongoing involvement in the implementation process may be an 
important facilitator.  
7.5.2 Opinions of doctors about the study and the P-MYMOP 
Four doctors completed the Impression Forms after clinical consultation with patients who 
had completed the P-MYMOP; three were subsequently interviewed. In interviews with 
doctors 2 and 3, no additional major themes were raised and therefore the recruitment 
stopped. Of the four, two had seen one patient each with a completed P-MYMOP, one had 
consulted two patients with a completed P-MYMOP, and one had consulted about four or 
five patients (they were unable to confirm the exact number) with a completed P-MYMOP.  
All four doctors mentioned on the Impression Form (three subsequently confirming in 
interview) that the information provided in the Study Information Sheet (Appendix 7.1) was 
enough for them to understand the purpose of the P-MYMOP and its application in a clinical 
consultation, and they believed the use of the P-MYMOP should not require them to have any 
additional training. When asked in the interview if they would like to receive training on the 




no, not really. I think it was quite a self-explanatory thing. You don’t want to make it 
too much of a burden and it is quite easy too for them to fill out so I don’t think we 
need any further training. Having that quite simple, it would allow conversation to 
flow. I just didn’t have much opportunity to do that much.  
Another doctor wrote in the Impression Form, ‘questionnaire is self-explanatory and easy to 
understand. The faces make it more interesting.’ When this comment was explored further 
during an interview, they said ‘no. I don’t think any additional training is needed. After 
reading the Information Sheet I was clear on the purpose of the questionnaire and didn’t need 
more information.’ When asked if the participating doctors had previously used any PRO 
questionnaire, all three interviewed doctors stated that they had never used any PROM in 
their practice, one saying ‘no, I have not used anything similar. I like the idea.’ One doctor 
mentioned that they had seen PROMs used during their practice in the Palliative Care Unit at 
the WCH, although the only trainee doctor interviewed as part of the study noted that they 
had never heard about PROMs and was never trained on their use. One doctor who consulted 
with approximately five patients with a completed P-MYMOP noted on the Impression Form 
(see Appendix 7.4) that ‘no negative comments from parents or children about the P-
MYMOP were raised,’ and ‘the questionnaire was helpful and the children felt involved in 
their consult.’ The same doctor also noted that inclusion of the P-MYMOP affected their time 
management as ‘yes, took time for patients to complete. I had to wait for them.’ When 
explored further in the interview, however, they stated that ‘it didn’t impact the overall time 
management. I was able to finish the Clinic at the usual time.’ The other two doctors did not 
find that the P-MYMOP negatively impacted their time management.  
Three out of four doctors completing the Impression Form mentioned their concern that there 




(in red, at the top of the form) that it was to be completed by the child. The same concern was 
mentioned during interviews by two (out of three) doctors, one stating that ‘the questionnaire 
opened the conversation with the child. The child seemed interested in discussing the 
mentioned issue, but I am not sure if the form was completed by the child or the parent.’ 
Another mentioned  
The one experience I had with it was a boy who I think was seven who has 
intellectual disability and developmental delay. And I got the impression when he 
came in that his parents, his mother and grandmother, had filled that out and they 
gave it to me quite proudly and it had written on it that biggest problem was bullying 
at school. When I tried to explore that with the patient, he didn’t have much idea.  
The third doctor similarly state that ‘the child was involved in the discussion of the issues 
mentioned on the questionnaire’, but was unsure if the form was completed by the child or 
the parent.  Interestingly, the doctor who did not share this concern either on the Impression 
Form or during the Interview was one who had seen about 4 or 5 patients with the completed 
P-MYMOP; the others had consulted with only one (n = 2 doctors) or two patients (n = 1 
doctor) with the completed P-MYMOP.   
When asked about the willingness to include the P-MYMOP in their future clinical 
consultations, the doctors wrote on the Impression Forms that ‘it could be of value if [the] 
child completes it,’ that the ‘overall impression of the questionnaire is very good. I am happy 
to use it,’ and that it ‘could be helpful in some situations.’ These views were echoed in the 
Interviews as the doctors said ‘I think for the right patient it would work,’ and ‘Yes, 




with bullying for example, I am not sure a doctor can help much with that, but if that is their 
preoccupation, it is important to know that.’ 
The reason why the doctors who had provided the completed Impression Form and were then 
interviewed had consulted with only a few patients with completed P-MYMOP was explored 
in the interview with one doctor, who stated that ‘In my patient group I did not have that 
many patients between 7-11. In general paediatrics, I see a lot of babies so they are preschool 
age group and the ones I see over seven often they have severe autism or intellectual 
disabilities, so it is difficult to get them to fill that out.’  
Overall, participating doctors believed that: they did not need extra training to understand the 
purpose of the P-MYMOP in clinical consultation; time management for the overall shift was 
not an issue; they did not receive any negative comments about the tool; and, appeared to be 
positive about its use in the future if requested/needed. There were, however, some concerned 
that parents, rather than the intended children, might complete the P-MYMOP in clinic.    
7.6 Discussion 
This study examined the practical aspects of the implementation of the recently content-
validated P-MYMOP in a tertiary-care hospitals outpatient clinic. Clinical staff (i.e., nurses 
and doctors) working in the Department of General Medicine Outpatient clinic at WCH 
Adelaide were the participants of this study. All participating nurses were able to include 
distribution of the P-MYMOP into their daily clinic tasks, and most found this additional task 
easy. Similarly, participating doctors were willing to include the P-MYMOP in the clinical 
consultation with, albeit with a few expressing concerns on whether the P-MYMOP was 




interesting that the doctor who consulted with the largest number of patients with completed 
P-MYMOP did not have this concern. This possibility of parent proxy completion of the P-
MYMOP, however, cannot be ignored and in future, it might be strategic for the distributor of 
the P-MYMOP to include a reminder that the child, rather than another (e.g. a parent) should 
complete the form. It may also be helpful for the consulting doctor to ask the child-parent 
pair to indicate who had completed the P-MYMOP, in order to consider this when 
interpreting the outcomes.  
The acceptance of the P-MYMOP by all participant (nurses and doctors) in this study is 
similar to what has been observed in other PROM implementation studies [29-32]. For 
example, there are some reports that the routine assessment of HRQOL is considered to be 
important among paediatricians [32] and urologists [31]; in a survey of 362 members of 
Dutch Paediatric Association, over 80% thought routine assessment of quality of life was 
especially necessary for children with chronic diseases [32]. However, only 17% of 
paediatricians included QOL assessment to their clinical practice at the time of the survey 
[32].  
The issue regarding recruitment noted at the beginning of the study was also instructive. 
Specifically, whilst it was thought that registrars and residents would be unwilling to 
participate due to already heavy workload, the impossibility of ensuring that forms were only 
handed to patients consulting with participating doctors meant a change in the recruitment 
process. The method of recruiting all doctors consulting on the targeted clinic day proved 
successful, as all attending agreed to participate. This suggests that further studies to 
determine the feasibility of implementing the P-MYMOP through longitudinal studies would 




about the P-MYMOP for all practising doctors, with an opt-out option for doctors who may 
not wish to be involved.  
As per the ethical requirement to not add any distress to children/parents, the P-MYMOP was 
distributed to the scheduled, eligible children based on the judgement of the distributing 
nurse. While this could be considered gate-keeping, the selection of eligible children was 
made on ethical and feasible grounds based on the diagnosis (that the nurses either knew or 
could read from patients’ clinical records) and hence judge their ability to participate in the 
study. Children with severe intellectual disability for example were not offered the P-
MYMOP because presumably they would not be able to complete the P-MYMOP on their 
own as ideally required and parents/children may find the invitation distressing.  
 
Only certain information could be gathered in this feasibility study as the researcher was 
intentionally not present in the Clinic when the distribution of the P-MYMOP to patients 
occurred. This was to study the real life implementation and usage of the P-MYMOP in 
clinical setting where a researcher would not be present.   
 
Another observation was that, although 42 P-MYMOP Forms were distributed to eligible 
patients with 29 completed and taken into the consultation rooms, only four doctors 
completed the Impression Forms with only three of them interviewed after consultation with 
(a combined) seven patients who had completed a P-MYMOP Form. One partial explanation 
for this low proportion (7/29) was that some patients did not take their completed P-MYMOP 
with them to the consultation room, but rather they left the forms at the reception desk. In 
future, this issue can be resolved by clear instructions to both the clinic nurse and clerk to 




This may be expedited through the use of posters within the clinic stating, for example, 
‘Please take your completed P-MYMOP Form with you in the consultation room to discuss 
with your doctor.’ There is also potential for electronic data capture and sharing in future 
applications, which would streamline the implementation of PROMs. If IT infrastructure and 
electronic platforms are intended to be implemented, this would need to involve 
considerations of cost versus effectiveness. 
There were some misunderstandings of patients and clinic nurses about necessary processes 
involved in the use of the P-MYMOP which created barriers to its use. Several patients left 
their completed P-MYMOP Form at the reception desk rather than taking it to their doctor in 
the consultation room. Unfortunately, the number of such forms was not tracked as the 
researcher (SI) did not stay in the clinic once the process was explained and the printed P-
MYMOP Forms were handed over. A possible strategy to deal with this issue, to some extent, 
would be to provide ongoing support, reminders, and training to reception staff about the use 
of the P-MYMOP and to inform all the reception staff of a clinic that the completed P-
MYMOP should be taken by the patient to their clinic consultation room. The need for 
ongoing support to clinic staff, nurses, and practicing doctors has been previously noted as a 
facilitator to implementation of PROMs in the past [17,18,25], and confirmed in this study.  
In this study, the education to the clinicians on the use of P-MYMOP was provided via the 
Information sheet and the initial introduction provided by the researcher. The results of 
education/information provided to nurses and doctors about the use of P-MYMOP was 
captured by their completed impression forms and interviews. Of all participating clinicians, 
one nurse provided answers on the impression form demonstrating that her understanding 
about the P-MYMOP was not as expected/needed. I believe that this particular nurse 




PRO measures. It is expected that PROM implementation into clinical care requires 
continuous support and adaptation of the process until assimilation into a health care facility 
is complete. 
Another potential barrier identified in this study to the implementation of the P-MYMOP was 
that parents might have completed the P-MYMOP as a proxy for their child. This concern 
was voiced by three doctors, two of whom believed that the parent had completed the form. 
This would defeat the purpose of the P-MYMOP tool, designed to encourage self-assessment 
of child’s HRQOL, as if the tool is not completed by the child it would merely represent 
parental views. Although parent-proxy-completed PROMs might be needed in some 
situations (as discussed in Chapter 1, Section 2.4), this was not the focus of the P-MYMOP. 
In future, a strategy to circumvent this issue could be for the clinic staff to provide clearer 
instructions when handing the P-MYMOP to child-parent/child-guardian pair, namely, that 
the tool is to be completed by the child. In addition, parents could be instructed to let their 
doctor know who completed the form. 
There were other barriers affecting the feasibility of distributing and/or implementing the P-
MYMOP in a busy outpatient clinic. One of these was the impact of a busy clinic on nurses’ 
ability to hand out forms. Although five out of six nurses noted that they were able to achieve 
80% distribution rates, on one particularly busy day, the attending nurse could only distribute 
the P-MYMOP to 20% of eligible patients.  A further barrier was the language spoken by 
child-parent pairs, potentially affecting both the evaluation of the feasibility of the P-
MYMOP and its implementation in outpatient clinics. As it is routine practice to offer 
patients who cannot speak English a foreign language interpreter who accompanies them 
during their clinic appointment. According to international standards, a questionnaire needs 




with other first languages [33]. While I believe the simplicity of the P-MYMOP means that 
assessing suitability should be a simple process, it is one we should remain mindful of.  
While much was learned about the feasibility of integrating the P-MYMOP with clinical 
practice, this study has some limitations. The sample of doctors who completed the 
Impression Forms and were subsequently interviewed treated only a handful of patients with 
a completed P-MYMOP. Therefore, the results of this feasibility study in terms of 
understanding doctor’s opinions are limited. However, study results also provide a 
complementary understanding of nurses’ behaviours and opinions, contributing to an overall 
understanding of how the distribution of the P-MYMOPs to patients and its integration to 
clinical consultation (including inclusion in patient records) might occur in a busy tertiary-
care outpatient clinic. Although only few doctors were interviewed, all appeared happy and 
willing to use the P-MYMOP in their clinics, considering that the P-MYMOP, if completed 
by children, was a valuable addition to clinical consults. As already mentioned, the purpose 
of the feasibility study was to analyse the process of the clinical application of the P-
MYMOP and while taking part in the feasibility study required consent from doctors and 
nurses, none declined when asked so the selection bias was considered to be minimal in the 
recruitment process. I acknowledge that there is potential for selection bias in the responses 
gathered from nurses and doctors as although all of the participating clinicians (nurses and 
doctors) completed the impression forms, not all were available for an interview. However, 
their unavailability for interview is not obviously associated with their experience of the 
implementation of P-MYMOP. 
Only certain information could be gathered in this feasibility study and unfortunately I was 




numbers may have meant that I only spoke to people more likely to be positive about the 
experience. 
As this study did not include patients as participants, another limitation of this study was the 
researcher’s (SI) inability to observe the patients while they completed the P-MYMOP. This 
limitation made it impossible to know if the children who completed the P-MYMOP did so 
independently, or if their parents completed the form for them. However, in order to 
determine how the P-MYMOP would work in practice with minimal to no interference by a 
researcher, it was decided not to observe patient-parents when working with the P-MYMOP.  
There are guidelines available to design pilot and feasibility studies [20,34,35]. However, 
their main focus is on process of pilot studies before undertaking a full randomised controlled 
trial; as a consequence, there is little on assessing the process of implementing PROMs in a 
clinical setting. Some feasibility studies on the use of PROMs have been reported in the 
literature in the context of hip arthroplasty [36], rheumatology [29], neurology [37], and 
palliative care [38]. However, whilst these studies have included patients as participants, the 
current feasibility study aimed to understand the process of the implementation of the P-
MYMOP in a busy paediatric outpatient clinic, and assess the acceptability of the tool among 
the clinic staff and doctors. Furthermore, the opinions of children 7-11 years old and their 
parents/guardians were collected earlier during the content validation of the P-MYMOP as 
reported in Chapter 5 of this thesis.  
Another study limitation was the large number of missed appointments in the outpatient 
clinic; this occurred as the study took considerably longer than initially anticipated and 
estimated in the ethics protocol. Approximately 40% of booked patients aged 7-11 years old 




the researcher (SI), clinic nurses, and doctors. At present the WCH has a Fail to Attend 
(FTA) policy in place that helps the administration staff decide about further action required 
for a child who fails to attend an appointment. The policy takes account of the fact that 
children are dependent on their parents to attend appointments, that some children might be 
more vulnerable than others, and thus not rescheduling their appointment them might place 
the child at risk. Therefore, despite failure to attend their appointments without any notice, 
children are rebooked for the next available date. In the meantime, attempts to contact parents 
are made and only after all attempts at contact are unsuccessful is a child not rebooked, and is 
taken off the system. This FTA policy might account for why a large number of patients miss 
their appointment each day in the Outpatient Clinic—knowing that re-booking will be 
possible.  
The relatively small percentage of patients within the eligible age group for this study (i.e. 7-
11 years old), and thus consulting with participating doctors over time of the study (i.e. 19 
days), was also a limitation to a timely evaluation of feasibility of the P-MYMOP in the 
Outpatient clinic. Eleven doctors initially consented, but as four did not provide contact 
details requested on their consent form, only seven were approached for an interview. Of 
these seven approached, three doctors declined as they had not consulted with any patient 
who had a completed P-MYMOP during the study period; one doctor had completed an 
Impression Form but was not available for interview.  
Ideally, for implementation of the P-MYMOP as a part of routine practice, all children 
attending an outpatient clinic should be offered the tool. At present, however, the P-MYMOP 
is content-validated only for children 7-11 years old. This suggests the need for content 
validation of a self-report version for children 11-18 years old and possibly for children 5-6 




report [39,40] a parent proxy version of the P-MYMOP for young children might also be 
content-validated. Once completed, this would see the provision of similar care for all 
patients coming to the clinic and the issue of age-based eligibility would be resolved. 
Advocacy on the use of PROMs in research and clinical practice is widespread and has led to 
many global initiatives [41-45]. As the current paradigm of patient-centredness recognises 
patients as the key stakeholders in a healthcare system, development and use of PROMs for 
research and clinical purposes has grown rapidly [46]. However, mere development of a 
PROM for clinical (or research) use does not mean this tool would be useful and feasible in 
practice, as it may encounter barriers prohibiting its inclusion in routine practice by clinical 
managers and clinicians. As with other innovations/interventions, there is a wide gap between 
what researchers advocate and what is possible or probable in real life clinical settings [47-
51]. Integration of PROMs in a clinical setting can be much more complicated than, for 
example, the introduction of a new medical intervention prescribed by a doctor. Integration of 
PROMs involves multiple steps such as: selection of a suitable PROM for a population, 
distribution of PROM to eligible patients, addition of PROM data to patient records, 
discussion of PROM results between patients and their doctor, and finally clinical decision(s) 
made based on PROM results. Integrating these multiple steps into a clinical practice requires 
a change at system level. This study was planned to consider these multiple steps. The 
qualitative work included in this study provides an understanding of the perspectives of the 
Department of General Medicine Outpatient clinic staff regarding the use of the P-MYMOP 
in the clinic. More specifically, this study meets recommendations to perform feasibility 





A vital way to improve healthcare and make it patient-centred is to ask patients what is 
important to them, perhaps by using PROMs. This, however, requires that a PROM is 
feasible and acceptable to healthcare providers involved. This study collected evidence on the 
barriers and facilitators of implementing the P-MYMOP in a clinical practice. Both the 
participating nurses and doctors were able to implement the tool into their routine clinical 
consultations. The study provides an understanding of barriers and facilitators that can inform 
improvements in future application of the P-MYMOP. Further research on the tool to 
evaluate its feasibility and acceptability in longitudinal study design is needed before 
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7.9  Appendices 
7.9.1 Appendix 7.1 Study Information Sheet  
Title: Feasibility of using the Paediatric Measure Yourself Medical Outcome Profile (P-
MYMOP) at the Women's and Children's Hospital Paediatric Outpatient Clinic 
Primary Investigator:  
Sana Ishaque (PhD Candidate)  
(sana.ishaque@adelaide.edu.au; 083130603) 
Supervisors:  
Dr Amy Salter (amy.salter@adelaide.edu.au; 083134619)  
Prof Jon Karnon (jonathan.karnon@adelaide.edu.au; 083133562)  
Associate Professor Rachel Roberts (rachel.roberts@adelaide.edu.au; 083135228)  
Dr David Thomas (david.thomas@health.sa.gov.au; 081616484) 
What is the project about? 
Quality of life is important for everyone, it is a broad concept that covers self-perception 
of mental, physical, and social wellbeing. Health-related quality of life (HRQOL) is 
concerned with components of quality of life that are directly related to health.  
In order to provide better healthcare to children, it is important to ask them about their 
perceptions of their own health and related issues. The formal assessment of HRQOL 
using a validated instrument may assist the patient clinician relationship and better 




Paediatric Measure Yourself Medical Outcome Profile (P-MYMOP) is a brief 1-page 
individualized tool designed to quickly and validly assess HRQOL of children during a 
clinical encounter. 
This project involves completion of P-MYMOP by 7-11 year old children visiting Women’s 
and Children’s Hospital’s general medicine clinic for a consultation; this would be followed 
by interviews with paediatric outpatient clinic clerks, nurses, and paediatricians about their 
experience of the process.  
Why am I being invited to participate? 
You are invited to participate in the project because you work as a unit clerk, nurse, or 
paediatrician, registrar, or a paediatric resident at the general medicine outpatient clinic at the 
Women’s and Children’s Hospital, Adelaide.  
What will I be asked to do?  
If you are a nurse or a unit clerk, you will be asked to hand the P-MYMOP form to parents of 
7-11 year old children booked for the consultation on that day. You will be trained on 
introducing the form to families. After you have completed at least a couple of shifts at the 
general medicine outpatient clinic, you will be interviewed about the experience. The short 
interview will be performed at the Women’s and Children’s Hospital at a time convenient to 
you. 
If you are a paediatrician, registrar, or a paediatric resident and you agree to participate in the 
study; you will be asked to incorporate the P-MYMOP form into the consultation of 7-11 
year old children, provided that they have completed the form. After at least three such 
consultations you will be interviewed by the researcher, Sana Ishaque, at a time of your 




interview will take a maximum 10-15 minutes of your time, there will not be any monetary 
compensation for participation in the project. 
 What are the benefits of the project? 
There may be no direct benefits to participants. By participating in this study, you will help 
ensure that the health-related quality of life tool is administered in a practical and feasible 
manner which may assist the patient clinician relationship and better inform ongoing 
treatment decisions.  
Can I withdraw from the project? 
Participation in this study is completely voluntary, you are not obligated to take part. During 
the interview you can choose not to answer a question or to end the interview at any time. 
Following the interview, you can choose to withdraw your information from the study at any 
point before data analysis begins (approximately one week after the interview). If you wish to 
withdraw you can do so by contacting the Researcher (Sana Ishaque, phone: 08 8313 0603, 
email: sana.ishaque@adelaide.edu.au).  
What will happen to my information? 
With your permission, interviews will be audio recorded. This allows the interviewer to focus 
on the flow of discussion, rather than on taking notes. The interviewer or a paid transcriber 
who has signed a confidentiality agreement will transcribe the recordings. Any identifying 
information will be removed from the transcriptions.  
Transcriptions will be kept confidential and stored securely by the researchers. They will not 




The results of this study will be presented in a PhD thesis, and may be published in academic 
journals and presented at conferences. You will not be identified in any report or 
publications. If interview extracts are quoted, they will be anonymous with any identifying 
data omitted. 
Who will know that I participated? 
Any report published as a result of this study will not identify you by name.  All information 
will be stored in a password protected computer in a locked office at the University of 
Adelaide. The information will be kept for a minimum of fifteen years after the study is 
completed and will be destroyed after 15 years. 
Who do I contact if I have questions about the project? 
If you have any questions or would like additional information, contact Sana Ishaque (PhD 
student) by phone on 08 83130603 or by email at sana.ishaque@adelaide.edu.au 
What if I have a complaint or any concerns? 
The study was approved by Women’s and Children’s Health Network Human Research 
Ethics Committee (Approval number: HREC/17/WCHN/186). If you have any concerns 
or complaints about the study you may wish to contact the Women’s and Children’s 
Health Network Human Research Ethics Committee’s Research Information Officer Mr 
Luke Fraser by phone 08 8161 6521 or by email at luke.fraser2@health.sa.gov.au. 
If I want to participate, what do I do? 






7.9.2 Appendix 7.2 Consent Form 
1. I have read the attached Information Sheet and agree to take part in the following 
research project: 
 
2. I have had the project, so far as it affects me, fully explained to my satisfaction by the 
research worker. My consent is given freely. 
3. Although I understand the purpose of the research project it has also been explained that 
involvement may not be of any benefit to me personally. 
4. I have been informed that, while information gained during the study may be published, I 
will not be identified and my personal results will not be divulged. 
5. I understand that I am free to withdraw from the project up to a week after participating. 
6. I agree to the interview being audio recorded.  Yes  No  
I am aware that I should keep a copy of this Consent Form, when completed, and the attached 
Information Sheet.  
  
Title: 
Feasibility of Using the Paediatric Measure Yourself Medical Outcome 








Participant to complete: 
Name:   
Signature:    
Date:    
Email (optional)    
Researcher/Witness to complete: 
I have described the nature of the research to 
  , 
and in my opinion she/he understood the explanation. 





7.9.3 Appendix 7.3 Impression Form for clinic nurses     
Date: 
This handout covers the questions Sana Ishaque will be asking you at the end of the trial of 
the P-MYMOP. Feel free to use this to capture your impressions of the measure. You are 
welcome to share this with Sana in the interview if you wish, but this is not required. 
1. Did you feel that the introduction/training on the P-MYMOP that was provided on the 
Handout was appropriate and adequate? 
 Yes 
 No 
 Other; please explain 
 









3. On average, what proportion of booked children in the 7-11 age group was it feasible to 
distribute the P-MYMOP to? 
4.  What were the reasons for not distributing the P-MYMOP to children in the 7-11 age 
group? 
 
5. Did introducing P-MYMOP and handing the form to parents affect your time 
management while attending patients? If yes, please explain 
  Yes   














6. What was your overall impression of the P-MYMOP? 
 
7. How do you think the P-MYMOP was received by children and parents? Did you get any 
feedback from them about the MYMOP? 
                                                                                                                                                                                     
 











7.9.4 Appendix 7.4 Impression Form for doctors     
Date: 
1. Did you feel that the introduction/training on the P-MYMOP that was provided (during 
the DGM meeting) was appropriate and adequate? 
  Yes 
  No 
  Other, Please explain 
 
2. What aspects of P-MYMOP were raised during the clinic consultation? 
3. Do you think the P-MYMOP improved the consultation? 
  Yes 









If yes, how did it improve the consultation?  
If no, why not?  
 
4. How do you think the P-MYMOP was received by children and parents? Did you get any 
feedback from them about the MYMOP? 
 
5.  Did the introduction of P-MYMOP affect your time management during or after 











6. What was your overall impression of the P-MYMOP? 
 







7.9.5 Appendix 7.5 Final Content-validated P-MYMOP 
 
Instructions for parent/guardians: the questionnaire below is designed for your child to 
select their own problems, with your help only when necessary.   
Choose one or two problems which bother you the most. Write them on the line (or ask 
someone to write them for you). Now look at the faces below and circle the face that shows 
how bad that problem has been over the last few days.   












Choose something that you really want to do but find it hard because of your problem (s). 
Write this on the line (or ask someone to write it for you).  
Thing that I really want to do:       
Now look at the faces below and circle the face that shows how hard has been to do over the 
last few days 
 
 
Look at the faces below and circle the face that shows how you have been feeling over the 
last few days. 
 
 
How long have you had Problem 1, either all the time or on and off? Please circle:  






The following questions may be completed by a primary caregiver  
3. Do you take any tablets, medicine, or treatment? Please circle: YES/NO  
IF YES:  
a. Please write in name of medication, and how much a day/week     
            
           ______ 
  
b. Is cutting down this medication: Please circle:  
Not important  a bit important  very important  not applicable  
IF NO:  
c. Is avoiding medication for this problem:  






8. CHAPTER 8 THESIS DISCUSSION  
This chapter summarizes the major findings of the thesis and provides recommendations for 
future research and practice. There were three objectives of this thesis. The first was to assess 
the evidence on the effectiveness of the use of PROMs as an intervention intended to support 
the representation of patient values and preferences in clinical encounters by examining 
published randomised controlled trials (RCTs) using patient-reported outcome measures 
(PROMs) as an intervention; the second objective was to adapt and assess the content validity 
of an adult generic individualised health-related quality of life (HRQOL) tool for use in a 
paediatric population; and the third objective was to test the feasibility of the adapted 
HRQOL tool (Paediatric Measure Yourself Medical Outcome Profile: P-MYMOP) in a 
tertiary-care hospital paediatric outpatients department.   
Results of the systematic review (Objective 1) and the content-validated P-MYMOP 
(Objective 2) were utilized to plan the feasibility study (Objective 3). The feasibility study 
collected evidence on practical issues of implementation and helped to establish the usability 
of the P-MYMOP in a tertiary-care outpatient clinic. The overall aim of this research was to 
review how the routine use of PROMs can help represent patient values and preference in 
their clinical care and to develop a self-report individualised paediatric PROM suitable for 
routine implementation in a time-constrained busy clinical practice.  
The combined results of this thesis provide guidelines for the implementation of the P-
MYMOP in a tertiary-care hospital outpatient clinic and can inform future studies to further 
test the psychometric properties of the P-MYMOP, as well as to implement an RCT on the 





8.1. Summary of the thesis research   
An initial impression of the lack of attention paid to the value of PROM use in paediatric 
research and clinical care, as discussed in Chapter 2, remained unchanged after the 
completion of the systematic review (Chapter 4). Of the 22 included studies, only two 
reported on the inclusion of a PROM in RCTs performed in paediatric populations [1,2]. In 
addition to the lack of attention to PROM research in children, there was a lack of 
consideration given to the value of individualised PROMs overall. A total of 23 PROMs were 
used as an intervention in the 22 RCTs included in the systematic review and none of these 
was a generic individualised tool. The two paediatric RCTs included used the PediQuest 
Memorial Symptom Assessment Scale (PQ-MSAS), the Pediatric Quality of Life Inventory 
4.0 Generic Core Scales (PedsQL4.0), the Pediatric Quality of Life Inventory (PedsQOL) 
Diabetic-specific, and an overall sickness question [1,2]. Again, none of these were 
individualised and generic. Nonetheless, the importance of a validated, individualised and 
generic HRQOL tool for children cannot be ignored. Globally, there is emphasis on the use of 
person-centred measures that can evaluate patient concerns regardless of their underlying 
diagnosis [3]. A key example of this international interest in PROMS is the Patient-Reported 
Outcomes Measurement Information System (PROMIS) initiated in the USA’ this 
organisation supports and promotes the valid measurement of life domains by instruments 
that are applicable to a wide variety of populations [3].  
As the experience of mental, physical, and social health issues are not influenced solely by 
the presence or absence of a particular health condition, a validated paediatric generic 
individualised tool such as the P-MYMOP can validly assess children’s perceptions of their 




current P-MYMOP has been content-validated with children 7-11 years old, the 
individualised selection of domains by the responding child in the P-MYMOP lends itself 
well to use in a broader age group of potential responders. The proposal that the P-MYMOP 
might be applicable to a wider age group of children should consider, however, that older 
children might not find the smiley faces appropriate, whilst younger children might need 
proxy completion of the P-MYMOP as their cognitive and language development might not 
allow for self-report. Therefore, the proposal needs to be examined in future research on the 
tool.  
The lack of validated paediatric PROMs for several populations with specific health issues 
has resulted in the use of adult tools in RCTs on paediatric populations [4-9]. The use of these 
tools in this context has been criticised [10] and a call for further research into the 
development of validated paediatric PROMS has been made in a number of disease-specific 
populations [10]. The adaptation of the MYMOP to a validated paediatric generic 
individualised tool is one important response to that call. The P-MYMOP is the first content-
validated generic individualised HRQOL tool for children. Prior to the adaptation of the P-
MYMOP a partly individualised disease-specific paediatric questionnaire (Pediatric Asthma 
Quality of Life Questionnaire—PAQLQ) was validated for use in children [11]. As the name 
indicates the PAQLQ is not generic and is therefore only applicable to children who have 
asthma. In comparison, the P-MYMOP has much wider potential for application. The 
children who participated in the adaptation process on the P-MYMOP were recruited from 
the Department of General Medicine Outpatient Clinic at Women’s and Children’s Hospital 





As indicated in the systematic review (Chapter 4), routine collection of PROs in clinical 
settings along with the presentation of their results to treating doctors has demonstrated 
benefits to patient outcomes in some contexts. The ultimate goal for the adaptation of the P-
MYMOP is to integrate it successfully into paediatric clinical practice. The fulfilment of this 
aim, however, requires further validation of the P-MYMOP and evaluation of the 
effectiveness of the new tool, which was beyond the scope of this thesis. In preparation for 
these further research projects, studies conducted as part of this thesis investigated the 
acceptability and potential value of the tool from the patient and health professionals’ 
perspectives.  
The adaptation and content validation of the P-MYMOP involved interviews of 24 children 
7-11 years old and their parents/guardians. Children as young as seven years old were able to 
complete the tool. Most participating parent/guardians perceived the P-MYMOP to be a 
useful adjunct to the healthcare of their child and were interested to use the tool during future 
clinic visits.  
Feasibility studies are considered necessary in the planning of RCTs and large-scale 
observational studies [12-16]. The feasibility study performed as part of this thesis examined 
the process of the P-MYMOP implementation in the Department of General Medicine 
Outpatient clinic at the Women’s and Children’s Hospital. The study collected the views of 
nurses and doctors working in the Clinic to identify barriers and facilitators to the 
implementation of the P-MYMOP from the health professionals’ perspective. The feasibility 
study results were promising in that the nurses and doctors were able to introduce the P-
MYMOP into their usual practice without much of a perceived burden to their allotted time 




8.2. Key Findings of the Thesis  
This section discusses the key finding of the Thesis. The section has five subheadings, each 
heading summarises one main finding of the thesis and where possible connects the learning 
points from the three studies conducted.  
8.2.1. Utility of PROMs in routine clinical care 
As reported in Chapter 4, the systematic review performed as part of this thesis included 22 
RCTs. There were two different kinds of RCTs addressing PROM interventions: a) RCTs 
comparing the presentation of PROM summary scores to clinicians vs. no presentation of 
summary scores (labelled ‘PROM ± summary’ studies) and b) those that compared patient 
completion of a PROM with standard care in the control group (i.e. no use of a PROM) 
(labelled ‘± PROM’ studies). The outcomes reported in the 22 included RCTs were divided 
into three categories: process of care outcomes, health outcomes, and satisfaction with 
healthcare. Reported effects were considered ‘robust’ if they were statistically significant and 
pertained to a single reported comparison or there was evidence that the study was adequately 
powered for more than one comparison. Other positive effects were considered as ‘non-
robust.’  
As reported in Chapter 4, analysis of tabulated results led to the following findings: more 
positive results were reported for health outcomes (n = 11 studies, three considered ‘robust’), 
compared to those for the process of care or satisfaction with care; PROM interventions 
worked better when PROM results were provided to clinicians; and, the inclusion of PROM 
training to clinicians prior to a trial commencement appeared to result in no obvious 
differences in positive results. This analysis of results was combined with the learning from 




final study of this thesis.  As reported in the Chapter 6 linking piece before the feasibility 
study, the results of systematic review (Chapter 4) informed the methods of the feasibility 
study performed as part of this thesis. For example, given that PROM interventions had more 
positive results in RCTs in which PROM scores were presented to clinicians, this pilot 
feasibility study planned to ensure this took place. Similarly, given that the systematic review 
revealed that clinician training did not appear to be significantly associated with more 
positive results, it was planned that the participants (nurses and doctors) of the feasibility 
study would be advised to discuss the completed PROM with their patient, but, other than 
basic introduction to study as required under the ethics protocol as outlined in the Participant 
Information Sheet used to commence the feasibility study reported in Chapter 7 (Appendix 
7.1), no special training on the integration of PROM scores into clinical consultation would 
be provided. 
8.2.2. Methodological issues identified in the systematic review (Chapter 4) and 
recommendations for future RCTs  
There were a number of methodological concerns identified in the RCTs included in the 
systematic review (Chapter 4). These concerns limit the ability of many included RCTs to 
provide definitive conclusions about the effectiveness of PROM interventions. These 
methodological issues are discussed in detail in Chapter 4, but issues that are specific to the 
evaluation of PROMs are briefly discussed below.  
As a rationale for the use of a selected PROM, all RCTs included in the systematic review 
(Chapter 4) cited previous psychometric evaluation of their chosen PROM. However, none of 
these RCTs that used PROMs as their primary or secondary outcome reported on whether the 
context and demographic characteristics of the population in which the psychometric 




psychometric properties of a PROM are not inherent properties and that a PROM is only 
valid and reliable for a population in which the primary validation study was performed, it 
was not possible to ascertain if the PROMs identified in the included RCTs were valid for the 
context in which they were being used. Developing a new PROM before each RCT is 
extremely challenging and would result in multiple PRO tools, thus rendering comparison of 
RCTs impossible. Nonetheless, at the minimum researchers performing a RCT should match 
the baseline characteristics of the population in which the PROM was validated with the 
baseline characteristics of their target population. The provision of citations to previous 
validation work as well as reporting a rationale for the selection of a particular PROM in 
RCTs is recommended by the CONSORT PRO extension developed in 2013 [17]. However, 
the recommendation of provision of ‘a rationale’ by RCTs is broad and consequently open to 
interpretation and does not clearly identify the need to match demographic characteristics and 
context of the PROM psychometric study with the intended RCT population; this requires 
further clarification in the guideline document [17]. As included RCTs in Chapter 4 were 
published between 1989 to 2016 and the CONSORT PRO Extension was published in 2013, 
the trials previous to this date cannot be criticised for not reporting their rationale for the 
selection of the PRO tool used. In addition, the uncertainty that this issue created regarding 
the conclusions of RCTs included in Chapter 4 could be addressed with a retrospective 
analysis of the populations from which psychometric properties of PROMs were evaluated, 
their suitability for the RCT population and for use within clinical studies where outcomes 
are aggregated over individuals. An examination of their suitability in all contexts would be 
informative.  
A PROM that is selected for evaluation of its effectiveness in a population must be 




When choosing a PROM to assess pre-defined primary or secondary outcomes in future 
RCTs, a clear rationale behind the selection process should be stated. If the rationale cannot 
be reported in the publication of the RCT due to space limitations it should be noted in the 
RCT protocol required to register the RCT prior to commencement.  
8.2.3. Perspectives of child-parent/guardian pairs about the P-MYMOP  
The P-MYMOP is the first self-report, content-validated, generic, individualised tool for 
children 7-11 years old. As reported in Chapter 5, the adaptation and content validation study 
utilised multi-iterative mixed methods. The multiple iterations in the study ensured that all 
relevant stakeholders contributed their knowledge of the field to the process. 
Typically, PROMs are initially developed for research purposes and then introduced into 
clinical use. Implementation of such PROMs to a clinical setting may be limited due to their 
pragmatic characteristics [18]. Pragmatic characteristics of PROMs—such as appropriateness 
for relevant clinical setting, self-administration, response options, and scoring—are 
considered important factors affecting their acceptance and feasibility of implementation in a 
clinical setting [18]. Lengthy, complicated PROMs are often not readily adopted in clinical 
settings due to the training, knowledge, time and resources required for their implication in 
already busy clinics. In this study, the wording, layout and length of the P-MYMOP was kept 
simple and succinct for ease of successful implementation in paediatric clinical settings.  
The final phase of the content validation of the P-MYMOP included children 7-11 years old 
from the Department of General Medicine and Diabetes/Endocrine Outpatient clinics at the 
Women’s and Children’s Hospital, Adelaide. Twenty-four children participated in the study 
along with their accompanying parents/guardians. The purpose of the study was to test the 




scale of the P-MYMOP. In addition, the opinions of children and their parents/guardians 
were sought about the usefulness and acceptability of the P-MYMOP in their clinical care in 
the outpatient clinics. Details of the adaptation process are reported in Chapter 5. The P-
MYMOP was developed to encourage self-reporting, and it was confirmed in the adaptation 
study that most participating children were able to complete the P-MYMOP on their own, 
with only a few exceptions where parents completed the form for the child or helped with the 
process. Children as young as 7 years old were able to understand the tool and to report their 
main problems. All participating children and their parents/guardians considered the use of a 
faces scale on the tool as a positive addition. The participating parents/guardians perceived 
the P-MYMOP as a valuable addition to the healthcare of their child and that it would 
provide an opportunity for children to speak about concerns they felt were important to them. 
As asserted in section 5.10, the P-MYMOP is the first paediatric generic individualised tool 
content-validated for children 7-11 years old. In summary, the wording, layout, and scale of 
the P-MYMOP has been successfully adapted for children 7-11 years old, and children and 
their parents/guardians have found the tool acceptable. 
8.2.4. Perspectives of nurses and doctors about the implementation of the P-MYMOP to 
clinical care  
The feasibility study was performed to examine the implementation of the P-MYMOP in the 
Department of General Medicine outpatient clinic at the Women’s and Children’s Hospital. 
Nurses and doctors working in the outpatient clinic were study participants. As reported in 
Chapter 7 in the feasibility study results, the overall impression of the participating nurses 
about the P-MYMOP was positive, as they perceived that the tool distribution had a 
negligible impact on their time management. Nonetheless, the need to train nurses about the 




doctors did not think that they needed training to understand the purpose of the P-MYMOP in 
clinical consultation, stating that time management for the overall shift did not appear to be 
compromised, and, as they did not receive any negative comments about the tool from 
families, they were happy to use it in the future if requested/needed.   
8.2.5 Involving clinical staff in the integration of PROMs into routine clinical practice  
Involving clinical staff in the integration of PROMs in a clinical setting is essential. Any 
clinic operates with a number of staff, such as unit clerks/receptionists, nurses, doctors, 
dietitians, physiotherapists, and others. Generally, clinic reception staff as well as clinicians 
in general are not trained on the use and utility of PROMs. Therefore, the introduction of a 
new PRO tool might cause confusion and raise questions about its utility for clinical 
purposes.  
In addition, because clinic staff are required to facilitate distribution to eligible patients, the 
format of a PROM (e.g. in hardcopy, as is currently the case for the P-MYMOP, or as an 
electronic version) will affect its use in routine clinical care. At the time of distribution 
patients or their parents/guardians may have queries about the purpose of completing this tool 
and its role in their clinical care. Therefore, successful integration of a PROM may require 
distributing staff to have some understanding of its purpose and role in clinical consultation. 
As the results of the systematic review (Chapter 4) demonstrated that PROMs are more likely 
to have a positive impact on patient outcomes if their results are presented to clinicians, 
during integration of the P-MYMOP it is recommended that the results of completed forms 
are presented to doctors (or caring clinicians) for discussion during clinical consultation, and 
that staff are aware of likely benefits for patients. Furthermore, doctors presented with PROM 




Whilst the systematic review of RCTs (Chapter 4) demonstrated that clinician-training 
regarding the interpretation of PROM results was not significantly associated with the 
effectiveness of the PROM interventions, the present feasibility study results (Chapter 7) 
suggested otherwise. Although participating doctors did not feel it was necessary for 
additional training, they did need to understand what the purpose of the P-MYMOP, how 
they could interpret the results, and how it might be integrated into routine clinical care of 
their patients. This brief training was provided by the researcher (SI) at the time of their 
recruitment to the feasibility study. It is possible that additional training was not needed by 
participating doctors because some had been involved in the adaptation and content 
validation phase of the P-MYMOP (Chapter 5).  
Engaging healthcare providers into the integration process of PROMs is also likely to create a 
collective responsibility among stakeholders involved [19-22]. With increased advocacy on 
the use of PROMs in clinical care [19-22], educational programs on what PRO and PROMs 
are, what constructs they might incorporate, as well as the value of PROs for patients with 
chronic health conditions may prove useful for clinicians. Given the rapid emergence of and 
uptake of PROMs, such educational programs could be targeted at undergraduate nursing and 
medical education programs, as well as constituting part of continuing professional 
development education for practising doctors. 
8.3. Future research implications  
8.3.1. Further validation of the P-MYMOP for children 7-11 years old 
At the time of writing, the P-MYMOP is only content-validated for children 7-11 years old. 
The measurement properties for a particular application/use of a PRO tool depend upon the 




the P-MYMOP, it is critical to undertake further validation processes. This should include 
assessment of construct validity, responsiveness, and internal consistency for children 7-11 
years old. The evaluation of construct validity and internal consistency requires single use of 
a PROM by patients [24,25], but evaluation of responsiveness requires a longitudinal study 
involving application of a tool on more than one occasion with the same patients [24]. During 
the present study, it was noted that the time interval between clinic appointments of visiting 
patients can be anywhere between two and twelve months. Responsiveness evaluation 
requires a much shorter time interval between two consecutive administrations of a tool 
[24,26], in part because a longer time interval between two applications of the tool might see 
changes in multiple aspects of the patient, such that a different score on the tool might not 
represent change on the domains originally measured. This is particularly salient given the 
rapid developmental changes likely to be present in children within a targeted age range. 
Therefore, the evaluation of responsiveness of the P-MYMOP might require a different 
setting, such as recruitment of children from a school. Guidelines available for the evaluation 
of measurement properties can be referred to in designing these future research studies [23-
26].  
8.3.2. Adaptation and content validation of the P-MYMOP for children below 7 years old 
and above 11 years old 
At the commencement of this thesis the decision was made to focus the development of the 
P-MMOP only on children 7-11 years old. This age group was chosen based on the cognitive 
homogeneity of age bracket [27-29]. The successful adaptation, content validation, and 
feasibility evaluation of the P-MYMOP for children 7-11 years old in an outpatient clinic has 
provided sufficient evidence to support continuing this work for children of other ages. 




to offer a PROM to children of all ages. To promote successful implementation of the P-
MYMOP in a clinical setting, the tool should therefore be validated for children below 7 and 
above 11 years of age. The P-MYMOP was adapted and content-validated to promote self-
assessment of individualised HRQOL among children, but self-report may not be possible for 
children below 5 years old and a parent proxy version of the tool might be needed [30,31]. 
Nonetheless, future versions of the P-MYMOP should continue to promote self-report of 
paediatric HRQOL whenever possible.   
8.3.3. Longitudinal testing of the implementation of the P-MYMOP  
The feasibility study performed as part of this thesis evaluated a cross-sectional use of the P-
MYMOP. It would, however, be important to evaluate how the tool performs when used in a 
longitudinal fashion, that is, to evaluate patients on their repeat visits for the issues that they 
had mentioned on their P-MYMOP forms previously. In practice, the use of the P-MYMOP 
is likely to occur longitudinally as patients visit a clinic on multiple occasions. Therefore, it 
would be important to gather the opinions of patients, reception clinic staff, nurses, and 
doctors in a longitudinal feasibility evaluation of the tool [32]. 
8.3.4. Implementation of the P-MYMOP in a clinical setting 
As the first generic, individualised, paediatric HRQOL tool, the P-MYMOP was developed 
for routine use in paediatric clinical practice. Once additional measurement properties of the 
P-MYMOP are evaluated, the tool may be implemented in paediatric clinical setting. The 
hypothesis behind the proposed implementation of the P-MYMOP is that the tool will help 
identify and monitor patient symptoms and treatment planning by providing a voice to 
children and helping them play an active participatory role in their clinical care. Due to its 




it provides a unique opportunity for responding children to inform clinicians about important 
areas of their life for which they would like help. The current version of the P-MYMOP is 
available in a paper format. It is a one-page tool that is two-sided as a large font size was 
required for readability purposes. There are specific instructions for parents/guardians at the 
top of the tool printed in red requesting that the tool is for their child to select and rate their 
own problems, with parental help only when necessary. As reported in the feasibility study 
(Chapter 7), clinic nurses responsible for the distribution of the tool were likely to feel better 
supported for integration if a printed blank copy of the tool was added to the health records of 
eligible patients. Besides this, no other additional resources or requirements are needed to 
implement the current paper version of the P-MYMOP. If implementation of the tool is done 
in a clinic where electronic health records are already in place, development of an electronic 
format of the tool and process of integration with electronic health records would be required.    
As the P-MYMOP is a self-completed tool, staff distributing it should be asked to make a 
judgement as to which children in the eligible age group would not be able to complete the 
tool on their own. This necessary element of judgement mirrors the content adaptation 
process when the researcher (SI) was only allowed to approach patients once they had agreed 
to be approached after the initial contact by clinic nurses; similarly, in the feasibility study, 
clinic nurses were able to make this judgement, informing the researcher at the end of the 
clinic day as to why they would not distribute the tool to a particular children. Based on this 
learning, clearer guidance on criteria for distribution could be added to an information 
pamphlet handed to reception staff and clinic nurses. Further general directions to the 
implementation of the P-MYMOP in a clinical setting can be obtained from published 





8.4. Thesis strengths and limitations  
The systematic review performed as part of this thesis is the first systematic review in which 
all statistically significant and non-significant results of the included RCTs were taken into 
account. This foundation lay the groundwork for the first research (to my knowledge) to 
develop a paediatric individualised generic HRQOL measure. Given the value that generic 
individualised tools offer by their applicability to populations with different health 
conditions, this new tool is likely to benefit clinical research and practicing clinicians. The 
tool is also short and succinct, and was developed to promote self-completion by children. 
The adaptation/content validation involved multiple stakeholders of the paediatric healthcare 
system and most importantly the opinions of the primary stakeholders, namely, children, 
were also sought. The involvement of paediatric researchers helped confirm that the content 
of the tool was suitable according to their experience in the field of paediatric PROMs. The 
involvement and collaboration with paediatricians helped in designing the P-MYMOP to be a 
clinically relevant and practically implementable tool. The feasibility study confirmed that it 
was feasible to implement the P-MYMOP in a clinical setting; results will also help with the 
planning of the next validation study of the P-MYMOP and the integration of the tool into 
routine clinical care.     
There are certain limitations of this thesis. The adaptation of the P-MYMOP was planned to 
include opinions of a large group of paediatricians via an online survey. However, 
participation was limited and paediatricians from only one tertiary-care hospital could be 
recruited. In addition, the feasibility study was conducted in the same department, with 
participating child-parent/child-guardian pairs also recruited from the same outpatient clinic. 




hospitals across Australia. Finally, the study only tested cross-sectional use of the P-MYMOP 
and further research on doctors’ ability and understanding of the longitudinal use of the P-
MYMOP (including information concerning their interpretation of the qualitative information 
reported in the P-MYMOP and P-MYMOP scores (P-MYMOP data)) may be required.  
8.5. Concluding remarks 
It may be argued that the use of PROMs in routine clinical care is simply an adjunct (or 
alternative) to clinical history-taking. However, there are reports in the literature that 
healthcare providers underestimate the level of patients’ functioning and under-report 
symptoms that patients find worrying [35-42]. This suggests that medical history-taking alone 
is likely to miss important patient-centred values. Though the need for systematic use of 
PROMs is increasingly recognised, actual integration of these tools in routine clinical care 
remains challenging. Despite evidence on effectiveness, the implementation of a new practice 
requires that the end users perceive it to be useful and in line with their needs and values.  
The P-MYMOP is a succinct self-report generic individualised tool that was found acceptable 
by children and parents/guardians and feasible by nurses and doctors during its 
implementation in an outpatient clinic and provided a voice for children to play an active 
participatory role during their clinical encounter. As such it is my hope that, pending 
additional validation and longitudinal feasibility work, this tool will empower children with 
the knowledge that their views and opinions (always) matter and that they can play an active 
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